The role of Sonic Hedgehog signalling in satellite cell-mediated myogenesis by Cruz Migoni, Sara Betania
The role of Sonic Hedgehog
signalling in
satellite cell-mediated myogenesis
Sara Betania Cruz Migoni
The University of Sheffield
Department of Biomedical Science
This thesis is submitted on September, 2015 in partial fulfilment of the
requirements for the degree of Doctor of Philosophy

Abstract
Adult skeletal muscle regeneration depends on the existence of tissue-specific stem cells
known as satellite cells. Satellite cells are found in a quiescent state in homeostatic
conditions but become activated, re-enter the cell cycle, proliferate and differentiate or self-
renew in response to muscle injury, exercise or disease. These events are tightly regulated
by intrinsic and extrinsic cues, including well-characterised embryonic signalling cascades.
The Sonic Hedgehog (Shh) signalling pathway has multiple roles in tissue patterning,
cell fate determination, cell survival and proliferation in the embryo. Previous studies
have shown that during embryonic myogenesis, Shh signalling controls the specification,
migration and proliferation of muscle progenitor cells, as well as muscle patterning by
the regulation of genes encoding basement membrane proteins. As the myogenic program
carried out by satellite cells recapitulates, to a certain extent, embryonic myogenesis, I
hypothesised that Shh signalling controls satellite cell activity in a manner reminiscent to
its effect on muscle progenitor cells in the embryo. In this study, through a combination
of ex vivo and in vivo approaches, I showed that, although quiescent satellite cells are
refractory to Shh signals, activated satellite cells respond to Shh signalling. Shh response
persists during the expansion phase and declines as satellite cells enter differentiation.
Through the use of pharmacological agonists and antagonists of Shh signalling, as well as
of an inducible conditional knockout mouse line of the Smoothened receptor in satellite
cells, I demonstrated that Shh signalling contributes to satellite cell proliferation ex vivo
and in vivo and to muscle regeneration following injury. Analysis of cell cycle dynamics
showed that Shh signalling promotes the entry of satellite cells into the cell cycle and
their progression through G1/S phase. Thus, the present study demonstrates that Shh
signalling is required for adult skeletal muscle regeneration and provides novel insights
into the role of Shh signalling in the control of satellite cell progression through the cell
cycle and through myogenesis.
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1.1 Adult skeletal muscle
1.1.1 Skeletal muscles have distinct levels of structural organi-
sation
Skeletal muscle is highly contractile tissue representing around 40% of the total body
mass. Skeletal muscles are not only important for support and locomotion but they
are also critical for maintaining and regulating glucose homeostasis and carbohydrate
metabolism (Richter et al., 1982).
Skeletal muscles are made up of bundles of multinucleated myofibres, which are the
fundamental unit of the muscle. Each myofibre contains bundles of myofibrils, which are
repetitions of filaments of actin (thin) and myosin (thick) that together form the sarcom-
ere, the functional unit of the muscle fibre (Hanson and Huxley, 1953). Skeletal myofibres
are surrounded by a 100 to 200nm thick layer of extracellular matrix (ECM) known as the
the basal lamina and a layer of connective tissue called the endomysium, which contains
capillaries, nerves and lymphatics (Purslow and Trotter, 1994). These tightly-packed my-
ofibres are assembled in bundles called fascicles, which are in turn surrounded by another
layer of connective tissue called the perimysium (Davies and Nowak, 2006). Bundles of
fascicles are covered by the epimysium, more connective tissue that surrounds the whole
muscle and has continuity with the tendons (Fig.1.1) (Lieber, 2002).
The contractility of skeletal muscles relies on the action of the actin and myosin fil-
aments of the sarcomere. Actin filaments are arranged in parallel and are joined by
α-actinin at each end to form the Z-line. Myosin filaments are arranged in anti-parallel
manner with the globular head bound to the actin filaments, which results in the sliding of
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Figure 1.1: Structure of skeletal muscles. Skeletal muscles are intimately attached to the bones by
tendons. The whole muscle is covered by the epimysium while bundles of myofibres are packed together
by the perimysium. Finally, individual myofibres are surrounded by the endomysium. Each myofibre
is composed of myofibrils, which contain sarcomeres. Each sarcomere is delimited by the Z-disks (or
Z-lines), which are bound to actin filaments. Myosin filaments are arranged in anti-parallel manner and
attached to the M band. Titin protein anchors the M to the Z line. The A-band corresponds to the
alignment of myosin whereas the I-band extends in the area between two adjacent sarcomeres and only
contains actin.
anism is mediated by calcium released from the sarcoplasmic reticulum, which binds to
the troponin complex associated to the actin filaments. This binding unlocks tropomyosin
from the actin binding site and allows the interaction of myosin with actin. This process
continues as long as calcium is being released and finishes when the tropomyosin adopts
its original position and covers the actin binding site (Szent-Györgyi, 2004).
1.1.2 Muscle fibre type and function
Skeletal muscle is a heterogeneous tissue made up of distinct myofibre types that deter-
mine the functional, molecular, metabolic and contractile activity of each muscle. First,
myofibres can be classified as type I or slow-twitch fibres and type II or fast-twitch fibres
(Schiaffino and Reggiani, 1994). Type I myofibres use aerobic metabolism and are resis-
tant to fatigue. They are rich in mitochondria, have good blood supply and contain high
levels of myoglobin and oxidative enzymes. These fibres are red in appearance due to the
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high density of myoglobin. In contrast, type II myofibres rely on anaerobic metabolism
and have faster contraction time but fatigue quickly. They contain little or no myoglobin
and have fewer blood vessels and mitochondria, which gives them a pink/white colour
(Eisenberg, 1983). Type II myofibres can be further categorised into type IIA and type
IIB fibres. IIA fibres are fatigue-resistant with high succinate dehydrogenase (SDH) ac-
tivity whereas IIB fibres are fatigue-resistant and have low SDH activity. An additional
category of myofibres, the type IIX, describes fast-twitch fibres with a different composi-
tion of myosin heavy chain (MYHC) proteins and with a resistance to fatigue intermediate
between IIA and IIB fibres (Schiaffino and Reggiani, 2011).
Different factors can determine the distribution of myofibre types in the whole organ-
ism. For instance, body size influences the functional demands of the musculature and it
has been shown that small-sized mammals have more IIX and IIB fibres (high oxidation)
than large-sized mammals, which have more type I and type IIA fibres (low oxidation)
(Schiaffino and Reggiani, 2011). Myofibre distribution also varies between muscles and
species. For example, type I fibres are abundant in the soleus muscle, whereas type II
fibres are predominant in the extensor digitorium longus (EDL) muscle. Extraocular
muscles (EOM) are of particular interest because they express a different type of MyHC
isoform in fast-twitch fibres (MYH13) as well as embryonic and neonatal MyHCs (MYH3
and MYH8) (Sartore et al., 1987). Moreover, unlike mice and rats, human muscles only
present type I, IIA and IIX myofibres (Ciciliot et al., 2013). Other determinants can also
modify the myofibre profile, including hormones, aging, exercise and disease.
1.1.3 Different cell types coexist within skeletal muscles
The skeletal muscle system is made up of a complex network of distinct cell types that
orchestrate the overall homeostatic activity of the tissue. First, bundles of muscle fibres are
surrounded by layers of connective tissue and ECM that provide functional organisation
and allow the attachment to tendons and bones. Underneath the most proximal layer of
ECM, the basal lamina, quiescent muscle stem cells or satellite cells are found, which are
responsible for muscle turnover and repair (Mauro, 1961). Additional cell types can be
found, including fibroadipogenic progenitors (FAPs), endothelial cells, interstitial cells,
vessel-associated cells (pericytes), fibroblasts and some immune cells (Bentzinger et al.,
2013a). All these cells show little to no mitotic activity in normal homeostatic conditions
but can enter proliferation in response to external stimuli, including injury and disease.
1. Endothelial cells
Muscles are supplied with nutrients and oxygen by a dense network of blood vessels
and associated endothelial cells (Fig.1.2). Importantly, satellite cells are likely to
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be found close to capillaries and endothelial cells (Christov et al., 2007). Following
injury, endothelial cells secrete diverse growth factors needed for the formation of
new capillaries (Ochoa et al., 2007). These factors also have mitogen and anti-
apoptotic activities and can promote the proliferation of muscle stem cells (Christov
et al., 2007).
2. Immune cells
Resting muscles contain few types of resident leukocytes such as mast cells and
macrophages. Furthermore, healthy muscles are also supplied with a subpopulation
of monocytes that patrol the tissue for rapid response in the event of injury (Auffray
et al., 2007). Following muscle injury, resident monocytes quickly differentiate into
M1 and M2 macrophages, which secrete pro-inflammatory and anti-inflammatory
chemokines and cytokines, respectively (Arnold et al., 2007). Neutrophils also se-
crete pro-inflammatory molecules and remove muscle debris. Importantly, imbal-
ance between neutrophils and M1 and M2 macrophages can impair the decrease of
oxidative activity and clearance of muscle debris, strongly affecting muscle regen-
eration (Bentzinger et al., 2013a). More about the function of these cells during
muscle regeneration is discussed in section 1.2.2.
3. Fibroadipogenic progenitors (FAPs) and fibroblasts
FAPs are non-myogenic mesenchymal stem cells that can give rise to fibroblasts,
adipocytes and cartilage cells (Joe et al., 2010). These cells are found in the inter-
stitial space of skeletal muscles in close contact with blood vessels (Fig.1.2). They
express the platelet-derived growth factor receptor alpha (PDGFRα) and the Sca-1
marker (Joe et al., 2010, Uezumi et al., 2010). During muscle regeneration, FAPs
promote fibrosis and fat deposition but can also induce proliferation of muscle stem
cells (Joe et al., 2010).
In resting muscles, fibroblasts are located in the interstitial space between myofibres.
These cells are the major source of ECM components and are essential for muscle
regeneration (Murphy et al., 2011). They have a peculiar spindle-like morphology
and are characterised by the expression of vimentin, desmin, α-actin-2 (ACTA2) and
the fibroblast-specific protein 1 (FSP1) (Kalluri and Zeisberg, 2006, Strutz et al.,
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Figure 1.2: Different cell types are found in skeletal muscles. (A) Tridimensional and (B) cross-
sectional representation of the cell identities found in the adult skeletal muscle system. Skeletal muscles
are made up of multinucleated myofibres that intimately harbour satellite cells (green), which are located
beneath the basal lamina. Blood vessels are intercalated between the fibres and are closely associated
to vessel-associated cells (purple). Other cell types can also be found in the interstitial space, including
mesenchymal progenitors (turquoise) and fibroblasts (red). Adapted from Pannérec et al. (2012).
1.2 Adult skeletal muscle repair
1.2.1 Evidence of regeneration in adult skeletal muscles
The idea of skeletal muscle regeneration dates back to the 19th century, with few studies
describing the fusion of aligned corpuscles or round cells to form muscle fibres during em-
bryogenesis (Scharner and Zammit, 2011). Further work by Wilhelm Waldeyer analysed
muscle injuries in animals, including frogs, guinea pigs and rabbits, where he described the
growth of muscle cells within the plasma membrane of degenerating myofibres (Scharner
and Zammit, 2011). Another important piece of work was done by Rudolf Volkmann
in 1893, who performed a wide range of muscle injuries on different animal species and
concluded that muscles regenerate from nuclei of old myofibres and that this process
could be continuous (new myofibres were formed from surviving fibres), discontinuous
(new myofibres were formed from the fusion of single cells, similar to embryonic myoge-
nesis) or a combination of both (Scharner and Zammit, 2011). This idea of ”amitotic”
regeneration from pre-existing myonuclei was further supported by a study describing the
generation and multiplication of adult skeletal muscles in vitro by culturing small frag-
ments of rat and human adult muscles (Pogogeff and Murray, 1946). Importantly, not
only muscle repair in injured muscles was documented, but almost complete regeneration
was observed in skeletal muscles of adult dystrophic rats supplemented with vitamin E
(Pappenheimer, 1939). Further studies reported that upon injury, only mononucleated
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cells such as myoblasts, leukocytes, fibroblasts and endothelial cells were labelled with
tritiated thymidine, which incorporates into the DNA of proliferating cells. Interestingly,
myoblasts were the most radioactive cells at early time points during regeneration and no
radioactivity was observed in mature myofibres, disproving the idea of amitosis (Walker,
1962). The presence of myoblasts was also observed by electron microscopy in regenerat-
ing muscles of mice and rabbits (Allbrook, 1962). In 1961, the presence of mononucleated
cells at the periphery of the adult skeletal myofibre was reported (Mauro, 1961). These
so-called ”satellite cells” were defined as dormant myoblasts that were morphologically
indistinguishable from undifferentiated cells found at the site of injury during muscle re-
generation (Muir et al., 1965). Interestingly, satellite cells were positively labelled for
tritiated thymidine in regenerating skeletal muscles from adult mice, demonstrating the
ability of these cells to synthesise DNA and divide mitotically (Reznik, 1969). Consis-
tently, ex vivo culture of intact myofibres demonstrated that after 24 or 48 hours (h) in
culture, mononucleated cells originating from myofibres had the ability to form colonies
and fuse into myotubes (Bischoff, 1975). These findings led to the idea that satellite cells
could be the precursors of the myoblasts found during skeletal muscle regeneration.
1.2.2 Cellular mechanisms of skeletal muscle repair
Adult skeletal muscle is a highly stable tissue that in homeostatic conditions shows little
myonuclei turnover. Nevertheless, skeletal muscles have an incredible ability to grow and
regenerate during normal development, as well as a result of intense exercise, mechanical
load, injury or genetic diseases such as muscular dystrophies (Carlson, 1973). Importantly,
adult muscles can be repaired within a period of 2 to 3 weeks after severe damage and
also in response to repeated injury (Luz et al., 2002, Rosenblatt, 1992).
In general, adult skeletal muscle repair follows different phases, including degener-
ation, inflammation, regeneration and fibrosis. During muscle degeneration, mechani-
cal/chemical trauma triggers the destruction of the integrity of the plasma membrane
and basal lamina of the muscle fibre. As a consequence, myofibres undergo necrosis and
protease mediated-degradation, increasing blood levels of muscle proteins like creatine ki-
nases and myoglobin (Sorichter et al., 1998a). The necrotic area becomes infiltrated with
immune cells and irrigated by small blood vessels. In particular, resident mast cells get
activated immediately and start secreting histamine and tryptase as well as cytokines like
tumour necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) (Bentzinger et al., 2013a).
These molecules are important since they can promote satellite cell activation and pro-
liferation (Serrano et al., 2008) as well as neutrophil recruitment (Wang and Thorlacius,
2005). Neutrophils secrete several chemokines to attract monocytes, which eventually dif-
ferentiate into macrophages (Arnold et al., 2007). Two distinct population of macrophages
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are recruited during muscle regeneration. Pro-inflammatory or M1 macrophages are the
first to appear, reaching a peak between days 2-3 and returning to basal numbers at days
7-9 post-injury (St Pierre and Tidball, 1994). These macrophages are characterised by the
expression of CD11b, CD31, CD68 and iNOS and are mainly responsible for phagocytosis
of any cell debris. They secrete the cytokines interleukin 1b (IL-1b), IL-6 and TNF-
α, which promote the proliferation of satellite cells while inhibiting their differentiation
(Saclier et al., 2013). On the other hand, anti-inflammatory or M2 macrophages appear
later that M1 macrophages, peaking at days 3-5 and returning to basal numbers by days
8-10 after injury. They share the expression of some surface markers (CD11b, CD31 and
CD68) with M1 macrophages but are also positive for CD206 and CD163 (McLennan,
1993). These M2 macrophages secrete interleukin 4 (IL-4) and insulin-like growth factor 1
(IGF-1), promoting satellite cell proliferation and differentiation (Fig.1.3) (Saclier et al.,
2013).
Efficient muscle regeneration also requires the recruitment and proliferation of fibrob-
lasts to synthesise ECM molecules including collagen, fibronectin, elastin, proteoglycans
and laminins (Murphy et al., 2011). Importantly, fibroblasts also secrete metallopro-
teinases to control ECM deposition and remodel the muscle architecture (Lindner et al.,
2012). Fibroblasts are mainly originated from mesenchymal stem cells or FAPs, which
produce interleukin 6 to promote satellite cell differentiation (Fig.1.3) (Joe et al., 2010).
Upon muscle injury, fibroblasts proliferate and reach a peak at 4-5 days post-injury and
persist throughout the repair process (Bentzinger et al., 2013a). The deposition of ECM
components by fibroblasts provide stability and support for the formation of new myofibres
and the subsequent degradation of ECM excess by metalloproteinases facilitate satellite
cell migration and differentiation (Chen and Li, 2009). Finally, endothelial cells also play
an active role during muscle regeneration through the close interaction with myogenic pre-
cursors to promote both myogenesis and blood vessel formation. Endothelial cells peak
at day 5 post-injury and secrete signalling proteins such as vascular endothelial growth
factor (VEGF), which can stimulate myoblast proliferation (Christov et al., 2007). Thus,
angiogenesis promotes the development of a new vasculature at the site of injury while
stimulating satellite cell function, which contributes to efficient muscle repair.
1.2.3 Satellite cells are responsible for muscle regeneration
Satellite cells are adult muscle-specific stem cells that are defined by their anatomical
position underneath the basal lamina (Mauro, 1961). Satellite cells have other particu-
lar morphological features, including a relative high nucleus-to-cytoplasm ratio with few
organelles and an increased amount of nuclear heterochromatin compared to myonuclei




















Figure 1.3: Cell dynamics during skeletal muscle repair. Following injury different signalling
molecules (cytokines and growth factors) are released by damaged myofibres, infiltrating macrophages
and fibroblasts to control satellite cell function, including their activation, proliferation and differentia-
tion. Fibroadipogenic progenitors (FAP) give rise to fibroblasts that secrete both ECM components and
metalloproteinases to promote remodelling of the muscle structure. Adapted from Wang and Rudnicki
(2012).
myofibre type and species. Satellite cells constitute around 30% of the muscle nuclei in
neonatal mice and decline to 4% in adult and 2% in old mice (Snow, 1977) and this is
similar for human satellite cells (Schmalbruch and Hellhammer, 1976). This reduction in
satellite cell number with age has been linked to changes in the satellite cell microenvi-
ronment or niche (Chakkalakal et al., 2012, Shefer et al., 2006). Satellite cell numbers
also varies between different muscles; for example, the fast-twitch EDL muscle in mice
contains less satellite cells (2.8%) than the slow-twitch soleus muscle (5.5%) (Zammit
et al., 2002).
In normal healthy skeletal muscles, satellite cells are in quiescent state and only be-
come activated in response to external factors released during injury or muscular disorders.
Satellite cells then proliferate to become myoblasts and then undergo differentiation into
myocytes and eventually fuse to form new fibres to repair the muscle (Charge and Rud-
nicki, 2004). As other stem cells, a fraction of satellite cells are able to self-renew and
return to quiescence to repopulate the stem cell pool (Collins et al., 2005).
Early studies in muscle regeneration suggested that satellite cells were able to divide
in response to injury (Reznik, 1969). Importantly, subsequent experiments showed that
satellite cells incorporate into growing muscle fibres from young rats to later become my-
onuclei (Moss and Leblond, 1971). Other studies supported this observation through the
use of isolated myofibres, showing the proliferation of satellite cells and their contribution
to muscle fibres (Bischoff, 1975, Konigsberg et al., 1975). Indeed, transplantation of sin-
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gle myofibres into irradiated muscles showed that donor satellite cells are able to produce
myogenic progeny and self-renew in vivo (Collins et al., 2005). The ultimate proof that
the regeneration of skeletal muscles in vivo is entirely dependent on satellite cells came
from genetic studies. Using the Pax7DTR mice, that express the diphtheria toxin frag-
ment A (DTA) receptor (DTR) under control of the Pax7 promoter, it was shown that
the depletion of Pax7-expressing satellite cells before muscle injury led to impaired muscle
repair (Sambasivan et al., 2011). Similar approaches to eliminate satellite cells in adult
skeletal muscles were applied, in which DTA expression was specifically induced in Pax7+
satellite cells prior to muscle injury, resulting in the failure of muscle regeneration. This
was achieved using conditional recombination with Pax7iCreERT2/+: R26RDTA/+ (83-91%
ablation), Pax7iCE/+: R26RDTA/+ (over 90% ablation) or Pax7CreERT2/+: R26RGFP-DTA/+
(100% ablation) mice (Lepper et al., 2011, McCarthy et al., 2011, Murphy et al., 2011).
Importantly, functional muscle regeneration in satellite cell-depleted injured muscles could
be rescued by grafting Pax7-nGFP satellite cells, indicating that satellite cells are neces-
sary and sufficient for muscle regeneration (Sambasivan et al., 2011).
1.2.3.1 Requirement for Pax3 and Pax7 in embryonic progenitors and satel-
lite cells
Pax3 and Pax7 belong to a family of transcription factors characterised by the presence
of a DNA-binding region known as the paired domain (Gruss and Walther, 1992). These
genes are thought to be originated by duplication from a common ancestral gene and
they share similarities at the protein level and in the expression pattern at some extent.
Pax3 -null mutant embryos display muscle abnormalities, including loss of both the epaxial
and hypaxial dermomyotome (Tajbakhsh and Buckingham, 2000). In contrast, Pax7 -null
mutant embryos do not present defects in muscle development but fail to maintain their
musculature postnatally (Mansouri et al., 1996). Therefore, Pax3 has a major role dur-
ing embryonic myogenesis, whereas Pax7 is important for postnatal muscle development
(Bryson-Richardson and Currie, 2008).
In the vertebrate embryo, Pax3 is expressed in the presomitic paraxial mesoderm
(Goulding et al., 1994) and becomes restricted to the dorsal part of the somite following
somite formation and is down-regulated when the myogenic regulatory factors (MRF) are
activated (Williams and Ordahl, 1994). On the contrary, Pax7 is not expressed in the
presomitic mesoderm or newly formed somites, but is progressively detected in the central
part of the dermomyotome, following Pax3 expression (Borycki et al., 1999a, Jostes et al.,
1990). In the hypaxial dermomyotome, Pax3 is required for the survival of progenitor
cells and it directly induces Myogenic factor 5 (Myf5) expression in cells that migrate to
the limb, which in turn activates myoblast determination protein (MyoD) (Bajard et al.,
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2006, Borycki et al., 1999a, Tajbakhsh et al., 1997). On the other hand, in the epaxial
dermomyotome, Pax3 can act independently of Myf5 to regulate MyoD (Tajbakhsh et al.,
1997). In fact, Pax3, Myf5 and the muscle-specific regulatory factor 4 (MRF4) can pro-
mote myogenic differentiation through MyoD activation (Kassar-Duchossoy et al., 2004,
Maroto et al., 1997, Tajbakhsh et al., 1997).
In adult skeletal muscles, Pax7 is specifically expressed by satellite cells and although a
subset of satellite cells also express Pax3, this transcription factor is unable to compensate
for the loss of Pax7 during postnatal myogenesis or adult muscle regeneration (Kuang
et al., 2006, Relaix et al., 2006). Pax7 -null mutant newborn die within two weeks after
birth, display a decrease in muscle mass and are depleted of satellite cells, indicating
the requirement for Pax7 for the specification of the satellite cell lineage (Seale et al.,
2000). Consistently, over-expression of Pax7 in CD45+:Sca1+ cells isolated from injured
Pax7 -null muscles is sufficient to activate the myogenic program (Seale et al., 2004).
Conditional inactivation of Pax7 in Pax7+ satellite cells results also in impaired muscle
regeneration after single or repeated injury, confirming the critical requirement for Pax7
during satellite cell-mediated myogenesis (von Maltzahn et al., 2013). Pax7 is expressed
at high levels in quiescent satellite cells and becomes progressively down-regulated as
satellite cells differentiate (McKinnell et al., 2008, Olguin and Olwin, 2004). siRNA-
mediated knock-down of Pax7 in satellite cells causes a reduction of Myf5 expression,
and chromatin immunoprecipitation assays have showed that Pax7 recruits a histone
methyltransferase (HMT) complex to directly activate Myf5 transcription (McKinnell
et al., 2008). Consistent with this, inactivation of Pax7 in Myf5+ satellite cells leads to
a decline in satellite cell numbers in mice older than 8 weeks and to an impairment of
muscle regeneration following injury, indicating a requirement of Pax7 for the maintenance
of satellite cells (Günther et al., 2013).
1.2.3.2 Satellite cells are formed during embryogenesis
Skeletal muscles in vertebrates originate from the segmented somitic paraxial meso-
derm, the unsegmented cranial paraxial mesoderm and the chorda mesoderm (Bryson-
Richardson and Currie, 2008). Somites are epithelial patches of mesodermal cells flanking
the neural tube and they give rise to various tissues, including skeletal muscles of the
trunk and limbs. As development proceeds, the dorsal and ventral somite compartments
differentiate into epithelial and mesenchymal structures known as dermomyotome and
sclerotome, respectively. The sclerotome will give rise to cartilage and vertebrae, while
the dermomyotome will generate skeletal muscle and dermal progenitors (Pownall et al.,
2002). The first skeletal muscle progenitor cells (MPC) to form during embryonic develop-
ment delaminate from the dorsal medial lip (DML) of the dermomyotome to incorporate
30
into a new structure, the myotome (Hollway and Currie, 2003). Cells entering the my-
otome grow bidirectionally to reach both the rostral and caudal edges of the somite.
Subsequently, myogenic progenitors delaminate from the caudal, rostral and ventro lat-
eral lip (VLL) domains and translocate to the myotome where they contribute to its
expansion (Gros et al., 2004). In this way, progenitors derived from the DML will give
rise to the epaxial myotome, while cells coming from the VLL will colonise the hypaxial
myotome (Gros et al., 2004).
The origin of satellite cells has been a subject of debate for several years. Early
quail-chick chimera strategies proposed that satellite cells were generated in the somites,
but no progenitor cell population giving rise to these cells could be identified at the
time (Armand et al., 1982). Other reports described that adult muscle progenitors in
the chick originated during mid and late foetal development based on in vitro assays
(Feldman and Stockdale, 1992). Lineage tracing experiments of GFP-electroporated der-
momyotome cells showed that some GFP+ cells that migrated into the myotome were
highly proliferative and expressed Pax7 and adopted a satellite cell position (Gros et al.,
2005). Similarly, using Pax3GFP/+:Pax7LacZ/+ reporter mice, β-gal+/GFP+ cells that do
not express myogenic markers and are actively proliferating could be detected as early
as at E.10.5 (Kassar-Duchossoy et al., 2005, Relaix et al., 2005). Around E.15.5, these
Pax3+/Pax7+ progenitors localise along differentiated myofibres and between E.16.5 and
18.5 they become surrounded by a basal lamina (Kassar-Duchossoy et al., 2005, Relaix
et al., 2005). Together, these data demonstrate that satellite cells of the trunk and the
limb muscles are specified during embryogenesis from undifferentiated Pax3+/Pax7+ pro-
genitors originating from the dermomyotome (Fig.1.4).
1.2.3.3 Satellite cells recapitulate embryonic myogenesis
Embryonic muscle progenitors and satellite cells share many similarities concerning the
expression of the myogenic regulatory factors (MRFs) and the dynamics of the myogenic
program during both embryonic and adult myogenesis.
In the developing embryo, the onset of Pax3 expression in the dorsal somites is followed
by the activation of Myf5 as early as at E.8 in the dorsal-medial somites and MyoD 2.5
days later (Cossu et al., 1996, Tajbakhsh et al., 1997). MRF4 expression starts at E.9.5
and gradually accumulates in the somites (Kassar-Duchossoy et al., 2004). Conversely,
Myogenin transcripts are expressed at E.8.5 in the myotome before MyoD expression
starts (Venuti et al., 1995). Both Myf5 -null and MyoD-null mutant are viable. Myf5 -
null mice show a delay in myotome formation until the onset of MyoD expression and
a reduction in the development of trunk musculature, but normal development of limb
muscles (Kablar et al., 1997, Tajbakhsh et al., 1997). In MyoD-null mutant mice, Myf5
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expression becomes up-regulated, probably compensating for the lack of MyoD (Rudnicki
et al., 1992). Skeletal muscles can form in Myf5::MyoD double-mutant mice when MRF4
expression is not compromised but not in the absence of MRF4, indicating that Myf5,
MyoD and MRF4 are essential for muscle progenitor formation (Kassar-Duchossoy et al.,
2004). In contrast, Myogenin is a MRF that is important for myoblast differentiation,
acting by regulating the transcription of genes involved in fibre formation and others
that encode contractile muscle proteins. In Myogenin-null mutant mice, the muscular
tissue consists of muscle progenitor cells but no differentiated myocytes are observed,
confirming the role of Myogenin in initiating muscle differentiation (Venuti et al., 1995).
As Mrf4::MyoD double mutants have a similar phenotype than Myogenin-null mice, it
suggests that MyoD acts upstream of Myogenin to drive myoblast differentiation (Rawls
et al., 1998).
In adult muscles, quiescent satellite cells express Pax7 rather than Pax3, although a
small fraction of cells express also Pax3 (Relaix et al., 2006). Upon activation, satellite
cells re-enter the cell cycle and initiate a myogenic program that recapitulates the events
taking place during embryonic myogenesis (Fig.1.4) (Cooper et al., 1999). For instance,
activated satellite up-regulate Myf5 and within the first 12 hours progressively up-regulate
MyoD expression while continuing to express Pax7 (Cooper et al., 1999, Yablonka-Reuveni
and Rivera, 1994, Zammit et al., 2004). Following the expansion phase, satellite cells
down-regulate Pax7 and Myf5 and begin expressing Myogenin and MRF4 (Cornelison,
2008, Yablonka-Reuveni and Rivera, 1994, Yablonka-Reuveni et al., 1999a). Finally, dif-
ferentiating myogenic cells fuse to each other to form new myofibres or fuse with damaged
fibres to contribute to their regeneration. This sequence of events is reminiscent to the
myogenic program that takes place in embryonic muscle progenitors (Fig.1.4).
1.2.3.4 Satellite cell heterogeneity
The satellite cell population is heterogeneous as evidenced by differences in the molecu-
lar/cellular signature of satellite cells. Studies using Myf5-nlacZ mice have shown that a
proportion of quiescent satellite cells does not express Myf5 or other satellite cell markers
such as CD34 and M-cadherin (Beauchamp et al., 2000, Zammit et al., 2002). Accordingly,
lineage tracing experiments using Myf5-Cre/Rosa26-YFP mice confirmed that around
10% of satellite cells never expressed Myf5 and contribute efficiently to the stem cell pool
upon transplantation (Kuang et al., 2007). Satellite cell heterogeneity also translates into
differences in Pax7 expression. Although all satellite cells express Pax7 mRNA, levels of
the Pax7 protein in the satellite cell population are not homogeneous. Immunofluores-
cence analysis of single myofibres have shown that the satellite cell population is made
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Figure 1.4: Parallels between embryonic and adult myogenesis. Muscle progenitor cells (Pax3+)
and satellite cells (Pax7+) are formed during embryogenesis and they follow similar dynamics to generate
fully differentiated myofibres. Both cell populations become specified and activate Myf5 and MyoD
expressions. Their entry into differentiation is characterised by the expression of Myogenin and MRF4
expression, resulting in the formation of myotubes and functional myofibres.
is more prone to myogenic commitment and differentiation (Olguin and Olwin, 2004).
Consistently, fluorescence-activated cell sorting (FACS) of satellite cells from post-natal
Pax7-nGFP transgenic mice has revealed the existence of two distinct cell populations:
Pax7-nGFPHi, which expresses high levels of Pax7 and contain more slow-dividing label-
retaining cells (LRC), and Pax7-nGFPLo, which expresses low levels of Pax7. Upon muscle
injury, Pax7-nGFPHi satellite cells are less prone to commitment than Pax7-nGFPLo and
their first cell division is slower (Rocheteau et al., 2012). Importantly, Pax7-nGFPHi are
the only satellite cell population able to give rise to Pax7-nGFPLo cells following several
transplantations, indicating a strong self-renewal potential (Rocheteau et al., 2012). Sim-
ilarly, experiments using the TetO-H2B-GFP mice, which carry a conditional transgene
consisting of a fusion of the histone H2B to GFP and controlled by tetracycline (Tumbar
et al., 2004), identified two satellite cell populations in adult mice on the basis of the
cells ability to retain H2B-GFP: LRCs and non-LRCs. LRC satellite cells divide and
differentiate less than non-LRCs and contribute to the maintenance of satellite cells that
adopt a sublaminar position (self-renewal) (Chakkalakal et al., 2012). This is consistent
with other studies showing that satellite cells fated to differentiate are fast-dividing cells,
whereas self-renewing satellite cells are considered to be slow-dividing (Ono et al., 2012).
Together, these studies support the idea that the satellite cell population is heterogeneous,
with most of the cells being committed to the myogenic lineage and a subset representing
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a stem cell population able to self-renew to sustain the regenerative potential of skeletal
muscles.
1.2.4 Non-myogenic cells also contribute to muscle repair
Although Pax7+ satellite cells are required for skeletal muscle regeneration, other non-
muscle cell types have the potential to contribute to the repair process. These cells include
bone marrow-derived cells, pericytes and mesoangioblasts. Some of them can differentiate
both in vitro and in vivo into multiple lineages depending on the extrinsic signals they
are subjected to. Importantly, they have also shown potential to differentiate into the
myogenic lineage.
1. Hematopoietic stem cells (HSCs)
HSCs are responsible for the continuous generation of blood and immune cells in the
body. HSCs can be isolated from blood or the stroma of the bone marrow, and are
characterised by their non-adherent behaviour in vitro (Domen et al., 2006). The
injection of HSCs from MLC3f-LacZ mice (muscle specific promoter) into myotoxin-
injured mouse muscles results in the incorporation of β-gal+ nuclei in regenerating
myofibres (Ferrari et al., 1998), indicating that cells of HSC origin contribute to
the regeneration program. A subpopulation of HSCs that express the cell surface
marker CD45 has myogenic potential when grafted into injured muscles (McKinney-
Freeman et al., 2002). Furthermore, HSCs expressing the CD133 marker also ex-
pressed myogenic markers, including Pax7, Myf5 and MyoD. Importantly, CD133+
cells isolated from humans contribute to myofibres when grafted into dystrophic
mice (Torrente et al., 2004). This indicates that different populations of HSCs have
a myogenic potential although their contribution to muscle regeneration in vivo is
still low.
2. Mesenchymal stem cells (MSCs)
MSCs are found in the stroma of the bone marrow. MSCs adhere rapidly when
cultured at low density, allowing separation from non-adherent hematopoietic cells
(Bianco et al., 2001). MSCs can give rise to cells that express skeletal muscles
markers and are able to fuse in vitro after treatment with basic fibroblast growth
factor (bFGF), forskolin, platelet-derived growth factor (PDGF), Neuregulin and
subsequent transfection with the Notch1 intracellular domain (NICD) gene. Impor-
tantly, following transplantation into dystrophic-nude mice, these cells incorporate
into newly formed myofibres (Dezawa et al., 2005). Furthermore, MSCs can also
be harnessed into the myogenic lineage by transfection of Pax3, which have a good
engraftment efficiency but fail to improve the dystrophic phenotype in mice mainly
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due to lack of contractility (Gang et al., 2009). This suggests that other factors
than Pax3 may be required to improve the functionality of these cells in vivo.
3. Side population (SP) cells
SP cells were initially identified in the mouse bone marrow and were characterised
by the exclusion of Hoechst 33342 dye, which gave them a particular pattern when
analysed by fluorescence-activated cell sorting (FACS) (Goodell et al., 1996). A
similar fraction of SP cells has been identified in the interstitium of skeletal muscles
but these cells are different from bone marrow SP cells (Asakura et al., 2002).
Similar to satellite cells, muscle SP cells have mainly an embryonic origin and are
derived from Pax3+ cells in the hypaxial somite (Schienda et al., 2006). Muscle
SP are multipotent, express the Sca-1 marker and do not express myogenic proteins
like Myf5 (Asakura et al., 2002). Consistently, SP cells are still present in Pax7 -null
mice, indicating that SP and satellite cells are two distinct cell populations (Seale
et al., 2000). Although when cultured in vitro, muscle SP cells (CD45+, Sca-1+) give
rise to hematopoietic colonies, they can also adopt a myogenic fate if co-cultured
with myoblasts (Asakura et al., 2002). Injection of muscle SP cells into injured
muscles results in the incorporation of SP cells in regenerating fibres (Asakura et al.,
2002). Moreover, SP cells injected intravenously into irradiated dystrophic mice
can re-established the hematopoietic system and contribute to muscle regeneration
(Gussoni et al., 1999).
4. Pericytes
Pericytes are vascular smooth muscle cells that surround the surface of blood vessels
and capillaries. They originate from the embryonic sclerotome and in adult tissues
express the alkaline phosphatase (ALP) protein and the endothelial marker CD31.
Pericytes can usually differentiate into smooth muscles, osteoblasts and adipocytes
but display also a low myogenic potential (Doherty et al., 1998). However, co-culture
of pericytes with myogenic cells or muscle-differentiation medium increases the fre-
quency of fusion into myofibres and the frequency of spontaneous differentiation into
myotubes, respectively (Dellavalle et al., 2007). Unlike satellite cells, proliferating
pericytes do not up-regulate Pax7 or the MRFs (Myf5 and MyoD), and the expres-
sion of these markers is only visible during terminal differentiation, indicating that
distinct mechanisms of myogenesis occur in pericytes and satellite cells (Dellavalle
et al., 2007). Nevertheless, the interarterial injection of isolated human pericytes
into dystrophic mice resulted in the restoration of Dystrophin expression in regen-




Mesoangioblasts are foetal mesodermal progenitors that express endothelial and
pericyte markers depending on the stage during which they are isolated (Cossu and
Bianco, 2003). Mesoangioblasts isolated from the mouse dorsal aorta are able to
form satellite cell-like colonies and express the myogenic markers MyoD, Myf5 and
c-Met (De Angelis et al., 1999). Upon injection into injured muscles of immun-
odeficient mice, MLC3f-LacZ mesoangioblasts contribute to regenerating myofibres
(De Angelis et al., 1999). One interesting feature of mesoangioblasts is their ability
to cross the vessel wall in response to inflammation, allowing therapeutically rele-
vant approaches such as their transplantation via arteries towards the interstitium
of skeletal muscles. Using this approach, it has been shown that the injection of
wild-type mesoangioblasts or mesoangioblasts isolated from α-Sarcoglycan-null mice
and transfected with α-Sarcoglycan-encoding lentivirus ameliorates the dystrophic
phenotype of mice lacking α-Sarcoglycan (Sampaolesi et al., 2003). Likewise, deliv-
ery of wild-type mesoangioblasts into dogs affected with golden retriever muscular
dystrophy (GRMD) resulted in improvement of dystrophin expression and gain of
muscle function (Sampaolesi et al., 2006). Therefore, mesoangiblasts are powerful
candidates for the treatment of muscular disorders.
6. Fibroadipogenic progenitors (FAPs)
FAPs are important player of muscle regeneration, they proliferate rapidly in re-
sponse to injury to generate adipocytes and fibroblasts and to secrete factors to
promote myoblast proliferation, such as interleukin 6 (IL-6) (Heredia et al., 2013,
Joe et al., 2010). FAPs show little to no myogenic differentiation even when co-
cultured with muscle progenitors in vitro (Joe et al., 2010). Also, FAPs are thought
to be responsible for ectopic fat formation and decreased muscle contractility dur-
ing muscle regeneration (Uezumi et al., 2010). However, it has recently been shown
that blockade of FAP adipogenic differentiation improves muscle regeneration of
young dystrophic mice (Mozzetta et al., 2013). More specifically, the use of HDAC
inhibitors can derepress FAPs myogenic potential by inducing MyoD and BAF60C
expression, as well as specific miRNAs (miR-133 and miR-206), which can also pro-
mote myogenic differentiation (Saccone et al., 2014). Therefore, modification of
FAPs behaviour and differentiation in situ is a promising strategy for the treatment
of muscular dystrophies.
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1.3 Satellite cell function
1.3.1 The quiescent state of satellite cells
Generally speaking, the eukaryotic cell cycle consists of four discrete phases: G1 (Gap
1), S (DNA synthesis), G2 (Gap 2) and M (Mitosis), which are active phases leading
to the division of a cell (Nurse, 1994). An additional phase, named G0 (Gap 0), is an
inactive, non-cycling state where cells do not divide at all (Fig.1.5). Cells in G0 state
include terminally differentiated cells that have irreversibly exited the cell cycle and cells
in quiescence, which is a reversible growth arrest where cells can re-enter the cell cycle
upon stimulation (Cheung and Rando, 2013). Quiescence is an important characteristic
of several stem cells, including hematopoietic, intestinal, epithelial and muscle stem cells.
In healthy skeletal muscles, satellite cells are found in a quiescent state, which is essential
to maintain the satellite cell pool and the homeostatic balance of the muscle.
Satellite cells transition into an intermediate state between G0 and G1, named GAlert
state (Fig.1.5). Satellite cells at GAlert arise in response to injury-induced systemic signals
and have an intermediate phenotype between G0 and G1 cells. For instance, GAlert
satellite cells are larger, have a greater propensity to cycle and have a higher metabolic
activity than G0 cells, making them comparable to G1 cells. However, when grafted
into injured muscles, GAlert satellite cells exhibit similar engraftment and self-renewal
efficiency to quiescent G0 satellite cells (Rodgers et al., 2014). The biological importance
of this intermediate state translates into a greater and faster ability for satellite cells to
carry out the first cell division compared to G0 cells.
1.3.1.1 The satellite cell quiescence signature
Quiescent satellite cells are characterised by high expression levels of the transcription
factor Pax7, which is required for the specification of the satellite cell lineage (Fig.1.7)
(Seale et al., 2000). Moreover, microarray analyses have shown that about 500 genes are
exclusively up-regulated in quiescent satellite cells compared to activated and proliferating
myoblasts. These genes include cell adhesion molecules, cell cycle regulators, cytoskeletal
proteins, signalling molecules and extracellular components among others (Fukada et al.,
2007).
Because quiescent satellite cells are in a G0 state, it is not surprising that some of the
most relevant markers of quiescence are negative regulators of the cell cycle. This includes
the G-protein signalling 2 and 5 (Rgs2, Rgs5 ), peripheral myelin protein 22 (Pmp22 ),
cyclin-dependent kinase inhibitor 1A (Cdkn1a/p21Cip1 ), 1B (Cdkn1b/p27Kip) and 1C
(Cdkn1/p57Kip2/p57 ), the retinoblastoma protein (Rb1 ) and the Sprouty homolog 1























Quiescent satellite cell (G0)  
Alert satellite cell  
(GAlert)  
Activated satellite cell (G1)  
Activated satellite cell (S)  
Dividing satellite cell (M)  Differentiated   
cell (G0)  
EXIT 
ENTRY 
Figure 1.5: The satellite cell cycle. Quiescent satellite cells are in a reversible G0 state. Following
muscle injury, satellite cells become activated and enter the mitogen-dependent early G1 phase, transi-
tioning through the R-point and committing to the cell cycle. Hyperphosphorylation of retinoblastoma
protein (Rb1) by Cdk4/Cyclin D is important for passage through the R point. Quiescent satellite cells
can also transition into a GAlert state as a result of injury-induce systemic signals and enter the cell cycle
from there. Activated satellite cells in G1 enter the S phase to replicate their DNA. The Cdk2-Cyclin
E complex is an important regulator of the G1-S transition. Once the DNA is duplicated, activated
satellite cells go the G2 phase. Cdk1/Cdk2-Cyclin A complexes regulate the completion of the S phase.
Satellite cells then enter mitosis to generate two daughter cells. Transition from G2-M phase depends
on the control of Cdk1-Cyclin B complex. The resulting cells continue into G1 phase, where they can
undergo further cell divisions or if differentiating, exit the cell cycle into the G0 state.
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entry or cell cycle progression, and are needed to prevent premature activation of satellite
cells. Accordingly, muscles from p27Kip-null mice displayed a decrease in the number of
quiescent LRCs and, as a consequence, an increase in the number of proliferating satellite
cells (Chakkalakal et al., 2014). Likewise, the conditional deletion of the Rb1 gene in
satellite cells results in an accelerated cell cycle re-entry, leading to a drastic increase in
the number of Pax7+ cells (Hosoyama et al., 2011).
Amongst the cell surface and cell adhesion molecules enriched in quiescent satellite cells
are M-cadherin, the Notch co-receptor Syndecan-3, Caveolin-1, Sca-1, calcitonin receptor
(CTR), Integrin α7, the tyrosine kinase receptor c-Met, the sialomucin surface receptor
CD34, VCAM-1 and NCAM-1 (Allen et al., 1995, Beauchamp et al., 2000, Fukada et al.,
2007, Gnocchi et al., 2009, Irintchev et al., 1994). Some markers, like Caveolin-1 and
M-cadherin are not only expressed during quiescence, but are maintained as satellite cells
become activated (Gnocchi et al., 2009). Other markers are generally used in combination
with other proteins because their expression is not exclusive of satellite cells. This is the
case for the CD34 protein, which is also expressed by hematopoietic progenitor cells
(Krause et al., 1994).
1.3.1.2 Regulation of satellite cell quiescence
1. The Notch signalling pathway
Quiescent satellite cells express high levels of components and targets of the Notch
signalling pathway, including Notch1, Notch2, Notch3, HeyL and Hesr3 (Fukada
et al., 2007, Mourikis et al., 2012b), which are down-regulated when satellite cells
become activated, suggesting a role for Notch signalling in the control of satellite
cell quiescence (Fig.1.7) (Bjornson et al., 2012).
The Notch ligand delta-like 1 (Dll1) is expressed by myofibres and stimulates Notch
activity by binding to Notch receptors, which are expressed by quiescent satellite
cells (Conboy and Rando, 2002). Following ligand binding, the Notch receptor
undergoes protease-mediated cleavage and releases the Notch intracellular domain
(NICD), which translocate to the nucleus and interacts with recombining binding
protein suppressor of hairless (Rbpj). Finally, the resulting NICD-RBPJ complex
activates the transcription of Notch target genes, including Hey and Hes genes
(Kopan, 2012). Notch signalling facilitates the transition of muscle progenitors into
quiescence, as forced expression of the NICD in Myf5+ satellite cells at postnatal
stages results in their precocious exit from the cell cycle and the return of quiescence
(Mourikis et al., 2012a). Likewise, forced expression of NICD in Pax7+ satellite cells
(Pax7-NICDOE) promotes self-renewal and inhibits myoblast proliferation, as shown
by Pax7 up-regulation and MyoD down-regulation (Wen et al., 2012). Conversely,
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conditional deletion of Rbpj in adult satellite cells (Pax7CreERT2/+: RBP-Jflox/flox)
results in the loss of quiescence and spontaneous activation and differentiation of
satellite cells, ultimately causing a depletion of the satellite cell pool (Bjornson et al.,
2012, Mourikis et al., 2012b). Hesr1/Hesr3 double mutant satellite cells display
also an increased expression of proliferation and differentiation markers (Ki67 and
MyoD) and fail to maintain quiescent satellite cells post-natally, indicating that the
Notch signalling pathway is required for the generation of satellite cells and their
maintenance in a quiescent state (Fukada et al., 2011).
2. Control of satellite cell quiescence by miRNAs
miRNAs are small RNA molecules that bind to specific coding mRNAs to inhibit
mRNA translation or to promote mRNA degradation (Bartel, 2004). They are
derived from longer hairpin-containing precursors named pri-miRNAs, which are
processed in the nucleus by the RNase III Drosha. Pri-miRNAs are transferred to
the cytoplasm where they undergo further processing by another RNase III enzyme,
Dicer. Finally, the resulting miRNA molecules are coupled to the RNA-induced
silencing complex (RISC) to regulate their targets (Han et al., 2009).
Conditional deletion of Dicer in satellite cells results in their spontaneous exit
from quiescence and entry into the cell cycle. Consequently, muscle regeneration
is severely impaired in the absence of a functional miRNA machinery (Cheung
et al., 2012). Microarray analysis of quiescent versus activated satellite cells has
shown that a group of miRNAs are highly expressed during quiescence and down-
regulated upon satellite cell activation. Among these, miR-489 inhibits satellite cell
activation and proliferation, and suppresses the Dek oncogene, which is strongly
up-regulated during satellite cell activation and it is preferentially distributed in
differentiating cells (Cheung et al., 2012). One of the mechanisms behind miRNA
control of quiescence is illustrated by miR-31, which is another miRNA enriched
in quiescent satellite cells and whose main target is the Myf5 mRNA. miR-31 is
associated to messenger ribonucleoprotein (mRNP) complexes, which control its lo-
calisation within the cell. When miR-31 is present, Myf5 transcripts are sequestered
into mRNP-miR-31 complexes and silenced during quiescence, and are released upon
satellite cell activation, allowing their translation (Crist et al., 2012).
1.3.2 Satellite cell activation
1.3.2.1 Molecular signature of activated satellite cells
The activation of satellite cells involves their exit from quiescence and concomitant entry
into the cell cycle, leading to a transition from G0 to G1 phase. G0 cells usually spend
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more time to enter the S phase than G1 cells (Coller, 2007). This may result from the fact
that some regulatory proteins required for the initiation of DNA replication complexes,
such as the cyclin-dependent kinase 6 (Cdk6), are removed from the chromatin in qui-
escence cells but not in G1 cells (Madine et al., 2000). For instance, quiescent satellite
cells express high levels of p27Kip, which inhibits Cdk6 and other kinases, preventing cell
cycle progression from G0 to G1 and G1 to S (Toyoshima and Hunter, 1994).
Morphologically speaking, quiescent satellite cells have low cytoplasm-to-nucleus ratio
and low transcriptional activity whereas activated satellite cells have a bigger size, a more
expanded cytoplasm and increased transcriptional activity (Rodgers et al., 2014). This
translates into the ability of most Pax7+ satellite cells to up-regulate the expression of
MRFs, including Myf5 and MyoD as early as 3 hours following stimulation/injury, with
particularly high levels of MyoD being expressed in cells in G1 phase (Cooper et al., 1999,
Kitzmann et al., 1998, Rocheteau et al., 2012, Zammit et al., 2002). The expression of
these factors is crucial for cell fate determination and for further mechanisms such as cell
differentiation and self-renewal.
1.3.2.2 Signals that control satellite cell activation
Quiescent cells going into G1 phase can go back to the G0 state before they reach the
restriction point (R-point) (Fig.1.5). The R-point occurs between the G1 and S phases
(2 to 3 hours before the initiation of DNA synthesis), it depends on the presence of
growth factors and once a cell reaches it, it becomes committed to the next phase of the
cell cycle (Cheung and Rando, 2013, Pardee, 1974). Following muscle injury, mitogen
factors released from damaged fibres and infiltrating cells induce quiescent satellite cells
to enter the cell cycle. For instance, hepatocyte growth factor (HGF), insulin-like growth
factor (IGF-1) and fibroblast growth factor (FGF2) can stimulate receptor tyrosine kinase
(RTK)-mediated signalling pathways and induce satellite cell activation, probably by
promoting their transition over the R-point (Fig.1.7) (Montarras et al., 2013).
One of the main signals that mediates the initial activation of satellite cells is nitric
oxide (NO)-HGF signalling (Fig.1.7). Nitric oxide synthase (NOS) is normally associ-
ated to the dystrophin cytoskeleton of muscle fibres and mediates the synthesis of NO.
The activity of NOS increases under the influence of shear forces generated by contrac-
tion/retraction of damaged myofibres, promoting the production of NO (Anderson, 2000).
NO in turn activates matrix metalloproteinases (MMPs), which degrade proteoglycans in
the ECM to release HGF (Tatsumi et al., 2002, Yamada et al., 2006). HGF then binds
to the tyrosine kinase receptor c-Met, which is strongly expressed in satellite cells (Allen
et al., 1995, Gonzatti-Haces et al., 1988). Thus, pharmacological inhibition of NOS or
blockade of the HGF ligand using anti-HGF antibodies leads to decreased satellite cell
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activation (Tatsumi et al., 2002, Yamada et al., 2006). Although the effectors acting
downstream the NO-HGF cascade have yet to be defined, a recent report has found that
HGF signalling lies upstream mTORC1 signalling, which controls the entry of quiescent
G0 satellite cells into the GAlert state. Conditional deletion of the mTORC1 signalling
inhibitor TSC1 in satellite cells converts all quiescent satellite cells into GAlert. Con-
versely, conditional inactivation of the mTORC1 signalling component Rptor in satellite
cells blocks their responsiveness to injury-induced systemic signals that leads to the tran-
sition into the GAlert state (Rodgers et al., 2014).
IGF-1 is another growth factor that can stimulate satellite cell activation. IGF-1 ac-
tivates the phosphatidylinositol 3-kinase (PI3K)/AKT signalling cascade, which in turn
phosphorylates the forkhead transcription factor FoxO1, causing its inactivation (Guo
et al., 1999). This leads to the down-regulation of the kinase inhibitor p27Kip, which
facilitates G1-S cell cycle progression (Chakravarthy et al., 2000, Machida et al., 2003).
Interestingly, transcripts of the protein Igfbp6, which sequesters IGFs, are highly ex-
pressed in quiescent satellite cells, supporting the idea that IGF-1 signalling promotes
satellite cell activation (Pallafacchina et al., 2010).
Another growth factor involved in satellite cell activation is FGF2, which activates
MAPK signalling in satellite cells. FGF2 is associated with ECM components at the sur-
face of muscle fibres, thus is released in response to injury (Clarke et al., 1993). Quiescent
satellite cells express different FGF receptors, including FGFR1, FGFR4, Syndecan-3
and Syndecan-4 (Cornelison et al., 2001), indicating that they are responsive to FGF sig-
nalling. Exogenous administration of FGF2 in satellite cell cultures leads to an increase
in ERK1/2 (Mapk3/1) signalling and in satellite cell numbers (Yablonka-Reuveni et al.,
1999b). Moreover, chemical blockade of ERK1/2 pathway prevents the satellite cells
transition from G1 to S phase (Jones et al., 2001). FGF2 can also stimulate the p38α/β
MAPK pathway and chemical blockade of p38α/β MAPK decreases satellite cell prolifer-
ation due to their inability to enter the cell cycle. Interestingly, inhibition of this pathway
drives satellite cells into a reversible quiescent-like state, confirming its requirement for
cell cycle entry (Jones et al., 2005).
subsectionSatellite cell proliferation
1.3.2.3 Markers of satellite cell proliferation
Cell proliferation can be defined as the increase in cell number that results from cycles
of cell division. Broadly speaking, activated satellite cells are proliferating cells because
they have exited quiescence and have entered the cell cycle. Conversely, proliferating
satellite cells are activated cells until they undergo terminal differentiation or self-renewal,
returning to the G0 state. However, for the sake of simplicity, proliferating satellite cells
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will be considered as those cells that have transitioned beyond the R-point and that have
undergone a finite number of cell cycles.
Cycling satellite cells maintain the expression of the transcription factor Pax7 as well
as Myf5 and MyoD (Fig.1.7). Furthermore, cycling satellite cells can be identified by
the use of broad-spectrum proliferation markers like Ki67 or phase-specific markers like
the proliferating cell nuclear antigen (PCNA), which labels cells in S phase, and the
phospho-histone 3 protein (PH3), which labels cells undergoing mitosis (Madsen and
Celis, 1985, Scholzen et al., 2000). Satellite cells in S phase can also be identified by the
incorporation of the thymidine analogs 5-bromo-2-deoxyuridine (BrdU) or 5-ethynyl-2-
deoxyuridine (EdU). More recently, the use of fluorescent ubiquitynation-based cell-cycle
indicator (Fucci) system in cultured myofibres and the mVenus-p27K- mice on whole
muscle sections has deepened the understanding of the proliferative status of satellite
cells (de Lima et al., 2014, Oki et al., 2014).
1.3.2.4 Signals that regulate satellite cell proliferation rate
As mentioned earlier, satellite cells that have exited quiescence (G0) have a prolonged G1
phase and enter the S-phase around 18h after injury in vivo or when plated after FACS
isolation (Mourikis et al., 2012b, Rocheteau et al., 2012). Satellite cells complete their
first division between 24 and 48h after stimulation in vivo, in vitro and ex vivo, with
satelite cells expressing high levels of Pax7 (Pax7-nGFPHi) taking the longest to complete
it (Rocheteau et al., 2012, Siegel et al., 2011). Subsequent satellite cell divisions occur in
average every 8 to 10h (Rocheteau et al., 2012, Siegel et al., 2011).
Several signalling molecules are known to modify the rate of satellite cell prolifera-
tion, influencing the overall number of satellite cells (Fig.1.7). For instance, the canoni-
cal Wnt-β-catenin signalling pathway has been implicated in the control of satellite cell
proliferation. Quiescent satellite cells express non-activated β-catenin, which becomes
functional in activated satellite cells (between 24 and 48h in ex vivo cultured myofibres)
(Otto et al., 2011). Indeed, following satellite cell activation, Wnt ligands are expressed,
including Wnt1, Wnt3, Wnt4, Wnt5, Wnt6 and Wnt11, and the exogenous administra-
tion of Wnt1, Wnt3 or Wnt5 induces satellite cell proliferation, whereas Wnt4 and Wnt6
have the opposite effect (Otto et al., 2011). The mechanism responsible for this mitogenic
effect appears to be linked to the translocation of active β-catenin into the nucleus and
the subsequent activation of cell cycle regulators (Otto et al., 2011).
Another signalling molecule involved in satellite cell proliferation is Sonic Hedgehog
(Shh). Treatment of primary myoblasts or C2C12 cells with recombinant Shh protein
increases BrdU incorporation, and this effect can be reversed by cyclopamine, an inhibitor
of the Shh pathway (Elia et al., 2007, Straface et al., 2009). However, the mechanism by
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which Shh signalling modulate satellite cell proliferation is still poorly understood.
Bone morphogenetic proteins (BMP), which are members of the transforming growth
factor-beta (TGF-β) family, have also been implicated in the control of the balance be-
tween proliferation and differentiation of satellite cells. BMP binds to BMP receptors at
the cell surface, which leads to the phosphorylation of Smad proteins and the regulation
of target genes (Feng and Derynck, 2005). Studies have shown that transcripts of BMP
signalling components are enriched in quiescent satellite cells and that exogenous adminis-
tration of the BMP signalling inhibitor Noggin to cultured myofibres results in precocious
differentiation and a decrease in satellite cell numbers (Ono et al., 2011, Pallafacchina
et al., 2010). The same effect is observed when BMP receptor 1, Smad5 or Smad4 are
knocked down by siRNA, and is mediated by Inhibitor of differentiation (Id1), a down-
stream target of BMP signalling and a negative regulator of MyoD expression (Ono et al.,
2011).
1.3.2.5 Specific control of satellite cell progression through the cell cycle
1. G1/S transition
Myostatin is a member of the TGF-β family and has an important regulatory role
in skeletal muscles. Myostatin-null mice have an increased size and muscle mass due
to muscle hyperplasia and hypertrophy (McPherron et al., 1997). Conversely, over-
expression of Myostatin in skeletal muscles leads to loss of muscle mass and decreased
myofibre size, indicating that Myostatin negatively controls muscle growth (Reisz-
Porszasz et al., 2003). Myostatin-null mice have also a higher number of activated
satellite cells and an increased number of cells in S phase compared to control
satellite cells. Indeed, Myostatin inhibits the G1-S transition by up-regulating p21
expression, which represses Cyclin E-cyclin dependent kinase 2 (Cdk2 ) complex
activity (McCroskery et al., 2003). More recently, it has been shown that this
mechanism is likely to be transduced via Smad3 protein (Ge et al., 2011).
2. S phase
One of the main regulators of the completion of the S phase is the Cyclin A2-
Cdk2 complex, which accumulates during early S phase and drops in prometaphase
(Girard et al., 1991, Morgan, 2007). The Cyclin A2-Cdk2 complex mediates the
phosphorylation of the cell division control protein 6 (CDC6), which ensures that
only one round of DNA replication occurs in every cycle (Bendris et al., 2011).
Reports have shown that C2C12 muscle cells cultured in mitogen-rich medium can
be synchronised in a reversible arrest in a quiescent-like state without differentiation
(Sachidanandan et al., 2002). Under these conditions, mixed lineage leukemia 5
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(MLL5), a tumour suppressor gene that encodes for a methyltransferase able to
regulate gene expression, is induced (Sebastian et al., 2009). RNAi-mediated Mll5
knock-down in C2C12 cells results in the up-regulation of both Cyclin E and Cyclin
A2, which regulate the entry and exit from S-phase, respectively. Therefore, MLL5
represses Cyclin A2 to prevent transition into the S-phase and to maintain cells in
a quiescent-like state (Sebastian et al., 2009). However, whether this mechanism is
conserved in satellite cells in vivo has yet to be determined.
3. G2/M transition
Cyclin B1 is one of the main positive regulators of the G2/M transition in verte-
brates. Cyclin B1 accumulates during G2 and peaks during metaphase. Cyclin B1
associates with cyclin dependent kinase 1 (Cdk1). However, the complex is main-
tained inactive by Wee1 kinase-mediated phosphorylation (Morgan, 2007), until its
dephosphorylation mediated by Cdc25 phosphatase, which allows the cell to transit
into M phase (Berry and Gould, 1996). A recent mass spectrometry-based protein
analysis has also shown that the histone arginine methyltransferase Prmt5 affects
the activity of satellite cells by repressing the expression of p21, which regulates Cy-
clin B1-Cdk1 negatively (Zhang et al., 2015). Consistently, conditional deletion of
Prmt5 in Pax7+ satellite cells results in impaired muscle regeneration and a drastic
arrest of cell proliferation linked to the up-regulation of p21 (Zhang et al., 2015).
1.3.3 Symmetric and asymmetric cell divisions
Activated satellite cells divide symmetrically to give rise to two identical daughter cells,
or asymmetrically to generate two daughter cells that are different in size, protein profile
or developmental potential (Knoblich, 2008). One of the key determinants of the type of
cell division is the orientation of the division plan (and mitotic spindles) with respect to
the basal lamina (basal surface) and the plasma membrane (apical surface) of the muscle
fibre. Symmetric cell divisions occur mainly in a planar orientation (parallel to the fibre)
and promote satellite cell expansion, whereas asymmetric cell divisions occur mainly in
an apico-basal orientation (perpendicular to the fibre) and generate two daughter cells
with distinct fates: the daughter cell close to the apical surface commits to the myogenic
lineage and the daughter cell close to the basal lamina maintains the stem cell identity
(Fig.1.6) (Wang and Rudnicki, 2012).
Lineage tracing analysis using the Myf5-Cre/Rosa26-YFP mice has shown that 10%
of the total number of satellite cells never express Myf5 (YFP-) during development.
Importantly, these YFP- (Pax7+/Myf5-) cells can undergo both symmetrical cell division
to generate more YFP- (Pax7+/Myf5-) daughter cells and asymmetrical cell division to
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produce one YFP- (Pax7+/Myf5-) and one YFP+ (Pax7+/Myf5+) cell (Kuang et al.,
2007). Using this model, it has been observed that around 30-40% of YFP- first cell
divisions are symmetric, whereas the rest are asymmetric (Le Grand et al., 2009).
One characteristic of asymmetric cell division is the differential distribution of cellular
components or cell fate determinants into only one of the two daughter cells. For instance,
components of the Notch signalling pathway display a differential localisation in satellite
cells: the Notch ligand Dll1 is expressed in Pax7+/Myf5+ cells and the Notch-3 receptor
is highly expressed in Pax7+/Myf5- cells (Kuang et al., 2007). Similarly, the Notch
inhibitor Numb is asymmetrically expressed in satellite cells and cosegragate with BrdU-
retaining cells, suggesting a role for this protein in the control of self-renewal (Conboy
and Rando, 2002, Shinin et al., 2006). The partitioning-defective proteins (PAR) are
also asymmetrically distributed in satellite cells. For instance, the PAR3-PKCl complex
segregates into one daughter cell and activates p38α/β MAPK signalling and MyoD
expression, resulting in its commitment into the myogenic lineage. The other daughter
cell does not activate the p38α/β MAPK pathway and instead returns to quiescence
(Troy et al., 2012). Another characteristic of asymmetric cell division is the differential
segregation of old and new DNA strands, also known as non-random DNA segregation. As
DNA is replicated semiconservatively, this results in chromatids containing new and old
DNA strands and it has been proposed that the older DNA strand is maintained through
successive asymmetric cell division in only one of the two daughter cells. Through this
mechanism, stem cells ensure the protection of DNA against damage (Cairns, 2006).
One way to study this phenomenon is through pulse-chase experiments to mark DNA
so that slowly dividing cells (such as stem cells) would retain the label (LRC) and the
progeny of myoblasts would dilute the label after random DNA segregation (non-LRC).
Using this approach it has been observed that the majority of Pax7-nGFPHi satellite stem
cells perform non-random DNA segregation whereas Pax7-nGFPLo perform random DNA
segregation (Rocheteau et al., 2012). Importantly, old DNA strands tend to segregate with
Pax7, whereas nascent DNA strands are more likely to segregate with Myogenin (Yennek
et al., 2014).
In contrast, symmetric cell expansion of satellite cells are regulated by the Wnt planar
cell polarity (PCP) pathway. Following muscle injury, Wnt7a is up-regulated at the time
satellite cells are replenish the stem cell pool (6 days post-injury), and bind to the Wnt
receptor Frizzled 7 (Fzd7), which is expressed in both quiescent and activated satellite
cells (Le Grand et al., 2009). Stimulation of YFP- satellite cells from Myf5-Cre/Rosa26-
YFP mice with Wnt7a results in a drastic increase in the proportion of symmetrical cell
divisions (Pax7+/Myf5-) without affecting proliferation rate or differentiation (Le Grand
et al., 2009). Wnt7a treatment promotes the symmetric distribution of the polarity ef-
fector Vangl2, and in the absence of the latter, Wnt7a can not stimulate symmetric cell
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Figure 1.6: Asymmetric and symmetric satellite cell division. During asymmetric cell division,
satellite stem cells (green) divide following an apico-basal orientation to give rise to one committed muscle
progenitor (yellow) associated to the plasma membrane (pink line) and one satellite cell (green) located
close to the basal lamina (purple mesh). On the other hand, during symmetric cell division, both satellite
stem cells and committed muscle progenitors divide following a planar orientation to give rise to identical
daughter cells. Adapted from Dumont et al. (2015a).
division (Le Grand et al., 2009). Consistently, Wnt7a over-expression in injured muscles
results in enhanced muscle repair linked to a greater number of satellite cells, bigger fibre
size and increased muscle mass (Le Grand et al., 2009).
1.3.4 Satellite cell self-renewal: how the return to quiescence is
regulated?
Self-renewal is the process by which stem cells divide to generate a progeny that has the
same developmental potential as the mother cell. This mechanism is essential to maintain
the stem cell pool within a tissue after regeneration (Shenghui et al., 2009). The regulation
of self-renewal is closely linked to the ratio of symmetric and asymmetric cell divisions,
which were discussed in section 1.3.3. Indeed, asymmetric cell division generates 50%
of daughter cells with a self-renewal fate, whereas symmetric cell division yields 100%
of daughter cells that either self-renew or differentiate. Hence, depending on the tissue
requirement and the overall environment, symmetric or asymmetric cell division will be
privileged to ensure that homeostasis is preserved (Fig.1.6).
The process of self-renewal involves the exit of satellite cells from the cell cycle. This
return to the quiescent state occurs when cells are in G1 phase and re-enter G0 before
reaching the R-point, so they do not commit to the next round of the cell cycle. As
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mentioned in section 1.3.1, the maintenance of quiescence largely depends on the ex-
pression of negative regulators of the cell cycle. For instance, p27Kip1 is required for
self-renewal, as p27 -null mice have a decreased ability to cope with repeated rounds of
muscle regeneration (Chakkalakal et al., 2014). Another important regulator of satellite
cell self-renewal is the negative regulator of RTK signalling, Sprouty (SPRY1). SPRY1 is
highly expressed in quiescent satellite cells, is down-regulated during activation but it is
re-expressed in cells returning to quiescence (Fukada et al., 2007). Conditional deletion
of Spry1 in satellite cells results in a 40% decrease in the number of Pax7+ satellite cells
found at 50 days post-injury, when the satellite stem cell pool is thought to be completely
replenished (Shea et al., 2010). Importantly, SPRY1 promotes self-renewal by inducing
cell cycle exit via ERK signalling inhibition (Shea et al., 2010).
The satellite cell niche also plays an essential role in the maintenance of satellite cell
stemness and in the control of self-renewal. Indeed, several ECM components can influ-
ence satellite cell behaviour (Bentzinger et al., 2013b, Urciuolo et al., 2013). For instance,
the glycoprotein Fibronectin binds to the Syndecan-4/Fzd7 complex at the surface of
satellite cells, resulting in the stimulation of Wnt7a signalling and the symmetric expan-
sion of satellite cells (Bentzinger et al., 2013b). Also, Collagen VI (COL6A1), a major
component of the ECM of skeletal muscles, has been implicated in the control of satellite
cell self-renewal. Col6a1 -null mice show a delay in muscle regeneration, accompanied by
a decrease in satellite cell numbers. Furthermore, mutant mice display aberrant muscle
repair following repeated muscle injury, indicating a failure to replenish the satellite cell
pool after the initial round of regeneration. One mechanism by which Collagen VI may
regulate the return to quiescence is an increase in muscle stiffness, which enhances the
biomechanical properties of the satellite cell niche (Urciuolo et al., 2013). Consistently,
satellite cells are able to self-renew in vitro when cultured in soft hydrogels that have
similar elasticity and stiffness as myofibres (Gilbert et al., 2010). This indicates that the
biophysical and mechanical characteristics of the satellite cell niche are essential cues to
control satellite cell self-renewal.
1.3.5 Satellite cell differentiation
1.3.5.1 Molecular signature of satellite cell differentiation
Differentiating satellite cells are characterised by the expression of the transcription factor
Myogenin, which is an important driver of differentiation (Fig.1.7). Following crush injury,
Myogenin mRNA is detected as early as 6h post-injury, reaching the highest levels between
24 and 48h and progressively declining at 8 days post-injury (Grounds et al., 1992).
Myogenin-deficient mice die perinatally and have loss of differentiated myofibres (Hasty
et al., 1993). MRF4 is not expressed in quiescent satellite cells but is co-expressed with
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MyoD and Myogenin in regenerating myofibres following muscle injury, indicating a role in
terminal differentiation (Zhou and Bornemann, 2001). Both Myogenin and MRF4 induce
the expression of other muscle specific differentiation markers, including creatine kinase
(Ckm) and MyHC proteins (Molkentin and Olson, 1996).
Other proteins up-regulated during muscle regeneration and satellite cell differentia-
tion are the Myocardin family of transcription factors MASTR and MRTF-A (Mokalled
et al., 2012). Conditional MASTR removal in Pax7+ satellite cells results in an inca-
pacity to regenerate skeletal muscles in reponse to injury and in low expression levels of
Desmin, an intermediate filament protein essential for muscle structure (Mokalled et al.,
2012). Interestingly, both MASTR and MRTF-A positively regulate MyoD expression,
promoting satellite cell differentiation. Furthermore, the transcription factors MEF2A,
C, and D, which belong to the family of the myocyte enhancer factor 2 (MEF2) are also
required for satellite cell differentiation. These factors become up-regulated during muscle
regeneration and their conditional deletion in Pax7+ satellite cells impairs the regenera-
tion process in response to injury. More specifically, MEF2 -deficient satellite cells do not
differentiate in culture and they down-regulate muscle differentiation proteins like MRF4,
Ckm, MyHC1 and MyHC4 (Liu et al., 2014).
Finally, the satellite cell markers Pax7 and Caveolin-1 become progressively down-
regulated as satellite cells enter differentiation (Gnocchi et al., 2009). Indeed, Pax7 and
Myogenin expression are mutually exclusive and Pax7 over-expression prevents Myogenin
induction and alters muscle differentiation (Fig.1.7) (Olguin and Olwin, 2004, Zammit
et al., 2006). Interestingly, Pax7 is repressed post-transcriptionally during satellite cell
differentiation by microRNA-1 and microRNA-206, which regulate negatively proliferation
of satellite cells while promoting their differentiation (Chen et al., 2010a).
1.3.5.2 Signals that control satellite cell differentiation
Similar to satellite cells returning to quiescence, differentiated myocytes need to exit the
cell cycle (Fig.1.5). Myogenin dictates the commitment to differentiation and its expres-
sion in myoblasts is accompanied by the up-regulation of the cell cycle inhibitor p21, in-
ducing irreversible cell cycle exit (Walsh and Perlman, 1997). The retinoblastoma protein
(Rb1) is also of interest during differentiation, as is required for mitotic arrest, for main-
taining the post-mitotic state and for protecting myotubes against apoptosis (Burkhart
and Sage, 2008). Suppression of Rb1 expression in primary mouse myotubes leads to cell
cycle re-entry and up-regulation of the tumour suppressor p19ARF. Interestingly, inhibi-
tion of p19ARF alone does not have any obvious effect on differentiation but inactivation
of Rb1 and p19ARF together results in extensive loss of myoblast differentiation, indi-
cating the requirement of both proteins for cell cycle arrest (Pajcini et al., 2010). More
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recently, it has been reported that one of the catalytic subunits of the SWI/SNF chromatin
remodelling complex, Brahma (Brm), directly binds to Cyclin D1 (a R-point regulator)
to repress its expression, leading the exit of myoblasts from the cell cycle (Albini et al.,
2015).
Signals that control satellite cell differentiation include Wnt, Shh and BMP. Canonical
Wnt signalling promotes satellite progression through the myogenic program. Indeed,
treatment of primary myoblasts or single myofibres with Wnt3A results in an increase in
the number of differentiated Desmin+ cells and the opposite effect is observed upon Wnt
inhibition both in vitro and in vivo (Brack et al., 2008). Another signalling pathway that
has been implicated in the control of muscle differentiation is Shh. Treatment of C2C12
cells or primary chick adult myoblasts with recombinant Shh protein results in an increase
of muscle differentiation marked by the expression of MyHC. In this context, Shh mediates
its signal through Akt phosphorylation, leading to the stimulation of MAPK/ERK and
phosphoinositide 3-kinase (PI3K) pathways (Elia et al., 2007). Finally, consistent with
the role of the BMP signalling in muscle proliferation, it has been shown that blocking
BMP signalling results in increased cell differentiation and myotube formation in primary
satellite cells. During muscle regeneration in vivo, the effect of BMP signalling inhibition
on satellite cell differentiation seems to be mediated by Chordin, whose expression follows
the onset of Myogenin expression (Friedrichs et al., 2011).
1.4 The Hedgehog (Hh) signalling pathway
1.4.1 The Hh signalling ligands and their functions
The Hedgehog (Hh) proteins are widely conserved in both invertebrates and vertebrates.
The hh gene was initially discovered in a screen aimed at identifying genes involved in
embryonic segment polarity in the fruit fly Drosophila melanogaster (Nüsslein-Volhard
and Wieschaus, 1980). Whilst one single hh gene has been identified in D. melanogaster,
in birds and mammals three hh homologues have been described: Sonic Hedgehog (Shh),
Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh) (Tabata et al., 1992). In contrast, in
zebrafish five homologues have been identified: sonic (shha and shhb), indian (ihha and
ihhb) and desert (dhh) (Cruz-Migoni and Borycki, 2014, Currie and Ingham, 1996, Krauss
et al., 1993).
The importance of Hh genes during mammalian development has come from studies of
the Shh gene, which is the most widely expressed member of the family. The Shh protein
is involved in the control of proliferation, fate determination, patterning and survival
of different tissues, including muscles, brain, neural tube, eyes, testes and gut (Chiang
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Figure 1.7: Progression of the myogenic program in satellite cells. In resting conditions,
regulators like Notch signalling and mi-RNAs maintain satellite cells (Pax7+) in a reversible quiescent
state. Satellite cells become activated by the influence of HGF, IGF-1 and FGF signalling pathways
and up-regulate Myf5 and then MyoD expression. Satellite cells can then undergo several rounds of cell
division under the control of extrinsic signals like Wnt, BMP and Shh cascades. Cycling myoblasts exit
the cell cycle and become differentiating myocytes that express Myogenin and MRF4. Myocytes can then
fusion to each other to form multinucleated myotubes that express Myogenin, MRF4 and MyHC. Satellite
cells also self-renew to repopulate the stem cell pool and this mechanism is regulated by increased activity
of Notch signalling and Sprouty.
embryo, Shh is mainly produced by the notochord, the floor plate of the neural tube
and the polarising region or zone of polarising activity (ZPA) of the limb bud (Riddle
et al., 1993). In these tissues Shh acts as a morphogen that establishes a gradient to
dictate cell fate in a dose-dependent manner (Ericson et al., 1996). Shh is also produced
during late embryonic and post-natal stages by other tissues, including Purkinje neurones
in the cerebellum and progenitor cells in the retina, where it mainly acts as a mitogen
(Masai et al., 2005, Wechsler-Reya and Scott, 1999). Loss of Shh expression in mice is
embryonically lethal and results in the absence of ventral cell types in the neural tube as
well as truncated fore and hindlimbs (Chiang et al., 2001, 1996), a phenotype also observed
in mice carrying a germline mutation in Smoothened (Smo) (Zhang et al., 2001).
Shh and Ihh mRNA are both expressed in the early gut, where they have a redundant
role in the control of foregut development. In contrast, Ihh transcripts are specifically
detected in chondrocytes of early cartilage and embryonic bones (Bitgood and McMahon,
1995). Consequently, Ihh-null mutant mice have skeletal defects, including shortening of
the bones and partial formation of the joints, resulting in perinatal death (St-Jacques
et al., 1999). The Dhh gene has a more restricted expression domain in the Sertoli cells
of the male gonad and in Schwann cells of peripheral nerves (Bitgood and McMahon,
1995) and is important in the control of spermatogenesis (Bitgood et al., 1996). Although
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Dhh-null female mice have a normal development and are fertile, Dhh-null male mice are
infertile, have small gonads and develop as phenotypic females (Bitgood et al., 1996).
1.4.2 The biosynthesis and secretion of Hedgehog proteins
Prior to their secretion, the Hh proteins undergo several post-translational modifications
to generate active ligands. First, a 45kDa Hh protein precursor is generated in the endo-
plasmic reticulum (ER) by signal sequence cleavage, triggering its entry into the secretory
pathway. This precursor is autocatalytically cleavaged by its own C-terminal domain and
produces a 19 kDa N-terminal fragment (N-Hh), which is responsible for all signalling
activities of the protein (Bumcrot et al., 1995, Lee et al., 1994). The N-Hh product is
subsequently modified by the addition of an ester-linked cholesterol at its C-terminus
and a palmitic acid group at its N-terminus (Porter et al., 1996). The latter modifica-
tion is thought to enhance Hh protein secretion and is carried out by skinny hedgehog,
(ski) in Drosophila and Hh acyltransferase (HHAT) in mammals (Ingham and McMahon,
2001, Pepinsky et al., 1998). The secretion of the lipidated N-Hh to the extracellular
space requires the function of the twelve-pass transmembrane protein Dispatched (Disp)
and the glycoprotein Scube2 (Fig.1.8). Both proteins bind to different fragments of the
cholesterol moiety of Hh and promote its secretion (Burke et al., 1999). Upon release, Hh
stabilisation at the cell surface and subsequent diffusion require the participation of hep-
arin sulphate proteoglycans (HSPGs), which are synthesized by the tout-velu (ttv) gene
product in Drosophila and EXT-1 in humans (Bellaiche et al., 1998). Also of interest are
glypicans, which are glycosylphosphatidylinositol (GPI)-linked HSPGs associated to lipid
rafts that facilitate the recruitment of Hh into clusters (Fig.1.8). In particular division
abnormally delayed (dally) and dally-like protein (dlp) promote cluster formation of N-
Hh into lipoproteins for long-range diffusion and also interact with shifted (shf ), the fly
homolog of the vertebrate Wnt inhibitory factor-1 (WIF-1), to couple N-Hh with HSPGs
and regulate its distribution (Fig.1.8) (Eugster et al., 2007).
1.4.3 Different receptors mediate Hh response
Most of the knowledge on the reception of the Hh signal comes from studies in D.
melanogaster, although the mechanism is well conserved in vertebrates. In the fruit
fly, Hh response initiates with the binding of the Hh ligand to the receptors Ihog and
Boi (Cdo and Boc in vertebrates) located at the plasma membrane of responding cells
(Allen et al., 2011). These proteins bind to Hh via fibronectin domains and potentiate
Hh association with Patched (Ptc), the main receptor of Hh proteins (Allen et al., 2011).
In vertebrates, two additional proteins, the growth arrest-specific gene 1 (Gas1) and the
52
Hh-­‐N	   Hh-­‐C	  
Hh-­‐N	  
Hh-­‐N	  















Figure 1.8: Biosynthesis and release of the Hh ligands. Hh proteins are synthesised as 45kDa
precursors that are subjected to autoproteolytic cleavage to form a 19kDa product, which undergoes lipid
modifications in the endoplasmic reticulum (ER). Such modifications include the addition of cholesterol
to the C-terminus and the attachment of palmitic acid in the N-terminus, which is mediated by the
Ski/HHAT acyltransferase. Lipidated Hh proteins are released via Dispatched and Scube, which bind to
the cholesterol modification of the ligand. Additional mechanisms of Hh proteins release also include the
interaction with glypicans and lipoproteins to form soluble particles that are secreted to the extracellular
space. Adapted from Cruz-Migoni and Borycki (2014)†.
†All images taken/adapted from this source were made by the author (Sara Cruz-Migoni) and modified for this thesis.
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Hedgehog interacting protein (Hhip1) have the ability to interact with the Hh ligand to
enhance or inhibit the signal, respectively (Martinelli and Fan, 2007).
Ptc is a twelve-transmembane pass protein containing a sterol-sensing domain (SSD),
which has similarities with members of the Resistance-Nodulation-Cell Division (RND)
superfamily (Nakano et al., 1989, Tseng et al., 1999). The SSD domain is thought to
mediate Ptc intracellular trafficking and to be involved in the regulation of the seven-
transmembrane G protein-coupled receptor protein Smoothened (Smo) (Strutt et al.,
2001). A single ptc gene has been described in D. melanogaster, whereas two ptc genes
are found in vertebrates (Ptch1 and Ptch2 ) (Carpenter et al., 1998). Whilst loss of Ptc2
expression in mice only results in a mild phenotype, Ptch1 -null mice die before birth
and display aberrant activation of Hh targets (Goodrich et al., 1997, Ingham et al., 1991,
Nieuwenhuis et al., 2006). In Drosophila, Ptc localises in intracellular vesicles and at the
plasma membrane (Capdevila et al., 1994). In vertebrates, the dynamics of Ptch1 and
Smo trafficking largely depends on their location at the primary cilium, a microtubule-
associated non-motile structure that extend from the plasma membrane of most cells
(Huangfu et al., 2003).
Ptc is a transcriptional target of the Hh signalling and it is generally expressed at
high levels close to the source of the ligand (Nakano et al., 1989). Interestingly, studies
in the wing imaginal discs of the fly larvae and the mouse spinal cord have shown that
Hh-mediated ptc up-regulation results in a feedback mechanism, where Ptc sequesters Hh
and limits its range of signalling (Chen and Struhl, 1996, Jeong and McMahon, 2005).
Furthermore, mutations in Ptc phenocopy Hh over-expression and importantly, heterozy-
gous loss-of-function mutations in the PTCH1 human gene account for some cancers and
this is linked to Hh signalling over-activation (Ingham et al., 1991). In the absence of
Hh ligand, Ptc/Ptch1 is enriched at the plasma membrane (or primary cilia membrane)
and maintains the pathway in an ”off” state by preventing the translocation of vessicle-
associated Smo into the plasma membrane (or primary cilia membrane), repressing Smo
activity (Alcedo et al., 1996, Huangfu and Anderson, 2005). A single Smo gene has been
found in both D. melanogaster and vertebrates and its removal in mice is embryonically
lethal and results in a Hh loss-of-function phenotype (Alcedo et al., 1996, Zhang et al.,
2001). The mechanisms by which Ptc/Ptch1 inhibits Smo might involve the function of
the SSD of Ptc, since mutations affecting this motif abolish Ptc-induced Smo repression
(Taipale et al., 2002). Because no direct interaction between Ptc/Ptch1 and Smo has been
reported, it has been suggested that Ptc/Ptch1 might control the transport of another
ligand, possibly a sterol-like molecule that can regulate Smo function. Consistently, Ptc
is able to sequester lipophorin (Lpp) lipids and promote their accumulation at the mem-
brane of endosomes, preventing Smo trafficking to the plasma membrane and inducing its
degradation (Khaliullina et al., 2009). Binding of the Hh ligand to Ihog/Cdo, Boi/Boc
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and Ptc/Ptch1 receptors triggers the internalisation of Ptc/Ptch1 in endocytic vesicles,
which relieves the constitutive repression over Smo and triggers Smo accumulation at
the cell surface or at the primary cilia tip via intraflagellar transport proteins (Fig.1.9)
(Huangfu and Anderson, 2005).
1.4.4 The mechanism of Hh signalling transduction
Downstream of Smo, Hh signalling transduction continues with the processing of the
zinc-finger transcription factor cubitus interruptus, (ci) in a microtubule-bound complex
in Drosophila and of the three Ci homologs, the Gli proteins (Gli1, Gli2 and Gli3) in
the primary cilia in vertebrates (Alexandre et al., 1996). In the fly, ci mutant embryos
lose the transcription of Hh-responsive genes and the opposite effect is observed when
Ci is over or misexpressed (Alexandre et al., 1996, Forbes et al., 1992). Similar to Ci,
Gli2 and Gli3 can act as both transcriptional activators or repressors whereas Gli1 mainly
acts as an activator to potentiate Gli2 activity (Aza-Blanc et al., 2000). Post-translational
modifications of Ci/Gli are responsible for the activator or repressor activities; for instance
full-length Ci (155kDa) functions as an activator upon Hh stimulation or it is cleaved into
a repressor (75kDa) in the absence of Hh signalling (Aza-Blanc et al., 1997).
In the ”off” state, the kinesin-like protein Costal-2 (Cos2) (Kif7 in vertebrates) recruits
Hedgehog signalling complex (HSC) components, including Protein kinase A (PKA),
Glycogen synthase kinase-3β (Gsk3β), Casein kinase Ia (CKIa) and the Fused (Fu) kinase
(Chen et al., 1999, Jia et al., 2002, Robbins et al., 1997). These proteins cooperatively se-
quester Ci (or Gli2/Gi3) in a microtubule-bound (or primary cilium’s basal body-bound)
complex and mediate the sequential phosphorylation of full-length Ci/Gli2/Gli3. Ci is
then targeted for ubiquitination by Slimb, leading to its degradation by the proteosome
(Jiang and Struhl, 1998). Upon Hh signalling activation, Smo is phosphorylated succes-
sively by HSC kinases, including PKA, CKIa, CK2 and the G-protein coupled receptor
kinase 2 (Gprk2) (Chen et al., 2010b). This stabilises Smo and leads to its accumulation
at the cell surface (or at tip of the primary cilia), where it associates with the HSC via
Cos2/Kif7 and undergoes Fu-mediated phosphorylation (Jia et al., 2003). This in turn
induces Fu-dependent phosphorylation of Suppressor of Fused (SuFu), which results in
the release of full-length Ci/Gli from the HSC and its translocation into the nucleus to
activate Hh target genes (Fig.1.9) (Aza-Blanc and Kornberg, 1999).
Defects in primary cilia biogenesis or activity phenocopy the loss of Hh activity or re-
sult in defective transduction of the Hh signal (Murdoch and Copp, 2010). Consistently,
it has been shown that Gli regulation in vertebrates requires the primary cilia (Huangfu
et al., 2003). Indeed, the processing of the Gli proteins creates a balance between ac-
tivators and repressors, which is important for the optimal function of the pathway in
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different contexts. Genetic analysis in cultured cells have shown that both Gli2 and Gli3
have a C-terminal activator domain and a N-terminal repressor domain, whereas Gli1 only
has the activation domain (Sasaki et al., 1999). Gli1 is a transcriptional target of the Hh
signalling and this is mediated by the Gli2 activator, which is able to bind to the Gli1
promoter and in some cases also to its own promoter (Hu et al., 2006, Lee et al., 1997).
Therefore, Gli1 is not the initial transducer of the Hh signal, but instead potentiates
Gli2-mediated activation (Bai et al., 2002). Accordingly, Gli1zfd mutant mice (lacking the
zinc finger domain) are viable and only show a phenotype when the Gli2 allele is also
mutated (Park et al., 2000). Although known as bipotential transcription factors, Gli2
predominantly acts as an activator and Gli3 as a repressor (i Altaba, 1998, Litingtung
and Chiang, 2000). Gli2zfd mutant mice display a phenotype similar to Shh mutants, with
numerous neural and skeletal defects (Mo et al., 1997). Gli3 mutant mice also have neural
defects and display polydactyly (Hui and Joyner, 1993). Gli2/Gli3 double mutants have
a more severe phenotype that either single mutant, indicating that these transcription
factors have some non-overlapping functions (Motoyama et al., 1998).
1.4.5 Hh proteins can act as morphogens and mitogens in dif-
ferent contexts
The members of the Hh protein family have largely been known to function as morphogens.
These proteins act at a distance (short or long) from their source of synthesis and diffuse
to establish a gradient of activity across a tissue. This results in cells being exposed
to different concentrations of the proteins, a mechanism that can dictate their fate. In
vertebrates, examples of the long range morphogen activity of the Hh signalling have
been observed in the patterning of the spinal cord and the limb bud. In the spinal cord,
Shh secreted from the notochord and the neural tube establishes a gradient along the
dorso-ventral (D-V) axis, with high concentrations of Shh in the most ventral part and
low concentrations at the centre (Ribes and Briscoe, 2009). Therefore, progenitors are
exposed to different levels of Shh and, as a consequence, to different activities of the
Gli transcription factors. In the limb bud, Shh produced in the ZPA (posterior) creates a
gradient along the antero-posterior (A-P) axis (Riddle et al., 1993, Yang et al., 1997). This
gradient symmetrically mirrors a Gli3R gradient, which contributes to the specification
of digit identity. Therefore, the most posterior digits are exposed to the highest levels of
Shh (and to Gli2 and Gli3 positive activity) whereas the most anterior digits are exposed
to lower levels of Shh (and to Gli3 repressor activity) (Bowers et al., 2012).
On the other hand, Hh proteins can also act as mitogens and control cell proliferation
by affecting cell cycle dynamics. In vertebrates, some of the most representative tissues
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Figure 1.9: Transduction of the Hh signalling pathway. A. In D. melanogaster, the receptors
Ihog and Boi cooperatively promote the binding of the Hh protein to Ptc. In the absence of ligand
(inactive), Ptc constitutively represses the translocation of vessicle-associated Smo and promotes its
degradation. As a consequence, the HSC complex (PKa, CKIa, GSK3β, Fu and Ci) becomes associated to
microtubules, where the HSC kinases sequentially phosphorylate Ci to be processed into a repressor form
(CiR). Binding of the Hh ligand (active) relieves Ptc-mediated Smo repression, allowing its translocation
to the plasma membrane and its subsequent phosphorylation by PKA, CKIa and Gprk2. This leads
to the phosphorylation of Cos2 and SuFu by Fu, which results in the dissociation of the HSC and the
release of the activator form of Ci (CiA). B. In vertebrates, the receptors Cdo, Boc and Gas1 promote the
binding of the Hh ligand to Ptch1. In the absence of Hh (inactive), Ptch1 accumulates in and at the base
of the primary cilia and prevents the translocation of Smo. Consequently, Kif7 accumulates at the base of
the cilia and promotes the recruitment of HSC kinases, resulting in the phosphorylation of Gli2 and Gli3
and their cleavage into repressors (GliR). Binding of the Hh ligand (active) to Ptch1 promotes its release
from the primary cilia, allowing Smo translocation into the organelle. Smo and SuFu phosphorylation by
HSC kinases induces the dissociation of full-length Gli activators (GliA) from the HSC complex to travel
to the nucleus and positively regulate Hh target genes. Taken from Cruz-Migoni and Borycki (2014).
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in the cerebellum, SHH is secreted by Purkinje neurons and control the proliferation of
cerebellar granular neural precursors by inducing the expression of type D Cyclins, which
control the R-point transition (Kenney et al., 2004). Similarly, Shh secreted by a still
undefined source induces the proliferation of retinal progenitor cells by controlling Cyclin
D1 expression during early retinal development (Locker et al., 2006, Wall et al., 2009).
However, during late retinal development, Shh also controls the expression of Cyclin B1
and the cell division cycle 25 homolog C (Cdc25c), which are positive regulators of the
G2-M phase transition (Locker et al., 2006).
It is important to bear in mind that during development, progenitor cells can prolif-
erate and commit to a particular lineage synchronously and therefore the morphogen and
mitogen activities of Hh proteins can be coupled. This is the case of the limb bud, where
Shh acts as a morphogen to establish digit identity but also as a mitogen to control tissue
growth by the regulation of Cyclin D1 (Towers et al., 2008).
1.5 Shh signalling orchestrates embryonic myogene-
sis
1.5.1 Shh induces epaxial and hypaxial muscle cell fate specifi-
cation
The epaxial and hypaxial domains of the myotome are defined based on the innervation of
the different muscles derived from these regions: epaxial muscles include the deep muscles
of the back whereas hypaxial muscles are the muscles of the body wall and limbs (Cheng
et al., 2004, Christ and Brand-Saberi, 2002). The transcription factor Pax3 labels all
trunk muscle progenitor cells (Goulding et al., 1994). Myogenic differentiation of both
hypaxial and epaxial precursor cells is a highly dynamic regulated process where MRFs
orchestrate the determination and terminal differentiation of myoblast into functional
myofibres (Berkes and Tapscott, 2005, Pownall et al., 2002).
Different signalling pathways control the induction of MRFs expression and embry-
onic skeletal muscle development. These signalling molecules are produced by tissues
surrounding the paraxial mesoderm. For instance, epaxial precursor cells specification
and determination depends on signals from the neural tube and the notochord, while
hypaxial myogenesis requires signals coming from the surface ectoderm and the lateral
plate mesoderm (Bryson-Richardson and Currie, 2008, Buckingham, 2001). Among the
signals known to direct myogenesis is Shh signalling, which along with BMP and Wnt,
orchestrates the precise spatio-temporal expression of MRFs leading to muscle formation.
During vertebrate embryogenesis, the Shh ligand is produced by cells in the notochord
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and the floor plate of the neural tube and this signal is an essential driver of epaxial
myogenesis. For instance, studies in the chick embryo showed that Shh and Wnt proteins
were capable of inducing myogenesis in vitro, as culture of presegmental plate mesoderm
explants with both Shh and Wnt family members was sufficient to induce the expression
of muscle-specific markers such as MyoD and MYHC (Münsterberg et al., 1995). Addi-
tionally, bead implantation assays showed that recombinant Shh was sufficient to activate
MyoD expression in the dorsal somite, mimicking the function of the notochord (Borycki
et al., 1998). Moreover, knocking down of Shh using antisense oligonucleotides showed a
significant inhibition of myoD and myf5 activation in the anterior somites of the quail
embryo (Borycki et al., 1998). Further studies in the mouse embryo have shown that SHH
is required for Myf5 activation in epaxial muscle progenitor cells (Fig.1.10) (Borycki et al.,
1999b). More specifically, SHH controls directly the transcription of Myf5 in these cells
through the binding of GLI2/GLI3 to the epaxial enhancer of Myf5 (Gustafsson et al.,
2002, McDermott et al., 2005).
Shh transcripts are also detected in the posterior mesenchyme of emerging limb buds,
in the so-called zone of polarising activity (ZPA) (Riddle et al., 1993). Shh-null mu-
tant mice display reduced limb muscle formation (Kruger et al., 2001). Accordingly,
gain-of-function experiments have shown that addition of Shh-coated beads or grafting of
Shh-expressing cells in the chick limb bud (HH-20-24) causes the expansion of Pax3 and
MyoD expression, and this effect is accompanied by muscle hypertrophy (Duprez et al.,
1998, Johnson and Tabin, 1997). The effects of Shh on myogenic progenitor cells (MPCs)
remains controversial and has been reported to promote proliferation (Duprez et al., 1998),
survival (Kruger et al., 2001) or repress terminal differentiation (Bren-Mattison and Ol-
win, 2002). However, the specific deletion of Smo in Pax3+ cells using Pax3Cre;Smoflox/flox
mice showed a delay in the initiation of Myf5 and MyoD expressions and a drastic de-
crease in the number of Pax3+ and Myf5+ cells in ventral limbs without affecting cell
proliferation or survival (Anderson et al., 2012, Hu et al., 2012). Further analyses showed
that, similar to epaxial MPCs, SHH signalling directly controls Myf5 expression in ventral
limb MPCs through the interaction of the Gli proteins with the Myf5 enhancer (Anderson
et al., 2012) and controls the distal migration of limb MPCs to the muscle of the paw (Hu
et al., 2012).
1.5.2 Shh controls myotomal basal membrane assembly
During embryonic development, MPCs are in close contact with ECM components to sup-
port their proliferation, migration and differentiation. The myotomal basement membrane
is a specialised ECM made up of laminins (mainly Laminin-111 and Laminin-5111), type
IV collagen, nidogen and proteoglycans and it is the first basement membrane found in
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Figure 1.10: Different roles of Shh signalling in embryonic myogenesis. The first skeletal
MPCs to form during embryogenesis delaminate from the dorsal part the dermomyotome (red cells)
to incorporate into the myotome (yellow cells). The Shh ligand (blue dots) secreted from the neural
tube and the notochord is required for Myf5 activation in the dermomyotome. Myf5+ cells up-regulate
the expression of the Laminin receptor Integrin α6β1 (dark blue), which allows the incorporation of
Laminin-111 and Laminin-511 and the assembly of the basement membrane. Adapted from Anderson
et al. (2009).
embryogenesis (Tosney et al., 1994). As Myf5-expressing progenitor cells translocate into
the myotome, they up-regulate the expression of the Laminin receptors Integrin α6β1 and
Dystroglycan, leading to the onset of myotomal basal membrane assembly, separating the
myotome from the sclerotome (Anderson et al., 2007, Bajanca et al., 2006). Importantly,
blockade of the Laminin-Integrin interaction alters the structure of the basal membrane,
leading to aberrant differentiation of MPCs (Bajanca et al., 2006). Shh signalling pathway
plays a role in the assembly of the myotomal membrane by controlling Lama1 expression,
which encodes one of the subunits of the basement membrane protein Laminin-111, es-
sential for the assembly of the myotomal membrane (Anderson et al., 2009). Therefore,
the Shh signalling pathway is not only required for cell fate specification during em-
bryonic myogenesis, but it also important for the deposition of ECM components in the
muscle-associated basement membrane myotome, which in turn regulates MPC behaviour
(Fig.1.10).
1.5.3 Shh signalling regulates myofibre specificity in zebrafish
Muscle fibre specification is a major event during myogenesis occurring in foetal and
postnatal development in vertebrates. In general, the identity of myofibres is dictated by
the expression pattern of different MyHC isoforms and by innervation and is biologically
relevant as the content in slow and fast fibres in a muscle determines its contractile and
metabolic properties (see section 1.1.2).
In the zebrafish embryo, fibre specificity is determined during embryogenesis. Slow
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Figure 1.11: Myofibre type specification depends on the concentration and timing of Shh
exposure. Muscle precursor cells (MP) and superficial slow fibre cells (SSF) arise from adaxial cells
adjacent to the notochord. Unlike MP, SSF need to migrate to the surface of the somite to differentiate.
During migration, medial fast fibre (MFF) and fast muscle cells are also specified. Shh ligand is secreted
by the notochord is required for MP specification by high levels of Shh compared to MFFs and SSFs
MPs require longer exposure times to Shh signalling than MFFs and SSFs, whereas fast fibre formation
does no depend on Shh signalling. Adapted from Cruz-Migoni and Borycki (2014).
muscle fibres are derived from adaxial cells, mesodermal cells situated at either sides of
the notochord that give rise to two different cell populations: muscle pioneer (MP) cells
that generate from the myoseptum and superficial slow fibres (SSFs), which are generated
from medial cells that migrate to form a layer of slow fibres at the surface of the myotome
(Wolff et al., 2003). Finally, the medial fast fibres (MFFs) expressing fast MyHC iso-
forms, are the last to form and develop from somitic, non-adaxial cells (Roy et al., 2001,
Wolff et al., 2003). The Hh ligand secreted from the fish notochord controls the for-
mation of slow muscle. Treatment of zebrafish embryos with increasing concentrations
of the Smo inhibitor cyclopamine led to the progressive loss of MPs, MFFs and SFFs;
therefore, MPs require the greatest concentrations of Shh ligand for their specification
compared to MFFs and SFFs. Importantly, Hh-mediated myofibre specification occurred
in a time-dependent manner, where MP and MFFs require longer exposure to Shh ligand
than SSTs (Wolff et al., 2003). This demonstrates that the specification of the muscle
lineage by Hh signalling depends on both the concentration and the time of exposure to
the signal (Fig.1.11) (Wolff et al., 2003). How does Hh signalling mediate slow myofibre
lineage specificity? Hh signalling activates Prdm1/Blimp1 in adaxial cells, which nega-
tively regulates Sox6 expression and results in the repression of fast myofibre specification
(Baxendale et al., 2004, Wang et al., 2011).
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1.6 The Shh signalling pathway in adult skeletal mus-
cles
1.6.1 Shh signalling activity is recapitulated during adult myo-
genesis
Because of its essential and multiple functions in embryonic muscle development, the role
of the Shh signalling pathway in adult myogenesis, and more specifically in satellite cells
has been explored in vertebrate systems. Some studies have examined the effect of Shh
and the Smo inhibitor, cyclopamine, on cultures of the mouse myogenic C2C12 cell line
(Elia et al., 2007, Koleva et al., 2005, Li et al., 2004, Madhala-Levy et al., 2012, Straface
et al., 2009) or on primary cultures of adult myoblasts from chick, mice and frogs (Elia
et al., 2007, Koleva et al., 2005, Yamane et al., 2011). Additionally, one study has explored
the role of Shh in satellite cells in vivo by using a transgenic mice strain that express the
reporter LacZ under the control of the Ptch1 promoter (Straface et al., 2009).
Most reports have shown that both quiescent satellite cells and normal skeletal muscles
do not express Shh or any of its signalling components (Elia et al., 2007, Koleva et al.,
2005, Straface et al., 2009). However, up-regulation of Shh, Ptch1 and Gli1 mRNA as
well as the Gli3 protein has been been observed in regenerating skeletal muscles following
injury such as crush, cardiotoxin (CTX) injection and ischemia (Piccioni et al., 2014b,
Pola et al., 2003, Renault et al., 2013a, Straface et al., 2009). Moreover, C2C12 cells and
primary myoblasts up-regulate the Shh target genes Ptch1 and Gli1 following ligand-
triggered stimulation or induced differentiation (Elia et al., 2007, Fu et al., 2014, Koleva
et al., 2005, Li et al., 2004). This suggests that although no formal demonstration has
been reported yet, satellite cells may become responsive to Shh signals during muscle
regeneration. In the embryo, Shh functions as a paracrine factor and there is no evidence
of autocrine mechanism. In the adult muscle, the source of Shh remains elusive, although
it has been suggested that both Ptch1 and Shh proteins are expressed by interstitial
mesenchymal fibroblasts (Pola et al., 2003) or by Pax7-expressing satellite cells (Elia
et al., 2007), suggesting an autocrine mode of action.
1.6.2 Pleiotropic effects of Shh signalling on adult muscle pro-
genitors
The role of Shh in adult muscles is also controversial. Studies using C2C12 cells or pri-
mary myoblasts support the idea that Shh promotes proliferation, as shown by increase
in thymidine and BrdU incorporation upon Shh administration (Elia et al., 2007, Koleva
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et al., 2005, Straface et al., 2009). Other studies have reported that Shh induces terminal
differentiation, as the expression of myogenic proteins such as Myf5, MyoD and MYHC
increases in response to Shh (Elia et al., 2007, Koleva et al., 2005, Li et al., 2004, Straface
et al., 2009, Yamane et al., 2011) an effect that can be blocked by the addition of cy-
clopamine (Straface et al., 2009). However, one report claims that Shh maintains C2C12
myoblasts in an undifferentiated state (Koleva et al., 2005). Additional roles of Shh have
been reported, including the promotion of angiogenesis (Pola et al., 2003, Straface et al.,
2009), inhibition of apoptosis (Koleva et al., 2005) and activation of the MAPK/ERK
and PI3K/AKT pathways (Elia et al., 2007, Madhala-Levy et al., 2012). Thus, although
Shh signalling appears to act on adult muscle progenitor cells, its role and the mecha-
nisms involved have not been clearly determined yet. One major caveat in the studies
carried out previously is the absence of focus on satellite cells, leading to inappropriate
interpretations.
1.6.3 Shh as a therapeutic for muscle repair
Few studies have explored the effect of Shh signalling in vivo in models of muscle regen-
eration. However, the systemic injection of cyclopamine in CTX-injured mice results in a
decrease in the levels of VEGF and stromal-derived factor (SDF)-1alpha, which promotes
angiogenesis and impairs muscle regeneration (Straface et al., 2009). In another study, a
targeted knockout model of Gli3 (HSACreERT2; Gli3flox/flox) reported that Gli3 deletion
in post-mitotic skeletal muscles (using human α-skeletal actin promoter, which is active
in the myofibre but not in satellite cells) delays ischemia-induced myogenesis and impairs
angiogenesis (Renault et al., 2013b). Finally, another study using Smo haploinsufficient
mice has demonstrated that loss of a single copy of the Smo receptor alters muscle repair
(Renault et al., 2013a). On the other hand, two reports have demonstrated that intra-
muscular injection of a plasmid encoding human SHH (phShh) (Kusano et al., 2005) in
injured and dystrophic muscles results in a reduction of fibrosis, increased number of acti-
vated satellite cells, increased myofibre size and angiogenesis, and an overall improvement
of the muscle repair (Piccioni et al., 2014a,b). These studies suggest a role for the Shh
signalling pathway in adult muscle regeneration. However, the effects observed follow-
ing Shh therapy are diverse and systemic and the mechanism underlying them remains
unknown.
1.7 Conclusions
Satellite cells are muscle specific stem cells responsible for muscle growth and regenera-
tion. They are found in a quiescent state in homeostatic conditions but become activated,
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re-enter the cell cycle, proliferate and exit the cell cycle to differentiate or self-renew in
response to muscle injury. These events are tightly regulated by intrinsic and extrinsic
mechanisms to ensure that sufficient differentiating progeny is generated and that the
satellite stem cell pool is replenished. One of the extrinsic signals that has been impli-
cated in the control of satellite cell behaviour is the Shh signalling pathway. This pathway
is one of the key modulators of tissue patterning, cell fate determination, cell survival and
proliferation in both the embryo and the adult. Shh signalling controls skeletal myogen-
esis in the embryo by activating muscle-specific transcription factors and genes encoding
basement membrane proteins (Anderson et al., 2009, 2012, Borycki et al., 1999b) In the
adult, the Shh pathway components are up-regulated in skeletal muscles after injury, and
treatment of muscle cell lines or primary myoblasts with Shh has multiple effects, from
enhanced cell proliferation, increased differentiation and improved cell survival (Elia et al.,
2007, Koleva et al., 2005, Straface et al., 2009). Systemic injections of cyclopamine in
muscle-injured mice reduces the efficiency of muscle regeneration (Straface et al., 2009).
Conversely, injection of a plasmid encoding human Shh in injured and dystrophic mouse
muscles can alleviate the dystrophic phenotype to some extent and improve the regen-
eration process (Piccioni et al., 2014a,b). While these findings suggest a role for Shh
signalling in adult myogenesis, fundamental questions about the role of the Shh path-
way on satellite cells remain unanswered, and the molecular mechanisms of Shh-mediated
effects have not been described yet.
1.8 Hypothesis
I hypothesised that the target of Shh-mediated effects in adult muscles were satellite
cells and that Shh signalling controls satellite cell activity function in mammalian adult
muscles.
1.9 Aims of the thesis
To test the hypotheses of this project, the aims were:
1. To investigate the expression of Shh signalling components during satellite cell ac-
tivation ex vivo and during muscle regeneration in vivo.
2. To determine the effect of Shh signalling blockade and stimulation on satellite cells.
3. To conditionally inactivate Smo expression in Pax7-expressing satellite cells to assess
the requirements of Shh signalling during muscle regeneration in vivo.
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The requirement of the Shh signalling pathway in the specification of mouse embryonic
muscle progenitors and the growing evidence for its role in adult muscles makes Shh a
potential candidate for muscle regeneration. Unravelling the role of Shh signalling in
satellite cells and adult myogenesis will improve our understanding of this process and





2.1 Mouse models used
2.1.1 C57BL/6 mice
6 to 8 week-old adult mice were maintained in accordance with the UK Home Office
regulation and the UK Animal Act of 1986 (ASPA) under a UK Home Office licence. All
mouse lines were kept on a C57BL/6 background, referred also as wild-type (WT) mice.
Animal care and husbandry were carried out at Biological Services at The University of
Sheffield.
2.1.2 GBS-GFP mice
The Gli response Tg:GBS-GFP mouse line was generated as described (Balaskas et al.,
2012). Briefly, eight fragments of a FoxA2 enhancer, which contains a Gli binding site,
were cloned upstream the hsp68 promoter to drive the expression of eGFP. Mice were
kindly provided by James Briscoe at the National Institute of Medical Research (NIMR),
London.
2.1.3 Pax7CreERT2-Smoflox/flox mice
Smoflox/flox;Pax7CreERT2/+ mice, referred here as SmocKO, were generated by crossing Smoflox/+;
Pax7CreERT2/+ mice (Lepper et al., 2009) with Smoflox/flox mice (Long et al., 2001). Control
animals used were Smoflox/+ and PaxCreERT2/+ mice.
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2.1.3.1 Induction of Cre-mediated recombination
Tamoxifen (TM, Sigma-Aldrich) (10mg/ml diluted in corn oil; Sigma-Aldrich) was ad-
ministered in mice by intraperitoneal (IP) injections at a dose of 3mg/40g of body weight
daily for 4 days before injury. Subsequently, mice were fed with Tamoxifen chow (approx-
imately 40 mg/kg/day; Harlan Laboratories) until sacrifice.
2.1.4 Pax7GFP mice
The Tg:Pax7-GFP mouse line was generated as described (Sambasivan et al., 2009). These
mice carry a BAC transgene containing approximately 200 kbp of mouse genomic DNA
that includes the locus encoding Pax7, which drives the expression of a nuclear localised
EGFP (nGFP). This construct recapitulates the endogenous expression of Pax7 in both
embryo and adult mice (Sambasivan et al., 2009).
2.1.5 Fucci2 mice
The fluorescent ubiquitination-based cell cycle indicator (Fucci2) mice have been described
elsewhere (Abe et al., 2013). These mice carry a single transgene, in which the Rosa26
promoter drives the expression of mCherry-hCdt1 and mVenus-hGem. mCherry-hCdt1
consists of the fluorescent reporter mCherry fused to the ubiquitylation domain of the Cdt1
protein, which accumulates in the cell nucleus during G0/G1. mVenus-hGem consists of
the fluorescent protein mVenus fused to the ubiquitylation domain of the Geminin protein,
which accumulates in the cell nucleus during S, G2 and M phases.
2.1.6 Genotyping
Mice were ear-clipped to provide tissue samples for genotyping. The clips were digested in
10mM NaOH and boiled at 95◦C for 30 minutes. Samples were neutralised with 1M Tris
(pH 8.0). Genomic DNA was precipitated with ammonium acetate and ethanol before
gene amplification (see section 2.8.3).
2.2 Single myofibre culture system
2.2.1 Extensor digitorum longus (EDL) and Tibialis anterior
(TA) muscle harvesting
EDL and TA muscles were dissected out from 6 to 8 week-old mouse hindlimbs as follows.
First, mice were culled by cervical dislocation and one of the hindlimbs was cleared out
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of hair using a scalpel and 70% ethanol. When the skin was visible, toothed forceps were
used to tear the skin and peel it off to expose the muscles. Mice were then pinned down on
a polystyrene foam board with needles and observed under a stereo microscope. Next, the
superficial connective tissue covering the TA muscle was carefully removed using forceps.
Then, the excess of skin from the paw was removed to exposed one TA and four EDL
distal tendons. All tendons were cut carefully using springbow dissecting scissors and
they were looped out from the paw at the level of the ankle. Next, the EDL proximal
tendon was visualised on the external side of the knee and cut off with scissors. The TA
muscle was pulled away from the limb by grabbing it from the distal tendon and cutting
it off at its proximal end, as close to the bone as possible. The EDL muscle, which is
located beneath the TA muscle, was gently removed by holding it from its distal tendon.
Dissected TA muscles were fixed for 1 hour (h) at 4◦C in 2% paraformaldehyde (PFA,
Sigma-Aldrich) with 0.25% Triton 100-X (Sigma-Aldrich) in PBS. Dissected EDL muscles
were placed in collagenase solution for muscle fibre isolation.
2.2.2 Isolation of single EDL muscle fibres
EDL muscles were digested with Collagenase Type I (2 mg/ml in Dulbecco’s Modified
Eagle’s medium (DMEM) supplemented with Glutamax; Sigma-Aldrich) at 37◦C for 80
minutes. Meanwhile, three 60mm Petri dishes (numbered 1 to 3) were coated with 5%
sterile bovine serum albumin (BSA; Sigma-Aldrich) in PBS and prepared with 5ml of
isolation medium (DMEM+Glutamax; Life Technologies and 1% Penicillin-Streptomycin-
Fungizone (PSF); Sigma-Aldrich) and kept at 37◦C. Single muscle fibres were obtained
from muscles under the dissection microscope using two heat-polished Pasteur pipettes
pre-coated with BSA as follows: a digested EDL muscle was transferred with a large bore
Pasteur pipette to Petri dish number 1 and gently pipetting was applied to flush the
muscle with the medium and release fibres. Individual myofibres were then transferred to
dish number 2 and then to dish number 3 using the small bore Pasteur pipette to wash off
non-muscle cells. This procedure was repeated several times to get about 180 fibres from
one EDL muscle. Individual muscle fibres were immediately fixed in 4% PFA in PBS or
cultured for further analysis.
2.2.3 Culture of single EDL muscle fibres
60mm petri dished were coated with 5% sterile BSA in PBS and prepared with 5ml of
complete medium (DMEM+Glutamax,10% horse serum; GIBCO/Invitrogen, 0.5% chick
embryo extract; Seralab, and 1% PSF) and kept at 37◦C until use. 25 to 30 individual
muscle fibres were transferred into a dish with complete medium and incubated at 37◦C
and 5% CO2. Fibres were collected at the indicated time.
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2.2.3.1 Use of Shh signalling pathway agonist and antagonists
Myofibre and primary cultures were incubated with either 100nM of Smoothened Agonist
(SAG, Millipore) in dimethyl sulfoxide (DMSO, Sigma-Aldrich), 4µM of Gli Antagonist
(GANT61, Tocris Bioscience) in DMSO or 5µM of Cyclopamine in ethanol (Calbiochem)
for the indicated time points. Optimal concentrations were determined by treating float-
ing myofibres and C2C12 myoblasts with different concentrations and by assessing Gli1
expression levels by RT-PCR.
2.2.3.2 EdU assay
Satellite cells in S-phase of the cell cycle were detected using the Click-iT EdU assay
(Invitrogen) following the manufacturer instructions. Briefly, myofibre cultures were in-
cubated with 10µM EdU for 1h at 37◦C prior to their harvest and subsequently fixed
in 3.7% formaldehyde for 10 minutes. Fibres were washed three times with 3% BSA in
PBS and permeabilized with 0.5% Triton 100-X in PBS for 15 minutes and then washed
again twice with 3% BSA in PBS. Fibres were incubated with EdU reaction mix for 30
minutes at room temperature (RT) in the dark. Next, fibres were washed with 3% BSA in
PBS and blocked with 1% goat serum in PBS for 30 minutes at RT. Immunofluorescence
staining was then performed as described below.
2.3 Immunofluorescence of single muscle fibres
Individual muscle fibres were collected in a crystal clear eppendorf tube and fixed in 4%
PFA in PBS for 8 minutes and washed three times with PBS. Fixed myofibres were per-
meabilized with 0.5% Triton 100-X in PBS for 8 minutes, washed three times with PBS
and blocked for 30 minutes at RT in 20% horse serum in PBS. Fibres were then incu-
bated with primary antibodies diluted in PBS overnight at 4◦C with agitation. Next day,
fibres were washed 3 times with 0.025% Tween 20 (Sigma-Aldrich) in PBS (PBST) and
incubated with secondary antibodies diluted in PBS for 1h at RT with agitation. Single
fibres were washed 3 times with PBST and mounted on microscope slides in Vectashield
with DAPI (Vector Laboratories) for imaging. Primary and secondary antibodies used in
this study are shown in tables 2.1 and 2.2.
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Table 2.1: Primary antibodies
Name Host Reference Supplier Dilution
Pax7 Mouse monoclonal Pax7 supernatant DSHB 1:20
Myf5 Rabbit polyclonal sc-302 Santa Cruz 1:1000
MyoD Rabbit polyclonal sc-304 Santa Cruz 1:2000
Caveolin-1 Rabbit polyclonal sc-894 Santa Cruz 1:400
Myogenin Mouse monoclonal F5D DSHB 1:50
Myogenin Rabbit polyclonal sc-576 Santa Cruz 1:50
GFP Chicken ab13970 Abcam 1:600
Ki67 Rabbit polyclonal Ki67 Leica 1:300
PH3 Rabbit polyclonal MC463 Millipore 1:300
Laminin alpha2 Rat monoclonal mAb(4H8-2) Enzo 1:300
Patched1 Rabbit polyclonal sc-9016 Santa Cruz 1:50
Laminin Rabbit polyclonal L9393 Sigma-Aldrich 1:1000
Collagen Rabbit polyclonal AB765 Millipore 1:350
Table 2.2: Secondary antibodies
Name Host Reference Supplier Dilution
Alexa 594 anti-mouse Goat A11005 Life Technologies 1:500
Alexa 594 anti-rabbit Goat A11037 Life Technologies 1:500
Alexa 488 anti-rabbit Goat A11034 Life Technologies 1:500
Alexa 488 anti-chicken Goat A11039 Life Technologies 1:500
Alexa 488 anti-rat Donkey A21208 Life Technologies 1:500
Alexa 633 anti-rabbit Goat A21070 Life Technologies 1:500
Alexa 633 anti-mouse Goat A21046 Life Technologies 1:500
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2.4 Model of muscle injury in vivo
2.4.1 Cardiotoxin injections
Mice were maintained anaesthetised with Isoflurane (IsoFlo, Abbott) and 50µl of Car-
diotoxin (CTX) (10µM in PBS) from Naja mossambica were injected in the TA muscle
with insulin syringes to induce localised injury. The injections were carried out by Dr.
Anne-Gaelle Borycki. Injured and control muscles were harvested at the indicated time
points after damage.
2.5 Muscle transverse sections
2.5.1 Freezing protocol
TA muscles were harvested as mentioned in section 2.2.1 and then immediately fixed in 2%
PFA with 0.25% Triton 100-X in PBS for for 1h at 4◦C. Muscles were washed several times
with ice-cold PBS and then placed in 20% sucrose (VWR Chemicals) in PBS overnight at
4◦C with agitation. Next day, muscles were embedded in O.C.T compound and rapidly
frozen in cold isopentane (both from VWR Chemicals). Frozen muscles were kept at
-80◦C for long-term storage.
Frozen muscles were mounted on a dry ice-chilled metal chuck with O.C.T compound
and 8 to 10µm transverse sections were generated on a Bright cryostat. Sections were
collected on superfrost slides (Thermo Scientific) and were air-dried for 2h at RT for
immediate immunolabelling or stored at -20◦C until further use.
2.5.2 Haematoxylin and eosin (H&E) staining
Frozen muscle sections were air-dried for 30 minutes at RT and then rehydrated with 1X
PBS for 1h in a coplin jar. Sections were then incubated for 5 minutes in 1% eosin in
methanol (both from Fisher Scientific), rinsed with tap water, stained for 5 minutes in
haematoxylin (Richard-Allan Scientific) and rinsed again with tap water. Sections were
then dehydrated through an ethanol gradient (70 to 100% in water). Slides were finally
incubated for 10 minutes in Xylene (Fisher Scientific) and mounted with DPX mountant
(Sigma-Aldrich) for analysis.
2.5.3 Immunofluorescence of muscle sections
Frozen transverse sections were air-dried for 30 minutes before processing. Next, slides
were hydrated for 5 minutes with PBS and then blocked for 1h in 5% BSA, 1% foetal
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bovine serum (FBS), 1% heat-inactivated goat serum and 0.5% Triton 100-X in PBS
in a humidified chamber. Sections were then incubated overnight at 4◦C with primary
antibodies diluted in PHT (PBS with 1% heat-inactivated goat serum and 0.5% Triton
100-X). After incubation, sections were washed 3 times with PHT and incubated for 1h
at RT with secondary antibodies diluted in PHT. Finally, sections were washed 3 times
with PHT and then mounted in Vectashield with DAPI for imaging. For some primary
antibodies like Pax7, an unmasking or antigen retrieval step was applied before staining.
To do so, air-dried sections were immersed in a coplin jar with 50ml of pre-warmed
1X citrate buffer pH 6 in PBS. The slides were microwaved at high power until boiling
(around 1 minute) and then at low power for 10 minutes. The coplin jar was kept in
the microwave for additional 10 minutes and then the slides were removed from the jar
and cooled down at RT for 5 minutes. Finally, the slides were rinsed once with PBS and
blocked as mentioned above.
2.5.4 Imaging
H&E sections were observed with a Leica DMR upright microscope. Samples used for
immunofluorescence were observed under Olympus BX51 microscope with X-cite 120 illu-
mination system (EXFO, Quebec, Canada). Immunofluorescence images were taken with
a Zeiss Apotome with ZEN pro imaging system. Images were assembled using Photoshop
CS5 version 12.0.4. Cross-sectional area (CSA), fluorescence intensity and cell counting
were analysed with the ImageJ software.
2.6 Cell cycle analysis by flow cytometry
2.6.1 Single cell isolation from cultured myofibres
Myofibres in culture were collected in a 15ml conical tube and spun down at 100g for
3 minutes to obtain a pellet. The supernatant was discarded and fibres were incubated
for 1h at 37◦C in a water bath in digestion buffer (DB), which contains a mixture of
collagenase A (100µg/µl, Roche) and Dispase II (2.4U/ml, Roche) in PBS. The mixture
was vortexed every 10 minutes during the incubation period to help digestion. Digested
fibres were then dissociated by mechanical action with a 19-gauge syringe for 5 minutes
and filtered through a 70µm strainer (Falcon) to obtain a single cell suspension.
2.6.2 Propidium iodide and RNAse A treatment
Isolated satellite cells in solution were spun down at 1000g for 10 minutes to obtain a
pellet. The supernatant was discarded and the cell pellet was washed once with PBS
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and transferred to a 1.5ml eppendorf tube. The solution was spun down again at 1000g
for 5 minutes and the supernatant was discarded. Cells were carefully fixed with 1ml of
70% ethanol; to do so, the tube was placed on a vortex and ice-cold ethanol was added
drop-wise. At this point, cells could be stored at -20◦C until analysis.
For further processing, the cell solution was spun down at 1000g for 5 minutes at
4◦C to discard the supernatant. Cells were then incubated for 30 minutes at 37◦C with
propidium iodide (PI, 10µg/ml) and RNAse A in PBS. Finally, cells were taken to the
flow cytometry facility for analysis.
2.6.3 Flow cytometry analysis
Labelled cells were analysed according to their DNA content with an Attune Autosampler
(Life Technologies) and using the Attune Cytometric Software (Applied Biosystems).
2.7 Cell sorting
2.7.1 Single cell preparation from bulk of muscle
6 to 8 week-old Pax7-GFP mice were culled by cervical dislocation and hair from one of
the hindlimbs was shaved with a scalpel and 70% ethanol. The skin was pinched and
torn off with toothed forceps to expose the muscles. Large leg skeletal muscles (TA,
gastrocnemius, quadriceps and biceps femoris) were removed under the stereo microscope
using scissors for ophthalmology and forceps. The muscles were transferred to ice-cold
PBS in a 10 cm Petri dish to remove connective tissue, tendons, blood vessels and fat.
Muscles were placed into another dish with fresh ice-cold PBS for washing. Clean muscles
were then transferred into another dish and minced into a smooth pulp using scissors for
ophthalmology. The pulp was placed into a 50ml Falcon tube containing 7ml of collagenase
type 2 (0.2% Worthington collagenase type II (CLS2) and 10% FBS in DMEM) and
incubated for 1h at 37◦C in a water bath. The solution was vortexed every 10 minutes
during the incubation period to help digestion. After incubation, digested muscles were
triturated with a 19-gauge syringe and the mixture was incubated for another 15 minutes
at 37◦C. The solution was then filtered through a 70µm strainer to obtain a single cell
suspension. The solution was spun down at 1000g for 10 minutes and the supernatant
was discarded. The cell pellet was then resuspended in chilled medium (10%FBS and
1%PSF in DMEM) and kept on ice until analysis.
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2.7.2 Fluorescence activated cell sorting (FACS) analysis
Single cell solutions were brought to the Medical School flow cytometry core facility at the
Royal Hallamshire Hospital, Sheffield. Cell suspensions were transferred into flow cytrom-
etry test tubes with cell strainer cap (Falcon, Corning) and analysed by the technical staff
in a BD FACSAria cell sorter. To perform the analysis, control cells from C57BL/6 mice
were also prepared as mentioned above to gate the fluorescence signal.
2.8 Molecular biology techniques
2.8.1 Total RNA isolation from muscle fibres, whole embryo and
cells grown in monolayer
RNA extraction was carried out with sterile and RNAse free reagents. Muscle fibres were
collected in a 2ml eppendorf tube and allowed to sit at the bottom of the tube to aspirate
culture medium. Fibres were washed once with PBS and then 200µl of Trizol reagent
(Invitrogen) was added to the tube. Fibres were carefully homogenised with a pellet
pestle motor (Kontes) and the mixture was left for 5 minutes at RT to help dissociation of
nucleoproteins. 40µl of chloroform was added and the solution was mixed vigorously for 15
seconds and incubate for 3 minutes at RT. The solution was spun down at maximum speed
for 15 minutes at 4◦C. After centrifugation, the aqueous phase was carefully transferred
to a new, clean tube and two volumes of ethanol were added to the sample, along with
1/20 volume of LiCl and 1µl of glycogen. Samples were incubated overnight at -20◦C.
After incubation, samples were centrifuged at maximum speed for 10 minutes at 4◦C. The
supernatant was discarded and the pellet was washed in 75% ethanol and centrifuged again
at 7500g for 5 minutes at 4◦C. The supernatant was discarded and the pellet was air-dried
and dissolved in pre-warmed RNase-free water (diethylpyrocarbonate (DEPC) water).
To extract RNA from whole embryos or cells grown in monolayer, 1ml of Trizol reagent
was directly added to the tissue or culture dish and the lysate was passed several times
through the pipette. The mixture was transferred to a 1.5 ml eppendorf tube and was
further homogenised using a vortex or a pestle motor. After 5 minutes of incubation at
RT, 0.2ml of chloroform was added per 1ml of Trizol used. From this point, all the steps
were the same as described above.
2.8.2 Complementary DNA (cDNA) synthesis
cDNA synthesis was carried out as described in the Invitrogen Superscript First Strand
Synthesis handbook. Briefly, 1 to 5µg of mRNA was primed with 50µM oligo(dT) and
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Table 2.3: Standard PCR program
Step Temperature ◦C Time Cycles
Initial denaturation 94 5 minutes 1
Denaturation 94 30 seconds 30
Annealing Primer Tm 30 seconds 30
Extension 72 30 seconds 30
Final extension 72 10 minutes 1
Hold 4 undefined 1
10mM dNTP mix into a final volume of 20µl of DEPC water. The samples were incubated
at 65◦C for 5 minutes and then chilled on ice for 1 minute. Next, 10µl of synthesis mix
(10X RT buffer, 25mM MgCl2, 0.1M DTT, RNaseOUT (40U/µl) and Superscript III
reverse-transcriptase (200U/µl)) was added to the samples and incubated 50 minutes at
50◦C. After incubation, the reactions were terminated at 85◦C for 5 minutes and then
chilled on ice. Finally, 1µl of RNase H was added to each sample and incubated for 20
minutes at 37◦C. At this point the samples could be used immediately for PCR or stored
at -20◦C.
2.8.3 Reverse transcription polymerase chain reaction (RT-PCR)
Semi-quantitative RT-PCR was used to detect transcripts of different Shh signalling path-
way components in cultured muscle fibres. cDNA was used as a template and primers
listed in table 2.4 were used to amplify the region of interest. Primer stock concentration
was 100µM but 20µM aliquotes were made to prevent contamination of the main the
stock. PCR reactions were prepared by adding 10µl of 2x RedTaq ReadyMix (Sigma),
800nM of each primer and 500ng of cDNA adjusted to a final volume of 20µl of autoclaved
milliQ water. PCR reactions were performed in a Eppendorf mastercycler gradient PCR
machine (Eppendorf). Temperature and time conditions were optimised by adjusting
the melting temperature (Tm) in a gradient program. A standard PCR program was as
shown in table 2.3.
Finally, RT-PCR amplification products were run in 1% agarose/TAE gel containing
ethidium bromide (4µl/100ml of agarose). 1kb DNA ladder (Fermentas) was also loaded
to indicate band sizes.
2.8.4 Quantitative real-time PCR (qPCR)
qPCR was used to estimate relative expression levels of specific genes. These expression
levels can also be considered as the amount of PCR product (amplicon) that is synthesised
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as the reaction occurs. This amount of amplicon is directly related to the fluorescence
emitted by a reporter dye, in this case SYBR Green, which binds to double-stranded
DNA. The cycle threshold (Ct) value is taken as a reference of fluorescence accumulation,
and it is defined as the number of cycles required for the fluorescence to cross a threshold
or background level. The greater the initial concentration of the target gene in the sample,
the fewer the number of cycles required to amplify the product.
Before starting with the analysis, qPCR primer concentrations were optimised by dilu-
tion series of forward and reverse primers in different combinations (from 1000 to 62.5nM),
using embryo cDNA (150ng) or milliQ water as template. Primers and templates were
mixed with 2x SYBR Green JumpStart Taq ReadyMix (Sigma) to a final concentration of
1.25 units of Taq DNA polymerase in a 20µl reaction adjusted with milliQ water. Samples
were read with a iCycler instrument (Biorad) and using the iCycler software. Optimal
primer concentrations were determined using the melt curve to identify a single peak that
corresponds to the target amplicon.
Routine qPCR analysis was performed by preparing 20µl reaction mix as for primer
optimisation (2x SYBR Green JumpStart Taq ReadyMix, forward and reverse primers
at optimal concentrations, template DNA (150ng) adjusted with milliQ water). Samples
were run as triplicates in a non-skirted 96-well plate (Cell Projects), sealed with a Mi-
croseal film (Biorad) and analysed in an iCycler. Transcription levels were calculated
using the ∆∆Ct method. For qPCR analysis of cultured myofibres, Ct values were nor-
malised by subtracting the Ct value of the housekeeping gene Gapdh from the Ct value
of each target gene. Next, the relative mRNA levels of cultured myofibres at 24, 48 and
72h compared to freshly isolated myofibres at 0h were calculated.
2.8.5 Primer design
Primers were obtained either from the literature or designed using Primer Premier 5.
Primer-BLAST tool was used to verify the specificity of the primers and to prevent partial
binding to other sequences. Primer sequences for RT-PCR and qPCR are listed in tables
2.4 and 2.5 respectively. For qPCR analysis, forward RT-PCR primers for GAPDH, Ptch1
and Gli1 were used.
2.9 Statistical analysis
The number of positive cells per individual myofibre per experimental condition per mouse
were counted and averaged. The average number of positive cells on muscle cryosections
was based on four to six cross-sectional fields (x20 or 0.154 mm2) of regenerating muscle
per mouse. Mean values per experiment were then averaged across all subjects in each
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Table 2.4: RT-PCR primers
Gene Primer Sequence Tm ◦C Reference
Shh Forward CTGCGAGTGACCGAGGGCTG 65 This work
Shh Reverse GCGGTCCAGGAAGGTGAGG 62.4 This work
Ptch1 Forward CAACACCTGGACTCAGCACTCC 61.6 This work
Ptch1 Reverse GTGGCAGGGCAATCTGGGTC 62.5 This work
Gli1 Forward GAGAGCAGACTGACTGTGCCC 60.2 This work
Gli1 Reverse CCTGCGGCTGACTGTGTAAG 60.8 This work
Gli3 Forward GAAATGTCCCACGAGAACAGATGTC 59.8 This work
Gli3 Reverse GAGGAGGGTGGTAGTGAGGC 62.2 This work
Smo Forward TGCCACCAGAAGAACAAGCCA 59.8 (Zhao et al., 2006)
Smo Reverse GCCTCCATTAGGTTAGTGCGG 61.8 (Zhao et al., 2006)
Hip Forward CAAAGCCCAGTGACCAAGCAATG 62.6 This work
Hip Reverse CACGCTGGCTCACACTTGGC 64.3 This work
GAPDH Forward ACTCCACTCACGGCAAATTC 57.3 (Morita et al., 2005)
GAPDH Reverse ACTGTGGTCATGAGCCCTTC 59.4 (Morita et al., 2005)
Acta1 Forward GGCACCCAGGGCCAGAGTCA 66.5 (Londhe and Davie, 2011)
Acta1 Reverse TCATCCCCGGCAAAGCCAGC 65.6 (Londhe and Davie, 2011)
Table 2.5: qPCR primers
Gene Primer Sequence Tm ◦C Reference
GAPDH Reverse GACTCCACGACATACTCAGCACC 59.4 This work
Ptch1 Reverse GCAAGGGTAAAGGTATTCTATTATCTG 57.7 This work
Gli1 Reverse CATCTCCACGCCGCTGTCCG 65.8 This work
Gli2 Forward AGAACCTGAAGACACACCTGCG 62.7 (Rowbotham et al., 2007)
Gli2 Reverse GAGGCATTGGAGAAGGCTTTG 59.5 (Rowbotham et al., 2007)
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group. Values were expressed as either mean ± standard error of the mean (SEM) or
boxes (interquartile ranges, RQ) and whiskers (minimum and maximum values). Where
percentage data were used, these were transformed before statistical analysis. A minimum
of three individual mice were analysed for each experiment, unless stated otherwise in the
figure legend.
To determine significance between two groups, comparisons were made using unpaired
two-tailed Student’s t-test. Analyses of multiple groups (qPCR data and GBS-GFP inhi-
bition) were performed with one-way ANOVA and Tukey’s multiple comparison post-hoc
test. All data were analysed using Prism version 6.00 for Mac (GraphPad Software). p<








Since their initial anatomical characterisation through electron microscopy by Mauro in
1961, satellite cells have been largely studied using in vitro approaches to explore their
behaviour and myogenic potential. Subsequently, in vivo strategies to determine the con-
tribution of satellite cells during muscle regeneration have been established. More recently,
ex vivo culture strategies have also been implemented, which offer great advantages over
in vitro systems but without substituting for in vivo models.
3.1.1 In vitro systems to study satellite cells
There are two main in vitro approaches to study satellite cells and their progeny: immor-
talised muscle cell lines derived from satellite cells and primary myogenic cell cultures.
The C2 cell line, which was generated from adult injured thigh muscles of C3H mice
(Yaffe and Saxel, 1977) and one of its subclones, the C2C12, is one of the most widely
used myogenic cell lines due to its ability to differentiate easily (Blau et al., 1985). Fur-
thermore, the use of these lines has provided extensive knowledge on biochemical and
molecular characteristics and requirement of muscle cells in culture (Semesarian et al.,
1999) (Conboy and Rando, 2002) (Katagiri et al., 1997).
The second in vitro strategy to study satellite cells is the direct isolation of primary
myoblasts from whole muscles. This approach has been extensively used to study satel-
lite cell progeny as they proliferate, differentiate and fuse but also to overcome some
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issues with established cell lines, such as senescence, poor transplantation potential and
alteration of their phenotype and responsiveness to stimuli linked to constant passaging
(Rando and Blau, 1994). Moreover, primary myoblasts can be isolated from practically
any animal model, which is useful to study age-specific processes or when using genetically
engineered mice. It is important to mention, however, that in vitro cultures of satellite
cells might not mimic entirely the biological behaviour that satellite cells have in vivo,
mainly because satellite cells are taken out from their native environment, including the
muscle fibre, the basal lamina and other non-myogenic cells.
3.1.2 Study of satellite cells ex vivo: the myofibre culture sys-
tem
The isolation and culture of single myofibres from adult rat flexor digitorum brevi (FDB)
muscles was first established by Bekoff and Betz (Bekoff and Betz, 1977) and then op-
timised and further characterised by Bischoff (Bischoff, 1986). Later, isolation of mouse
extensor digitorum longus (EDL), tibialis anterior (TA) and soleus muscle fibres was also
implemented (Rosenblatt et al., 1995). Slightly different protocols of this ex vivo system
are available (Collins and Zammit, 2009, Pasut et al., 2013, Shefer and Yablonka-Reuveni,
2005), but all of them rely on the culture of individual muscle fibres in floating conditions
to study satellite cells in their native position, i.e. packed between the sarcolemma and
the basal lamina of the muscle fibre. Although this is a simplified system that removes
external cues coming from non-myogenic cell types, such as blood and connective tissue
cells (Zammit et al., 2004), when single muscle fibres are cultured in serum-rich medium
for 72h, satellite cells quickly activate, proliferate and eventually differentiate, mimicking
the events that happen during myogenesis in vivo (Beauchamp et al., 2000). Moreover,
single satellite cells can be visualised using specific satellite cell and myogenic markers
and different cell populations can be identified within the 72h-period, as shown in table
3.1).
The ex vivo culture system has provided a better understanding of the biology of
satellite cells, as well as meaningful information on the intrinsic and extrinsic cues required
in different stages of adult myogenesis. Importantly, this approach was not only key to
confirm the ”stemness” and ability of satellite cells to give rise to other muscle cells
(Bischoff, 1975) but also to study satellite cell behaviour with live imaging techniques
(Siegel et al., 2009). Finally, molecular and biochemical approaches are also possible
using this system (Pasut et al., 2013). Nevertheless, single myofibres cannot survive in
floating conditions for long periods of time (up to 96 or 120 hours), so later events like
satellite cell fusion into myotubes cannot be studied using this system.
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Table 3.1: Satellite cell populations found during ex vivo culture as reported in the literature
Population Description
Pax7+/Myf5-
Population made by either quiescent satellite cells or
satellite cells that have not activated myogenic factors
yet (Collins et al., 2007, Gnocchi et al., 2009)
Pax7-/Myf5+
Satellite cell population that has switched off Pax7 ex-
pression and is expected to also express MyoD (Zammit
et al., 2002)
Pax7+/Myf5+
Population of satellite cells that have become activated
(Zammit et al., 2004)
Pax7+/MyoD-
Self-renewing satellite cell population (Halevy et al.,
2004, Ono et al., 2011, Zammit et al., 2004)
Pax7-/MyoD+
Satellite cell population that has entered the differenti-
ation phase and would be expected to express Myogenin
(Ono et al., 2011, Zammit et al., 2004)
Pax7+/MyoD+
Satellite cell population undergoing expansion (Zammit
et al., 2004)
Caveolin-1+/Myogenin-
Population made by either quiescent satellite cells or
satellite cells that express MyoD but have not switched
on Myogenin expression yet. These cells are expected to
also express Pax7 (Gnocchi et al., 2009, Zammit et al.,
2004)
Caveolin-1-/Myogenin+
Satellite cells that have reached terminal differentiation
and do not express Pax7 (Gnocchi et al., 2009)
Caveolin-1+/Myogenin+
Differentiating satellite cells. These cells are expected to
also express MyoD but not Pax7 (Gnocchi et al., 2009,
Zammit et al., 2004)
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3.1.3 Models to explore satellite cell function in vivo
Contribution of satellite cells to repair muscles in vivo can be explored with injury mod-
els, where two main phases can be identified: a degenerative and a regenerative phase
(Charge and Rudnicki, 2004). The degeneration phase begins with cell necrosis caused by
the breakage of muscle fibres, which is accompanied by an increase in fibre permeability
and in cytosolic protein levels such as creatine kinases (Sorichter et al., 1998b). Cal-
cium homeostasis is also disrupted, triggering calpain-mediated proteolysis (Alderton and
Steinhardt, 2000). During the degeneration phase, damaged fibres release chemotactic
factors that activate and recruit mononucleated cells, including inflammatory and muscle
cells (Tidball, 1995). Within few hours after damage, the first inflammatory cells that
migrate to the injury site are neutrophils followed by macrophages, which can also affect
satellite cell behaviour (Merly et al., 1999).
Muscle degeneration is followed by a regeneration phase, which is characterised by
satellite cell activation, expansion, differentiation and fusion to repair damaged fibres
(Snow, 1978). This leads to the appearance of small, newly formed myofibres with
centrally located myonuclei that express embryonic forms of the Myosin Heavy Chain
(MYHC) protein (Whalen et al., 1990). Once satellite cells have repaired the damage,
new muscle fibres increase their size and some myonuclei might migrate to the periphery.
At this point, the muscle architecture is completely restored.
Different models of muscle injury have been established. These include models of
chronic muscle injury such as the mdx mouse, a genetic homologous equivalent of Duchenne
muscular dystrophy (DMD) and characterised by the absence of the protein Dystrophin
(Carnwath and Shotton, 1987). Acute models of muscle injury are also widely used and
contrary to chronic injury models, these are characterised by a single round of degenera-
tion with transient collagen accumulation and inflammatory response and restoration of
muscle architecture by 3 to 4 weeks after damage. These models include the injection
of myotoxins like bupivacaine, cardiotoxin (CTX) or neotexin, which results in around
80-90% damage of muscle membranes and necrosis without affecting satellite cell survival,
or the injection of BaCl2, which causes myofibre death by membrane depolarisation, exo-
cytosis and Ca2+ efflux blockage (Boldrin et al., 2012, Relaix and Zammit, 2012). Other
methods to induce acute injury are muscle crushing, freezing, denervation and ischemia
(Charge and Rudnicki, 2004). Both chronic and acute injury models present degeneration
and regeneration phases but their progression and duration may vary depending on the




The aim of this chapter is to reproduce different established models to study satellite cell
function, one in vitro, one ex-vivo and one in vivo, which form the methodological basis
of this project.
3.2 Results
3.2.1 Satellite cell-mediated myogenesis can be studied ex vivo
using the myofibre culture system
The ex vivo myofibre culture system has been widely used since the discovery of the
protocol to isolate single myofibres from whole muscles (Bischoff, 1975). To reproduce
this system in the lab, single muscle fibres from 6 to 8 week-old wild-type C57/BL6 mouse
EDL muscles were either immediately fixed to preserve satellite cell quiescence (time 0h)
or cultured ex vivo for 24, 48 and 72 hours. Quiescent satellite cells were identified at
time 0h by the expression of the transcription factor Pax7 (Seale et al., 2000) (Fig.3.1
A-C). A mean of four Pax7+ satellite cells were counted on each freshly isolated myofibre
at 0h (Fig.3.1 M), consistent with previous reports (Beauchamp et al., 2000). After 24h
in culture, Pax7+ satellite cells exited quiescence and became activated, as shown by the
expression of the myogenic transcription factor Myf5 (Fig.3.1 D-F). At this time point,
around 84.6% of the cells co-expressed both Pax7 and Myf5, indicating that the majority
of satellite cells become activated upon culture (Fig.3.1 M and table 3.1). Furthermore,
following activation, satellite cells underwent morphological changes, as they appeared
more round compared to quiescent satellite cells. A mean of six Pax7+/Myf5+ satellite
cells could be observed per fibre and this number was similar to time 0h (Fig.3.1 M).
In the ex vivo culture system, satellite cells undergo their first cell division between 24
and 48h (Siegel et al., 2011, Zammit et al., 2004). Consistently, I observed a 3-fold increase
in the number of satellite cells bewteen 24 and 48h (Fig.3.1 M) and satellite cells were
characterised by the co-expression of Pax7 and the myogenic transcription factor MyoD,
which follows Myf5 expression (Zammit et al., 2002) (Fig.3.1 G-I). By 48h, 86.7% of Pax7+
cells co-expressed MyoD, whereas 7.3% just expressed Pax7 and 6% expressed only MyoD
(Fig.3.1 M and table 3.2). The fraction of Pax7+/MyoD- cells might correspond to self-
renewing satellite cells needed to maintain the stem cell pool or to Pax7+ satellite cells
that have not up-regulated MyoD expression yet (Zammit et al., 2004).
At 72h, as Pax7 is down-regulated in differentiating cells (Ono et al., 2011, Zammit
et al., 2004), I labelled satellite cells with the marker Caveolin-1, which labels most of







Figure 3.1: Myogenic regulatory factors expression on satellite cells from single muscle
fibres cultured ex vivo. Individual mouse skeletal muscle fibres were cultured in floating conditions
for 0, 24, 48 and 72h. Myofibres were immunostained to detect Pax7 in red (B, D and G), Myf5 in green
(E), MyoD in green (H), Caveolin-1 in green (J) and Myogenin in red (K). Nuclei were counterstained
with DAPI in blue, as shown in A. Merged images for each time point are shown in C, F, I and L.
Magnified views for every channel are shown (regions indicated by an arrow). Scale bar represents 20µm.
Quiescent satellite cells at 0h expressed Pax7. Upon 24h in culture, satellite cells became activated
and up-regulated Myf5 and by 48h, MyoD. Beyond 48h, satellite cells expanded and most cells entered
differentiation so that, by 72h, Myogenin+ satellite cells could be detected. At this point, satellite cells
can also down-regulate myogenic factors and return to quiescence (Halevy et al., 2004, Ono et al., 2011,
Zammit et al., 2004). The onset of amplification of the satellite cell population occurred between 24 and
48h and a maximum expansion could be observed by 72h (M). Representative data from at least three
individual mice are shown, with 15 individual fibres per mouse counted for each time point. Values are
mean and error bars indicate standard error of the mean (SEM).
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differentiated cells (Gnocchi et al., 2009). As shown in Fig.3.1 J-L, most satellite cells
were labelled with Caveolin-1 at 72h and expanded greatly, increasing their numbers by
around four-fold (Fig.3.1 M). By 72h, 51.6% of cells expressed both Caveolin-1 and Myo-
genin, which represent differentiating satellite cells, while 8.6% only expressed Myogenin
and are terminally differentiated cells. The 39.8% remaining cells that were Caveolin-
1+/Myogenin-, may either not have switched Myogenin expression on yet or have already
down-regulated MyoD and returned to quiescence (Tables 3.1 and 3.2) (Gnocchi et al.,
2009, Zammit et al., 2004).
Together, using the ex vivo culture system, I managed to show the transition of satellite
cells from the activation phase (Myf5+) to the expansion phase (MyoD+) and to the
differentiation phase (Myogenin+), which goes in line with previous reports within the
literature (Gnocchi et al., 2009, Zammit et al., 2004).
3.2.2 Adult myogenesis can be studied in vivo by inducing mus-
cle injury with cardiotoxin
6 to 8 week-old C57/BL6 TA muscles were injected with cardiotoxin as described in
section 2.4.1. The left TA muscle was injured and the right muscle was kept as uninjured
control. Injured and control TA muscles were harvested at 2, 4, 7 and 14 days following
induced injury and were processed as described in section 2.5. Muscle transverse sections
were then analysed by hematoxylin and eosin staining (H&E). Normal uninjured TA
muscles had a highly homogeneous appearance, with muscle fibres of similar size and
myonuclei located at the periphery of fibres (Fig.3.2 A-C). In contrast, 2 days after CTX-
induced injury, the whole architecture of the muscle changed: myofibres lost their defined
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shape due to necrosis and infiltration of mononucleated cells to the site of injury was
observed, which are likely to be inflammatory cells, fibroblasts and satellite cells (Fig.3.2
D-F). At 4 days following injury, the infiltration of cells was still visible and some newly
formed myofibres were readily detected, as shown by the appearance of centrally located
myonuclei (Fig.3.2 G-I). Newly regenerated myofibres were more abundant at 7 days post-
injury (Fig.3.2 J-L). Finally, the architecture of the muscle was visibly restored at 14 days
after CTX-induced injury, showing larger fibres with centrally located nuclei (Fig.3.2 M-
O) (Charge and Rudnicki, 2004). Beyond 14 days, inflammation reduces greatly so by day
21, little or no inflammatory cells can be observed (Mann et al., 2011). Finally by day 28
post-injury, the muscle displays a normal morphology with myofibres of almost the same
diameter as non-injured ones, although centrally located nuclei are still visible (Charge
and Rudnicki, 2004, Rosenblatt, 1992). Thus, localised CTX muscle injury allows us to
follow the progression of muscle regeneration over time, with discrete events that span
over a 28 day-period.
3.2.2.1 Satellite cells become activated and expand upon muscle injury in
vivo
In order to identify satellite cells during adult muscle regeneration in vivo, immunoflu-
orescence analysis of Pax7 and Laminin was performed in uninjured and CTX-injured
TA muscles at 2, 4, 7 and 14 days post-injury. Non-injured muscles presented quiescent
Pax7+ satellite cells located under the basal lamina of muscle fibres, here labelled with
Laminin (Fig.3.3 A-D). Satellite cell activation occurs within a few hours after injury
(Cooper et al., 1999) and at 2 days following CTX-induced damage, satellite cells likely
to be activated were detected at the site of injury (Fig.3.3 E-H). By day 4 the satellite
cell population expanded as more Pax7+ cells were visible, which coincided with the ap-
pearance of newly formed myofibres with centrally located nuclei (Fig.3.3 I-L). Beyond
day 7, the muscle architecture was progressively restored and Pax7+ satellite cells were
less abundant and were re-positioned beneath the basal lamina of regenerating myofibres
(Fig.3.3 M-P), so that by day 14, CTX-injured muscles looked similar to uninjured control
muscles apart from the presence of centrally locates myonuclei (Fig.3.3 Q-T).
To detect activated satellite cells, immunofluorecence analysis of MyoD and Laminin
alpha 2 was performed in uninjured and CTX-injured TA muscles at 2, 4, 7 and 14
days post-injury. Unlike non-injured muscles, CTX-injured muscles at 2, 4 and 7 days
expressed MyoD+ satellite cells (Fig.3.4). MyoD+ satellite cells were more abundant
at 4 days post-injury (Fig.3.4 I-L) and declined at 7 days post-injury (Fig.3.4 M-P) to
became nearly undetectable by 14 days (Fig.3.4 Q-T), indicating a gradual completion of
the myogenic program once the muscle architecture was restored.
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Figure 3.2: Regeneration process following cardiotoxin induced muscle injury. Uninjured and
cardiotoxin-injured (2, 4, 7 and 14 days post-injury) TA muscles from C57/BL6 mice were analysed by
H&E staining to assess changes in muscle architecture. Non-injured TA muscle fibres had an homogeneous
size and appearance (A-C). In contrast, injured muscles were characterised by changes in myofibre shape
due to necrosis and cell infiltration of different types of mononuclear cells at 2 (D-F) and 4 days (G-I)
post-injury. Newly regenerating myofibres were visible from day 4 but more evident by day 7 post-
injury (J-L). Muscle architecture was restored by 14 days post-injury (M-O), with the presence of fully
regenerated myofibres. Non-injured areas, infiltrated cells and fibres with centrally located nuclei are
shown with green, yellow and red arrows, respectively. Representative images from three individual mice
for each time point are shown. Scale bar represents 200µm.
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Figure 3.3: Pax7 labels satellite cells during muscle regeneration. Uninjured and CTX-injured
(2, 4, 7 and 14 days post-injury) TA muscles from C57/BL6 mice were analysed by immunofluorescence
using antibodies against Pax7 (red) and Laminin (green). Cell nuclei were counterstained using DAPI
(blue). Merge images from three channels are shown for non-injured and 2, 4, 7 and 14 injured muscles
in D, H, L, P and T, respectively. Magnified views for every channel are shown (regions indicated by
an arrow). Non-injured TA muscles had quiescent Pax7+ cells positioned beneath the basal lamina (A-
D). 2 days after CTX-induced injury, Pax7+ satellite cells migrated to the site of injury (E-H). By 4
days post-injury (I-L) the satellite cell population expanded and persisted until day 7 (M-P). Finally,
at 14 days post-injury, the restoration of the muscle architecture was accompanied by a decline in the
number of Pax7+ satellite cells and the reintegration of self-renewing cells under the basal lamina (Q-T).
Representative images from three individual mice for each time point are shown. Scale bar represents
50µm.
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Figure 3.4: Activated satellite cells expressed MyoD during muscle regeneration. Uninjured
and CTX-injured (2, 4, 7 and 14 days post-injury) TA muscles from C57/BL6 mice were analysed by
immunofluorescence using antibodies against MyoD (red) and Laminin alpha 2 (green). Cell nuclei were
counterstained using DAPI (blue). Merge images from three channels are shown for non-injured and 2,
4, 7 and 14 injured muscles in D, H, L, P and T, respectively. Magnified views for every channel are
shown (regions indicated by an arrow). Uninjured TA muscles had quiescent satellite cells that did not
express MyoD (A-C). Upon CTX-induced muscle injury, satellite cells became activated and expressed
MyoD at 2 (E-H), 4 (I-L) and 7 days (M-P) but this expression declined by 14 days post-injury (Q-T).
Representative images from three individual mice for each time point are shown. Scale bar represents
50µm.
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3.2.2.2 Satellite cells proliferate in response to muscle injury in vivo
To assess the proliferative status of satellite cells during muscle regeneration, a pilot ex-
periment was carried out using muscles from Tg:Pax7-EGFP mice, which express EGFP
under the control of the regulatory elements of Pax7 and label all satellite cells (Samba-
sivan et al., 2009). These muscles were sectioned and analysed by immunofluorescence
using antibodies against GFP and the proliferation marker Ki67 at 1, 2, 4, 7 and 14
days post-injury. Uninjured TA muscles had quiescent GFP+ satellite cells (average of
39 cells/mm2) and did not express Ki67 (Fig.3.5 A-D and Y). In contrast, an important
increase in the number of Ki67+ cells was observed at 1 day post-injury, where an aver-
age of 62 cells/mm2 were GFP-/Ki67+, 7 cells/mm2 were GFP+ only and 39 cells/mm2
were GFP+/Ki67+ (which represents 85.4% of the Pax7+ population), indicating that
the majority of satellite cells have become activated and entered the cell cycle. In addi-
tion, other cell types proliferate in response to injury (Fig.3.5 E-H and Y). The expres-
sion of proliferating Pax7+ satellite cells increased by 3.6-fold at day 2 post-injury (143
cells/mm2) (Fig.3.5 I-L and Y), as was the number of non-myogenic cells (GFP-/Ki67+,
203 cells/mm2).
Between 2 and 4 days post-injury, the Pax7+ satellite cell population expanded further
although the overall number of Ki67+ cells decreased. By 4 days post-injury, an average
of 557 cells/mm2 were GFP+/Ki67-, 232 cells/mm2 were only positive for Ki67 and 51
cells/mm2 were both GFP+ and Ki67+ cells (just 8.5% of all Pax7+ cells) (Fig.3.5 M-
P and Y). At day 7 post-injury, there was a drastic reduction in the overall number
of both GFP+ and Ki67+ cells (Fig.3.5 Q-T and Y), with an average of 12 cells/mm2
co-expressing GFP and Ki67. Finally, by 14 days post-injury, a mean of 132 cells/mm2
only expressed GFP, 12 cells/mm2 only expressed Ki67 and no GFP/Ki67 co-expression
could be detected (Fig.3.5 U-X and Y). This suggests that satellite cells undergo an
important expansion between 2 and 4 days post-injury to reach a maximum number by 4
days. Satellite cell numbers decline beyond 4 days post-injury, which coincides with the
progressive down-regulation of Ki67 expression.
3.2.2.3 Satellite cells differentiate in vivo to contribute to muscle regenera-
tion
The progressive decline of proliferating Pax7 expressing-satellite cells from 4 days post-
injury suggests that myoblasts have initiated differentiation. To identify differentiating
progenitor cells, another pilot experiment was performed using Tg:Pax7-EGFP mice.
Here, Tg:Pax7-EGFP were analysed by immunofluorescence using antibodies against GFP
and the myogenic transcription factor Myogenin at 1, 2, 4, 7 and 14 days post-injury. In
uninjured TA muscles, quiescent GFP+ satellite cells did not express Myogenin (Fig.3.6
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Figure 3.5: The satellite cell population expands during muscle regeneration. Uninjured
and cardiotoxin-injured (1, 2, 4, 7 and 14 days post-injury) TA muscles from Tg:Pax7-EGFP mice were
analysed by immunofluorescence using antibodies against Ki67 (red) and GFP (green). Cell nuclei were
counterstained using DAPI (blue). Merge images from three channels are shown for non-injured and 1,
2, 4, 7 and 14 injured muscles in D, H, L, P, T and H respectively. Magnified views for every channel are
shown (regions indicated by an arrow). Scale bar represents 50µm. Uninjured TA muscles had quiescent
GFP+ satellite cells that did not show any Ki67 expression (A-D). Following CTX-induced muscle injury,
satellite cells became activated and expressed Ki67 at 1(E-H), 2 (I-L) and 4 (M-P) days post-injury. By
day 7 (Q-T), the number of Ki67+ satellite cells declined so that by 14 days, no Ki67 expression was
observed (U-X).(Y) shows the quantification of the number of Ki67 and GFP expression in Tg:Pax7-
EGFP uninjured and CTX-injured TA muscles. Mean values are shown. Each mean is based on four to
six random 0.154 mm2 regenerating areas from one mouse per each time point.
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A-D and Y). At 1 day post-injury GFP+ satellite cells were activated but had not induced
Myogenin expression yet (Fig.3.6 E-H and Y). In contrast, from 2 days post-injury, some
Myogenin+ cells could be detected (26 cells/mm2) (Fig.3.6 I-L and Y) and this number
increased further at 4 days post-injury, with 103 cells/mm2 being Myogenin+ (Fig.3.6
M-P and Y). By day 7, just 23 cells/mm2 were Myogenin+ (Fig.3.6 Q-T and Y) and
by 14 days post-injury the number of Myogenin+ cells was a little bit higher than at
7 days (48 cells/mm2) (Fig.3.6 U-X and Y). Together, these data suggest that satellite
cell differentiation starts as early as 2 days post-injury, peaks at 4 days post-injury and
progressively decreases from 7 days. This reduction coincides with the increase of fibres
with centrally located nuclei.
3.3 Discussion
3.3.1 The myofibre culture system recapitulates the events that
happen during satellite-cell mediated myogenesis ex vivo
The myofibre culture system is a simple yet useful approach to study satellite-cell me-
diated myogenesis ex vivo (Fig.3.7). This system preserves satellite cells in their native
environment while removing input from non-myogenic cells. Although this system does
not substitute for the in vivo system, it offers great advantages over in vitro models. In
particular, feedback mechanisms between satellite cells and the niche are preserved in the
ex vivo culture system. For instance, quiescent satellite cells express nitric oxide synthase
(NOS) and shear forces that occurs during myofibre isolation stimulate nitric oxide (NO)
synthesis (Anderson, 2000). This results in the release of hepatocyte growth factor (HGF)
from the extracellular matrix and the binding to its receptor c-Met, expressed by satellite
cells (Tatsumi et al., 2002, Yamada et al., 2006). Interestingly, NO is also involved in the
regulation of satellite cell migration along the muscle fibre following a blebbing movement
(Otto et al., 2011).
Here, I used the transcription factor Pax7 to identify quiescent and activated satel-
lite cells in freshly isolated myofibres. However, other satellite cell markers have been
described, including the proteins C-Met, Caveolin-1, M-Cadherin, Integrin α 7 and CD34
among others (Yin et al., 2013). A mean of four Pax7+ satellite cells was detected in
freshly isolated myofibres from EDL muscles, which is in agreement with previous re-
ports (Ono et al., 2010, Shefer et al., 2006). Furthermore, the proportion of satellite cells
progressing into the different stages of the myogenic program reported here, including
activation at 24h, proliferation at 48h and differentiation at 72h, was also consistent with
the literature (Gnocchi et al., 2009, Zammit et al., 2002).
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Figure 3.6: Satellite cells activate Myogenin expression during muscle regeneration in vivo
Uninjured and cardiotoxin-injured (1, 2, 4, 7 and 14 days post-injury) TA muscles from Tg:Pax7-EGFP
mice were analysed by immunofluorescence using antibodies against GFP (green) and Myogenin (red).
Cell nuclei were counterstained using DAPI (blue). Merge images from three channels are shown for
non-injured and 1, 2, 4, 7 and 14 injured muscles in D, H, L, P, T and H respectively. Magnified views for
every channel are shown (regions indicated by an arrow). Scale bar represents 50µm. Quiescent GFP+
satellite cells in uninjured muscles cells did not express Myogenin, a marker of muscle differentiation
(A-D). At 1 day following muscle injury, satellite cells became activated but did not express Myogenin
(E-H). However, Myogenin expression was detected at 2 (I-L), 4 (M-P), 7 (Q-T) and 14 days (U-X)
post-injury. (Y) shows the quantification of Myogenin and GFP expression in Tg:Pax7-EGFP uninjured
and injured TA muscles. Mean values are shown. Each mean is based on four to six random 0.154 mm2
regenerating areas from one mouse per each time point.
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Figure 3.7: The myofibre culture system recapitulates satellite cell-mediated myogenesis. In
this culture system, satellite cells maintain their association with the fibre and the basal lamina (niche)
and are able to undergo myogenesis ex vivo. Importantly, harvesting fibres at different time points allows
for the analysis of different cellular events, such as satellite cell in quiescent state labelled with Pax7
(T=0), Pax7+/Myf5+activated satellite cells (T=24h), Pax7+/MyoD+ proliferative cells (T=48h) and
Myogenin+ differentiating satellite cells (T=72h).
3.3.2 An acute model of muscle injury to study satellite cell
myogenesis in vivo
In this chapter I reproduced a previously described cardiotoxin-mediated acute model of
muscle injury to study satellite cell-mediated muscle regeneration. Satellite cell-mediated
muscle regeneration in vivo was visualised by immunolabelling of Pax7 and by immuno-
labelling Tg:Pax7-EGFP mice using an anti-GFP antibody. Both methods allowed me to
follow satellite cells as they progress through activation at 1-2 days post-injury, prolifer-
ation between 2-4 days post-injury and differentiation from 4 days post-injury onwards
(Fig.3.8) (Cooper et al., 1999, Yan et al., 2003). However, experiments done with Tg:Pax7-
EGFP mice should be taken exclusively for reference purposes, as just one Tg:Pax7-EGFP
mouse per time point was available for analysis.
My quantification of the number of satellite cells at the site of injury showed that the
number of GFP+ cells in injured muscles in the Tg:Pax7-EGFP mice peaked at 4 days
post-injury, with 91.2 cells/0.154 mm2 and then declined to 39 cells/0.154 mm2 by 7 days
post-injury. These figures are consistent with previous studies reporting 90.33 cells/0.154
mm2 by 5 day post-injury (Lepper et al., 2011) and around 38 cells/0.154 mm2 by 7 days
post-injury (Wen et al., 2012). In contrast, although I observed that Myogenin+ cells
peaked at day 4 post-injury, the numbers I recorded were lower than those reported pre-








   
Figure 3.8: Cardiotoxin-mediated injury triggers muscle regeneration in vivo. Satellite cels are
located at the periphery of muscle fibres and become rapidly activated upon CTX injection, which results
in 80-90% muscle degeneration (dotted lines) without affecting satellite cell survival. Once activated, some
satellite cells proliferate and differentiate to fuse to damaged myofibres and other return to quiescence.
Different non-myogenic cells, such as inflammatory cells, endothelial cells and fibroblasts are important
components of the satellite cell niche and also contribute to muscle repair. Adapted from (Schaaf, 2012)
of the Myogenin antibody used (F5D mouse monoclonal versus sc-576 rabbit polyclonal)
or to the insufficient number of Tg:Pax7-EGFP mice used for these experiments. Never-
theless, I observed that satellite cells are rapidly activated in response to injury and that
their proliferation and differentiation peak between 2 and 4 days post-injury (Fig.3.5).
Following this phase, the formation of new fibres with centrally located nuclei takes place,
a phenomenon that continues at 14 days post-injury (Charge and Rudnicki, 2004, Pas-
toret and Sebille, 1995). In line with this, cross-sectional area (CSA) analysis indicate
that fibre size in 14 day-injured muscles is comparable to uninjured muscles (Le Grand
et al., 2012), indicating the progressive restoration of the muscle architecture. Although
not analysed in this chapter, fibroblast-mediated collagen deposition and quantification
of inflammatory cells like macrophages are two additional strategies to assess the extent
of muscle repair in vivo, since persistent inflammation and fibrosis reflect perturbations




Characterisation of the expression
of Shh signalling pathway
components in satellite cells
4.1 Introduction
Adult stem cells reside in a niche or microenvironment where they interact with neigh-
bouring supporting cells and extracellular matrix (ECM) components (Lane et al., 2014).
The niche provides physical and biochemical cues for the adequate function of stem cells.
Satellite cells have a specialised niche made up of the muscle fibre, non-myogenic cells
and the basal lamina (Fig.3.8). This microenvironment provides extrinsic signals that
maintain an adequate balance between self-renewing and committed muscle progenitors.
Several signalling pathways involved in embryonic muscle development, including Wnt,
Notch and FGF have roles in satellite cell expansion, self-renewal, quiescence and activa-
tion, respectively (Chakkalakal et al., 2012, Le Grand et al., 2009, Mourikis et al., 2012b).
In contrast, the role of Shh signalling, another signalling pathway with essential role dur-
ing embryonic myogenesis, has not been explored in satellite cells. Although Shh signalling
pathway is inactive in normal adult skeletal muscles, up-regulation of Ptch1, Gli1 and
Smo mRNAs as well as Gli3 protein has been observed in regenerating skeletal muscles
following injury (Piccioni et al., 2014b, Pola et al., 2003, Renault et al., 2013a, Straface
et al., 2009). Moreover, C2C12 mouse myoblasts and primary myoblasts up-regulate the
Shh target genes Ptch1 and Gli1 following culture in the presence of Shh (Elia et al.,
2007, Fu et al., 2014, Koleva et al., 2005, Li et al., 2004), suggesting that satellite cells
may become responsive to Shh signals during muscle regeneration.
In this chapter, I examined the expression of Shh signalling components in cultured
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muscle fibres and in satellite cells. Specifically, Shh response was monitored in quiescent
and activated satellite cells using a Gli reporter mice and Ptch1 immunostaining.
4.1.1 Hypothesis and aim
My first hypothesis is that satellite cells are able to respond to Shh signalling. Therefore,
the aim of this chapter is to characterise the expression of the Shh signalling components
in satellite cells and to assess Shh response during satellite cell-mediated myogenesis using
ex vivo and in vivo approaches.
4.2 Results
4.2.1 Components of the Shh signalling pathway are up-regulated
during myofibre culture
To investigate the temporal expression of Shh and Shh signalling components, mRNA ex-
pression levels were evaluated by semi-quantitative RT-PCR and real-time PCR (qPCR)
analysis. cDNA was prepared from mRNA extracted from 0, 24, 48 and 72h-cultured my-
ofibres as described in section 2.8.2. RT-PCR analysis was carried out using primers for
Shh, Ptch1, Gli1, Gli3, Smo and Hip and primers for glyceraldehyde-3 phosphatedehy-
drogenase (Gapdh) and alpha-actin (Acta1 ) were used as internal controls. cDNAs from
E.11.5 mouse embryos and H2O were used as positive and negative controls, respectively.
Shh expression could not be detected at any time point using this technique, which sug-
gests that neither muscle fibres nor satellite cells are the source of Shh (Fig.4.1 A, first
panel). Likewise, most of Shh signalling components were not expressed in freshly isolated
myofibres. However, the expression of the Shh receptor Ptch1 and the G protein-coupled
receptor Smo was up-regulated at 48h and progressively down-regulated at 72h (Fig.4.1
A, second and fifth panels). Additionally, the transcription factor Gli1 and the Shh in-
hibitor Hip, which along with Ptch1 are transcriptional targets of Shh signalling, were
detected as early as 24h after culture. Finally, I observed that the expression of Gli1, Hip
and Gli3 peaked at 72h (Fig.4.1, third, fourth and sixth panels).
To confirm these RT-PCR data, I performed qPCR analyses to quantify Ptch1, Gli1
and Gli2 expression in myofibres cultured for 0, 24, 48 and 72h. qPCR primers for Shh,
Smo, Hip and Gli3 were also designed, but could not be optimised due to the prevalent
formation of primer dimers and were not included in the study. For the rest of the
primers used, the analysis showed that Ptch1 and Gli2 expression was significantly up-
regulated in cultured myofibres at 48h and then down-regulated at 72h (Fig.4.1 B). In
contrast, although Gli1 expression also increased at 48h, no significant difference was
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Figure 4.1: Temporal expression of Shh and its downstream components in cultured my-
ofibres. (A) mRNA expression levels evaluated by semi-quantitative RT-PCR analysis using Gapdh and
Acta1 as internal controls. Shh expression was not detected at any time point with this method. Ptch1
and Smo were up-regulated at 48h, while Gli1, Gli3 and Hip expressions peaked at 72h. Representative
images of myofibre cDNA coming from three individual mice are shown. (B) qPCR analysis of Ptch1, Gli1
and Gli2 expression levels normalised to 0h. For Ptch1, p=0.0022 (between 24h and 48h and between
48h and 72h); for Gli1, p=0.4667 and for Gli2 p=0.0173 (between 24h and 48h and between 48h and
72h). Values are mean and error bars show SEM. Each mean is based on log2-fold expression change in
myofibre cDNA from three individual mice. Statistical analysis was performed using one-way ANOVA.
observed compare to other time points (Fig.4.1 B), suggesting that Gli1 expression levels
remained fairly constant over the culture time. Thus, components of the Shh signalling
are up-regulated following ex vivo culture, peak at 48h before being down-regulated at
72h, when the main repressors of the pathway (Gli3 and Hip) increase their expression.
This suggests that satellite cells have a dynamic Shh response.
4.2.2 Quiescent satellite cells are not responsive to Shh sig-
nalling but become responsive during their activation and
expansion
To further address Shh response in satellite cells, I assayed the expression of Ptch1, the
receptor of Shh as it is a transcriptional target of Shh signalling (Nakano et al., 1989). In
order to validate the reactivity of the anti-Ptch1 antibody used in this study, immunoflu-
orescence analysis was performed on E.10.5 mouse embryo cross sections, where Ptch1 is
expressed in the floor plate of the neural tube. Additionally, myofibres were immunos-
tained with secondary antibody alone to control for non-specific binding (data not shown).
In freshly isolated muscle fibres, Ptch1 expression was not detected in quiescent Pax7+
satellite cells (Fig.4.2 A-D). However, after 24h in culture, Ptch1 expression was detected
in 42% of Pax7-expressing satellite cells (Fig.4.2 E-H and Q) and this number increased
to 92% as cells began proliferating at 48h (Fig.4.2 J-L and Q). Interestingly, by 72h, the
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Figure 4.2: Ptch1 is expressed in activated satellite cells. EDL muscle fibres were cultured for 0,
24, 48 and 72h. Myofibres were immunostained to detect Pax7 in red (B, F, J and N) and Ptch1 in green
(C,G, K and O). Nuclei were counterstained with DAPI in blue(A, E, I and M). Merged images for each
time point are shown in D, H, L and P. Magnified views for every channel are shown (regions indicated
by an arrow). Scale bar represents 20µm. Quiescent Pax7 satellite cells at 0h did not express Ptch1.
Following activation at 24h in culture, Pax7+ satellite cells up-regulated Ptch1 and by 48h most of Pax7+
satellite cells co-expressed Ptch1. By 72h, Ptch1 was expressed in both Pax7+ and Pax7- satellite cells.
(Q) Quantification of Pax7 and Ptch1 expression in 0, 24, 48 and 72h myofibre cultures. Representative
data from three individual mice are shown, with 10 to 20 individual fibres per mouse counted for each
time point. Values are mean and error bars indicate standard error of the mean (SEM).
number of Pax7+/Ptch1+ cells decreased to 46.3% of the total cell population, with a
concomitant increase in the number of Pax7-/Ptch1+ cells (49%), which may correspond
to differentiating satellite cells (MyoD+/Myogenin+) (Fig.4.2 M-P and Q). These data
are in agreement with my RT-PCR/qPCR results and indicate that quiescent satellite
cells are not responsive to Shh signalling but initiate Shh response upon satellite cell
activation.
To confirm these observations, Gli response was directly assessed in cultured myofibres
from Tg(GBS-GFP) mice, in which eight concatemerized binding sites for the Gli tran-
scription factor drive GFP expression (Balaskas et al., 2012). To validate the reactivity of
the anti-GFP antibody used in this study, immunofluorescence analysis was performed on
larvae fish cross sections, where a GFP construct was expressed in motoneurons. Addi-
tionally, GFP immunofluorescence analysis was performed on hippocampal cross sections
from 8-week-old Tg(GBS-GFP) mice, which show Shh response in the dentate gyrus (data
not shown) (Ahn and Joyner, 2005). In agreement with my observations using a Ptch1
antibody, GFP expression was not detected in quiescent Pax7+ satellite cells (Fig.4.3 A-D
and Q). However, Gli response was observed as satellite cells became activated at 24h, in
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Figure 4.3: Satellite cells become responsive to Shh signalling upon activation. EDL muscle
fibres from Tg(GBS-GFP) mice were cultured for 0, 24, 48 and 72h. Myofibres were immunostained
to detect Pax7 in red (B, F, J and N) and GFP in green (C,G, K and O). Nuclei were counterstained
with DAPI in blue (A, E, I and M). Merged images for each time point are shown in D, H, L and P.
Magnified views for every channel are shown (regions indicated by an arrow). Scale bar represents 20µm.
Quiescent Pax7 satellite cells at 0h did not show any Gli response. Following activation at 24h in culture,
Pax7+ satellite cells started up-regulating GFP and this number increased as cells proliferated at 48h.
By 72h, Gli response was detected in both Pax7+ (arrow) and Pax7- (arrowhead) satellite cells. (Q)
Quantification of Pax7 and GFP expression in 0, 24, 48 and 72h myofibre cultures from Tg(GBS-GFP)
mice. Representative data from three individual mice are shown, with 7 to 15 individual fibres per mouse
counted for each time point. Values are mean and error bars indicate standard error of the mean (SEM).
51.5% of Pax7+ (Fig.4.3 E-H and Q). At 48h, 61% of Pax7+ satellite cells were positive
for GFP (Fig.4.3 I-L and Q), and by 72h, GFP expression was associated with both Pax7+
and Pax7- cells, confirming that Shh response occurs in differentiating (Pax7-) as well as
proliferating (Pax7+) satellite cells (Fig.4.3 M-P and Q). These results confirm that Shh
response occurs in satellite cells that exit quiescence and become activated. Furthermore,
Gli response persists during satellite cell proliferation and differentiation ex vivo.
As the number of Ptch1+ satellite cells was noticeably higher than the number of
GFP+ satellite cells in 48h (92% vs 61%) and 72h (95% vs 68%) ex vivo cultures, I decided
to investigate whether Ptch1 and Gli response occurred in the same cells. Confirming
that quiescent Pax7-satellite cells did not respond to Shh signals, neither Gli response
nor Ptch1 expression was detected at 0h (Fig.4.4 A-E). However, from 24h onwards,
Ptch1 and GFP were co-expressed in Pax7+ satellite cells (Fig.4.4 F-J, K-O and P-T).
Interestingly, Pax7+ cells expressing Ptch1 but very low GFP were also observed (Fig.4.4
K-O arrowhead), suggesting that Ptch1 and GFP are expressed by the same type of
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Figure 4.4: Ptch1 and Gli are indicators of Shh activity and are co-expressed in activated
satellite cells. EDL muscle fibres from Tg(GBS-GFP) mice were cultured for 0, 24, 48 and 72h.
Myofibres were immunostained to detect Pax7 (B, G, L and Q), GFP (C, H, M and R) and Ptch1 (D, I,
N and S). Nuclei were counterstained with DAPI (A, F, K and P). Merged images for each time point are
shown in E, J, O and T. Magnified views for every channel are shown (regions indicated by an arrow).
Neither GFP nor Ptch1 were detected in quiescent Pax7+ satellite cells in freshly isolated myofibres at
0h. However, from 24h, Pax7+ satellite cells co-expressed GFP and Ptch1. Furthermore, Pax7+ cells
expressing Ptch1 and low levels of GFP were also observed (arrowhead). Representative data from three
individual mice are shown. Scale bar represents 20µm.
satellite cells but Tg(GBS-GFP) detects high levels of Shh response while Ptch1 detects
high and low levels.
4.2.3 Satellite cell progression through myogenesis and Shh re-
sponse ex vivo.
Shh response throughout the satellite cell myogenic program suggests that Shh signalling
occurs in proliferating and differentiating progenitor cells. To investigate this I immnuno-
labelled 24, 48 and 72h-cultured myofibres from Tg(GBS-GFP) mice for Pax7/Myf5/GFP,
Pax7/MyoD/GFP and Caveolin-1/Myogenin/GFP to distinguish cells undergoing activa-
tion, proliferation or differentiation, respectively. In agreement with my previous results,
Gli response was associated with half of activated satellite cells (47.5% of Pax7+/Myf5+
cells) at 24h, suggesting that Shh response is downstream of activation (Fig.4.5 A-E and
P). In contrast, Pax7+/Myf5- did not contain Gli-driven GFP, confirming that the Shh
signalling pathway is not active in quiescent satellite cells.
As shown in section 4.2.2, the total number of satellite cells responding to Shh sig-
nalling increased over time ex vivo. At 48h, for instance, Pax7/MyoD double-positive cells
remained the major population showing Shh response (around 60% of total cells counted)
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(Fig.4.5 F-J and Q). Interestingly, a proportion of proliferating Pax7+/MyoD+ cells (30%)
were GFP-, suggesting that not all the cells undergoing active proliferation respond to
Shh signalling. At 72h around 40% of total cells counted were Caveolin-1+/Myogenin+
differentiating satellite cells. From this population, 62.5% of cells also expressed GFP,
confirming that Shh response persists during the differentiation phase (Fig.4.5 K-O and
R). However, the remaining fraction of Caveolin-1+/Myogenin+ satellite cells (37.5%)
did not express GFP, indicating that some satellite cells undergoing differentiation may
progressively become desensitised to Shh signalling and down-regulate Gli response, a
process known as ”adaptation” (Balaskas et al., 2012). This is consistent with the fact
that no terminally differentiated satellite cells (Caveolin-1-/Myogenin+) expressed GFP.
Next, 46.6% of total cells counted at 72h were Caveolin-1+/Myogenin-. Within this
population, 26% were also GFP+ and expected to express MyoD, indicating that prolif-
erating satellite cells respond to Shh signalling (Fig.4.5 K-O and R). In contrast, 74% of
Caveolin-1+/Myogenin- cells were GFP-, which means that these cells may have never
expressed GFP or that have switched off GFP expression by the time of analysis. This
population is likely to be composed mainly by self-renewing/quiescent satellite cells, sup-
porting the idea that Shh signalling is not active in satellite cells undergoing self-renewal.
Strikingly, a small proportion of the total cells counted at 72h were GFP+ only
(12.8%). This was a very rare event, since most of the cells at 72h are either posi-
tively labelled for Caveolin-1, Myogenin or both (see section 3.2.1). Given that Myo-
genin labelling is generally very neat and precise in ex vivo myofibre cultures, it is pos-
sible that these GFP+ cells expressed low levels of Caveolin-1 protein, which was not
clearly detected during counting. In fact, MyoD/Myogenin immunofluorescence analy-
sis of Tg(GBS-GFP) myofibres at 72h shows that only 3.6% of total cells counted were
MyoD-/Myogenin-/GFP+ (Fig.4.6), confirming the previous statement. This analysis
shows that the Shh signalling pathway is not active in both quiescent and self-renewing
satellite cells (Pax7+/Myf5-/MyoD- and Caveolin-1+/MyoD-/Myogenin-) and that Shh
response predominantly occurs in activated satellite cells undergoing proliferation and
early differentiation (Pax7+/Myf5+/MyoD+ and Caveolin-1+/MyoD+/Myogenin+).
4.2.4 Shh response in satellite cells coincides with their entry
into the cell cycle
.
The transition from quiescence to activation involves the entry of satellite cells into
the cell cycle. To investigate the cell cycle status of satellite cells that respond to Shh
signalling, I immunolabelled cultured myofibres from Tg(GBS-GFP) mice for Pax7, GFP
and the proliferation marker Ki67. As previously shown, Pax7-positive satellite cells
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Figure 4.5: Shh signalling response during satellite cell-mediated myogenesis. EDL muscle
fibres from Tg(GBS-GFP) mice were cultured for 24, 48 and 72h. Myofibres were immunostained to
detect Pax7 (B and G), Myf5 (C), MyoD (H), Myogenin (L), Caveolin-1 (M) and GFP (D, I and N).
Nuclei were counterstained with DAPI (A, F and K). Merged images for each time point are shown in
E, J and O. Magnified views for every channel are shown (regions indicated by an arrow). Scale bar
represents 20µm. At 24h, a fraction of Pax7+/Myf5+ satellite cells also expressed GFP (A-E). Likewise,
at 48h the majority of Pax7+/MyoD+cells were also GFP+ (F-J). At 72h, a proportion of differentiating
(Caveolin-1+/Myogenin+) and proliferating (Caveolin-1+/Myogenin-) satellite cells preserved GFP ex-
pression (K-O). P, Q and R respectively show the quantification of Pax7/Myf5/GFP, Pax7/MyoD/GFP
and Caveolin/Myogenin/GFP in 24, 48 and 72h myofibre cultures from Tg(GBS-GFP) mice. Represen-
tative data from three individual mice are shown, with 12 to 15 individual fibres per mouse counted for
each time point. Values are mean and error bars indicate standard error of the mean (SEM).
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Figure 4.6: Differentiating cells are the main target of Shh response at 72h. EDL muscle fibres
from Tg(GBS-GFP) mice were cultured for 72h and immunostained to detect MyoD, Myogenin and GFP.
This graph shows the percentage of the different cell populations that respond or not to Shh signalling
(GFP+/GFP-). Representative data from three individual mice are shown, with 14 to 15 individual
fibres per mouse counted for each time point. Values are mean and error bars indicate SEM.
at 0h did not show any Gli response. At this time point, Pax7+ satellite cells did not
express Ki67, which is associated with G1, S, G2 and M phases, consistent with these cells
being quiescent (Fig.4.7 A-E). As satellite cells became activated at 24h, they expressed
both Ki67 and GFP and continued to do it at 48 and 72h (Fig.4.7 F-J, K-O and P-T),
suggesting a correlation with their entry into the cell cycle. Interestingly, some satellite
cells that did not respond to Shh signalling or stopped responding to it by the time of
analysis remained Ki67+, suggesting that cell cycle exit is not necessarily linked to the
cessation of Shh response. This is consistent with my previous finding that some satellite
cells undergoing active proliferation/differentiation did not respond to Shh signalling (see
section 4.2.3). Taken together, these results indicate that satellite cell responsiveness to
Shh signalling coincides with their exit from quiescence and their entry into the cell cycle.
4.2.5 Characterisation of Ptch1 distribution muscle regenera-
tion in vivo
To examine whether Shh signalling occurred in satellite cells in vivo, I performed a pilot
experiment using muscles from Tg:Pax7-EGFP mice1. To do so, TA muscles were har-
vested at different time points after CTX-mediated injury and GFP and Ptch1 expression
was analysed by immunofluorescence.
1For this experiment, only one Tg:Pax7-EGFP mouse per time point was analysed because no more
mice were available due to breeding issues.
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Figure 4.7: Gli response coincides with the entry of satellite into the cell cycle. EDL muscle
fibres from Tg(GBS-GFP) mice were cultured for 0, 24, 48 and 72h. Myofibres were immunostained to
detect Pax7 (B, G, L and Q), GFP (C, H, M and R) and Ki67 (D, I, N and S). Nuclei were counterstained
with DAPI (A, F, K and P). Merged images for each time point are shown in E, J, O and T. Magnified
views for every channel are shown (regions indicated by an arrow). Quiescent satellite cells at 0h did not
express GFP or Ki67. At 24h, Pax7+ satellite cells co-expressed GFP and Ki67 and these expressions
persisted at 48h. At 72h, some Pax7+ cells still co-expressed GFP and Ki67 (arrow) whereas some
other Pax7-expressing satellite cells just expressed Ki67 (arrowhead). Representative data from three
individual mice are shown. Scale bar represents 20µm.
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Ptch1 expression was observed in activated satellite cells at 1, 2 and 4 day post-injury
muscles (Fig.4.8 2a-2e, 3a-3e and 4a-4e, respectively). There was no Ptch1 expression
in GFP+ satellite cells in non-injured and in 7 and 14 day post-injury muscles (Fig.4.8
1a-1e, 5a-5e and 6a-6e). Quantitative analysis showed that the number of GFP+/Ptch1+
cells increased from 1 day (48 cells/mm2) to 2 day post-injury (90.6 cells/mm2) by almost
two-fold and then progressively declined between 2 and 4 days post-injury (30 cells/mm2)
until no GFP+/Ptch1+ cells were detected at day 7 and 14 post-injury (Fig.4.8 F). In
previous results (see section 3.2.2.2), I have shown that during muscle regeneration in
vivo Pax7+ satellite cells actively proliferate between day 1 and 4, peaking at 2 days and
declining by 7 days post-injury. Furthermore, differentiating satellite cells (Myogenin+)
can be detected from day 2 post-injury and persist after 14 days, reaching a maximum by 4
days post-injury (see section 3.2.2.3). Together, these data suggest that readily activated
satellite cells respond to Shh signalling and that the peak of responsiveness overlaps with
the expansion phase of satellite cells (2 days post-injury). Moreover, Ptch1 expression
importantly declines beyond 4 days post-injury, which correlates with the reduction in
the number of satellite cell undergoing proliferation and an increase of those reaching
terminal differentiation. Therefore, consistent with the data I generated with the ex vivo
culture system, I found that most of the satellite cells undergoing proliferation and early
differentiation may respond to Shh signalling in vivo.
Interestingly, I also observed a number of Pax7- cells that were positive for Ptch1
(Fig.4.8). These cells were detected at day 1 (55 cells/mm2), day 2 (172 cells/mm2),
day 4 (185 cells/mm2), day 7 post-injury (82 cells/mm2) and absent at day 14 post-
injury (Fig.4.8 F). A previous study has reported that in ischemic nls-Ptc1-lacZ muscles,
Vimentin-expressing fibroblasts are positive for β-galactosidase (Pola et al., 2003), sug-
gesting that the GFP-/Ptch1+ cells observed are fibroblasts. Further analyses would be
required to confirm this possibility.
4.3 Discussion
4.3.1 Quiescent satellite cells do not respond to Shh signalling.
In embryonic myogenesis, Shh signalling controls the specification of muscle progenitors,
the expression of basement membrane components in the somites and the development of
ventral autopod muscles in the limb (Anderson et al., 2009, 2012, Borycki et al., 1999b).
In contrast, the role for Shh signalling pathway in postnatal myogenesis is still poorly
understood. The origin and identity of Shh-responding cells in muscles had not been fully
characterised. In this chapter, I have shown unequivocally that satellite cells respond to
Shh signalling in a dynamic manner. For instance, there is no Shh response in satellite
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Figure 4.8: Ptch1 expression is associated with satellite cells and non-muscle cells during
muscle regeneration in vivo. Uninjured and cardiotoxin-injured (1, 2, 4, 7 and 14 days post-injury)
TA muscles from Tg:Pax7-EGFP mice were analysed by immunofluorescence using antibodies against
Laminin alpha-2 (Lama2, red), GFP (green) and Ptch1 (white). Cell nuclei were counterstained using
DAPI (blue). Merge images from four channels are shown for non-injured and 1, 2, 4, 7 and 14 injured
muscles in 1e, 2e, 3e, 4e, 5e and 6e, respectively. Magnified views for every channel are shown (regions
indicated by an arrow). Scale bar represents 50µm. Quiescent GFP+ satellite cells in uninjured muscles
cells did not express Ptch1 (1a-1e). However, Ptch1 expression was observed at 1, 2 and 4 days following
CTX muscle injury in both GFP+ satellite cells and in non-myogenic cells (2a-2e, 3a-3e, 4a-4e). Ptch1
expression in GFP+ cells declined at day 7 post-injury but it was maintained in non-muscle cells (5a-5e).
No Ptch1 expression was observed at 14 days post-injury (6a-6e). (F) shows the quantification of Ptch1
and GFP expression in Tg:Pax7-EGFP uninjured and CTX-injured TA muscles. Mean values are shown.
Each mean is based on four to six random 0.154 mm2 regenerating areas from one mouse per each time
point.
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cells of freshly isolated myofibres or of non-injured skeletal muscles, which are mostly
quiescent. This is the first clear evidence showing the absence of Shh activity in quiescent
satellite cells, as previous studies used myoblast cell lines or primary cell cultures, which
lack quiescent cells (Elia et al., 2007, Koleva et al., 2005).
So, how do quiescent satellite cells become responsive to Shh signalling? Several
mechanisms for the control of Shh responsiveness have been previously reported during
embryogenesis. In the developing somite, the initiation of Shh responsiveness depends on
the activation of Gli2 and the repression of Gli3 by surface ectoderm and neural tube-
derived canonical Wnt signalling (Borycki et al., 2000). Canonical Wnt signalling pro-
motes satellite cell progression through the myogenic program, especially during differen-
tiation (Brack et al., 2008). Although loss of β-catenin in satellite cells (Pax7CreERT2/+;β-
cateninflox/flox) does not affect muscle regeneration, constitutive activation of β-catenin
in satellite cells prolongs the regenerative response upon muscle injury (Murphy et al.,
2014). Conditional removal of the tumour suppressor adenomatous polyposis coli (APC),
a component of the β-catenin destabilisation complex in Pax7+ satellite cells results in cell
death and failure to enter the cell cycle and is associated with increased levels of β-catenin
(Parisi et al., 2015). Thus, although inactivation of Wnt signalling appears to be required
for satellite cell progression through the cell cycle, it is unclear whether Wnt signalling
acts upstream Shh to regulate the expression of Gli genes in satellite cells. To address
this, Shh response in satellite cells could be assessed in the absence of Wnt signalling by
using specific Wnt signalling inhibitors on myofibres cultures from Tg(GBS-GFP) mice
or in β-catenin conditional knockout mice. An alternative mechanism may be that used
in the neural tube, where Notch signalling is required for maintaining neural progenitor
cells (NPCs) in an undifferentiated state and for the maintenance of Shh responsiveness
(Huang et al., 2012). Notch signalling mediates also the trafficking and accumulation of
Smo in the primary cilia, sensitising NPCs to Shh signals (Kong et al., 2015, Stasiulewicz
et al., 2015). Given that Notch signalling is required to maintain satellite cells in a qui-
escent state and that its activity decreases as satellite cells become activated (Bjornson
et al., 2012, Mourikis et al., 2012b), it seems unlikely that Notch signalling induces Shh re-
sponse in satellite cells as Shh response is observed in activated satellite cells, when Notch
signalling activity decreases. Consistent with the activity of Notch in quiescent satellite
cells, recent work from our lab uncovered that quiescent satellite cells have primary cilia,
which are rapidly resorbed when satellite cells become activated (Jaafar Marican et al.,
unpublished data). Therefore, my observations converge towards a possible mechanism of
Shh signalling independent of primary cilia. The primary cilium is critical for processing
Gli proteins into repressors and it is also important for the accumulation of Shh signalling
components such as Gli2 and Smo (Huangfu et al., 2003). However, some studies have
shown that Smo accumulation in the primary cilia is not a prerequisite for Shh signalling
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activation (Chong et al., 2015, Fan et al., 2014). For instance, the Smo/SAG complex
or SmoM2 protein, which carries activating oncogenic mutations, can signal without cil-
iary accumulation (Fan et al., 2014). Moreover, disruption of Shh signalling activity can
be achieved even when Smo is enriched in the cilia (Chong et al., 2015, Rohatgi et al.,
2009, Yang et al., 2015), indicating that Smo accumulation in the primary cilium and
Shh activation via Gli proteins can be uncoupled (Chen et al., 2009). It remains to be
seen, however, whether any Shh signalling component is enriched in the primary cilia of
quiescent satellite cells.
4.3.2 Activated satellite cells become responsive to Shh signals.
I have shown that activated Pax7+ satellite cells become responsive to Shh signalling both
ex vivo and in vivo. Furthermore, Shh response in satellite cells coincides with their entry
into the cell cycle and persists during their expansion. Indeed, activated/proliferating
satellite cells are highly responsive to Shh, but Shh response is down-regulated over time,
especially in self-renewing satellite cells and terminally differentiated cells. This hetero-
geneous response to Shh signalling may arise from an asynchronous initiation of the cell
cycle (Siegel et al., 2011) and from the known heterogeneity of satellite cells (Kuang et al.,
2007). Shh response, as measured through Ptch1 accumulation was more widespread than
Shh response measured using the Gli reporter transgenic mice Tg(GBS-GFP). This may
reflect some intrinsic differences between the control of Ptch1 up-regulation and Gli ac-
tivity, in particular in the stability of the Gli proteins (activated versus repressor forms).
However, I favour the possibility that low levels of Gli activity are not detected by the
Tg(GBS-GFP) reporter mouse line, and this may account for the difference in the number
of Ptch1+ versus GFP+ cells (Balaskas et al., 2012, Kahane et al., 2013). Therefore, my
working model for the dynamics of Shh response is described in Fig.4.9. First, quiescent
satellite cells do not respond to Shh signalling. Upon activation or muscle injury, satellite
cells become responsive to Shh signals and up-regulate Ptch1 expression/Gli response. As
satellite cells enter the proliferation phase, Shh response peaks and persists during early
satellite cell differentiation to become progressively down-regulated as cells complete dif-
ferentiation or self-renew. This down-regulation may be linked to the up-regulation of
Gli3 and Hip, which are both repressors of Shh signalling, during the differentiation
phase. Another factor that may contribute to the termination of Shh signalling is the
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Figure 4.9: Working model of Shh signalling activity in satellite cells. During the initial stages
of adult myogenesis, activated satellite cells become responsive to Shh signalling and up-regulate Ptch1
expression. During the expansion phase, Shh acts on proliferating satellite cells. Later, differentiating
satellite cells may express specific Shh signalling repressors (Hip and Gli3) and may become less responsive
to Shh signalling, resulting in lower levels of Ptch1. This lesser response to Shh signalling may facilitate
satellite cell differentiation and/or the return to quiescence.
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4.3.3 Source of the Shh ligand during adult myogenenesis ex
vivo and in vivo.
The response of satellite cells to Shh signalling suggests the presence of ligands during
the activation phase of muscle regeneration. Shh mRNAs have been observed in the
interstitium of skeletal myofibres and in whole skeletal muscle preparations following
mechanical crush, CTX injury and ischemia (Pola et al., 2003, Renault et al., 2013a,
Straface et al., 2009). The expression of the Shh ligand has also been reported in Pax7+
cells and in Ptch1+ interstitial cells, suggesting an autocrine signalling mechanism (Elia
et al., 2007, Pola et al., 2003). However, my own PCR data showed that no Shh mRNA
could be detected at any time point in ex vivo cultured myofibres, arguing against Shh
being produced by myofibres or satellite cells. Where does Shh come from? In the ex vivo
system, it is highly likely that Shh is present in the chick embryo extract added to the
culture medium. In vivo, as Pola et al. reported, it is possible that Shh is synthesised
and released by interstitial cells within skeletal muscles (Pola et al., 2003). However, it is
also possible that secreted Shh proteins are maintained inactive in the muscle tissue and
recruited following muscle injury. A precedent for this was reported in the cerebellum,
where Shh interacts with different ECM components, including Vitronectin and Laminin-1
(Blaess et al., 2004, Pons et al., 2001), indicating that Shh can be sequestered in the ECM.
Shh binding partners may also limit the availability of the protein by sequestering it away
from its target cells. This is the case of the Boi-Hh interaction, where Boi sequesters
the Hh ligand in apical cells to regulate its levels in the follicle stem cell niche of the
Drosophila ovary (Hartman et al., 2010). Likewise, the binding of Shh to Ptch1, Ptch2
and Hip1 restricts its activity in patterning the ventral neural tube (Holtz et al., 2013,
Jeong and McMahon, 2005). Finally, it is also possible that Shh is delivered systemically
in the event of muscle injury. For instance, Shh is produced by stromal cells of the bone
marrow and lymph nodes, and this secreted protein could be delivered via lymphatic
vessels connected to skeletal muscles (Dierks et al., 2007, Korthuis, 2011). Shh is also
synthesised by smooth muscle cells and can be found in the blood plasma, opening the
possibility that this protein can be delivered to skeletal muscles through blood vessels (El-
Zaatari et al., 2012, Yao et al., 2014). Finally, Shh protein could be delivered to skeletal
muscles through peripheral nerves, as in the case of rodent incisors and adult mouse
skin (Brownell et al., 2011, Zhao et al., 2014). Nevertheless, the ultimate experiment to
determine which cell population is the source of the Shh protein will be the analysis of
different cell types from CTX-injured muscles isolated by FACS, including satellite cells,
fibroblasts, interstitial, blood and immune cells before, after and at the time of satellite
cell activation in vivo.
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4.3.4 Non-muscle cells may be influenced by Shh signalling dur-
ing adult skeletal muscle regeneration.
In vivo, I observed that non-myogenic cell types respond to Shh signalling. This is consis-
tent with a previous publication reporting that β-galactosidase expression was observed
in Vimentin+ fibroblasts upon ischemia in nls-Ptc1-lacZ muscles (Pola et al., 2003). The
high number of non-muscle cells that express Ptch1 in my in vivo analysis is consistent
also with the abundant number of Tcf4+ fibroblasts found in skeletal muscles following
BaCl2 injury (Murphy et al., 2011). This suggests that Shh response may occur in fibrob-
lasts in addition to satellite cells. This is interesting given that depletion of fibroblasts
in skeletal muscles affects muscle regeneration by inducing premature differentiation and
depletion of satellite cells (Murphy et al., 2011).
Endothelial cells and macrophages are other non-myogenic cells that have been re-
ported to respond to Shh signalling (Fabian et al., 2012, Ghorpade et al., 2013, Yao et al.,
2014). Indeed, the induction of Shh signalling activity in endothelial cells is in line with
the role of this pathway in promoting angiogenesis following skeletal muscle ischemia (Pola
et al., 2003, Straface et al., 2009). However, the expression of Shh signalling components
has not been reported yet in these cell types during muscle regeneration in vivo. Investiga-
tion of the role of the Shh signalling in these cells would highlight a role for Shh signalling





Effect of Shh signalling pathway
activation and blockade on
satellite cell progression through
myogenesis ex vivo.
5.1 Introduction
I have previously shown that activated satellite cells respond to Shh signalling ex vivo
and in vivo. During adult myogenesis, Shh signalling response corresponds with the entry
of satellite cells into the cell cycle and it persists during their expansion. Notably, Shh
signalling response becomes gradually down-regulated as satellite cells enter differentiation
or return to quiescence. Thus, Shh signalling activity in satellite cells in transient and
accompanies activation, expansion and early differentiation of adult myogenesis.
Shh signalling has multiple roles in patterning, cell proliferation and differentiation
during early development. Previous studies from the lab have shown that Shh signalling
controls skeletal myogenesis in the embryo by activating the muscle-specific transcription
factor Myf5 and genes encoding basement membrane proteins (Anderson et al., 2009,
2012, Borycki et al., 1999b). In contrast, in skeletal muscle regeneration, Shh has been
proposed to function as a proliferation and differentiation factor that can improve muscle
repair (Piccioni et al., 2014a). However, in vitro analyses of muscle cell lines and primary
myoblasts have yielded contradictory results, some demonstrating that Shh signalling
promotes proliferation (Koleva et al., 2005, Straface et al., 2009) differentiation (Elia et al.,
2007, Straface et al., 2009) and cell survival (Koleva et al., 2005) and others showing that
it inhibits muscle differentiation (Koleva et al., 2005). To date, it is unclear how Shh
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signalling affects satellite cell behaviour, and in particular, how this signalling pathway
may regulate the myogenic program.
In this chapter, I investigated the effect of Shh signalling in satellite cells from my-
ofibres cultured ex vivo. I performed gain and loss-of-function experiments using Shh
signalling agonists and antagonist to dissect the stages of adult myogenesis requiring Shh
signals.
5.1.1 Hypothesis and aim
As activated satellite cells respond to Shh signals, I hypothesised that stimulation or
blockade of Shh signalling will impair satellite cell behaviour. Therefore, the aim of
this chapter was to manipulate pharmacologically the Shh signalling pathway in cultured
myofibres and investigate the effects on satellite cell-mediated myogenesis ex vivo.
5.2 Results
5.2.1 Effect of the stimulation of the Shh signalling pathway in
satellite cells by the Smo agonist SAG
The induction of Shh responsiveness during satellite cell activation suggests a role for Shh
signalling in adult myogenesis. To investigate the function of Shh signalling in muscle
stem cells, I used experimental approaches to stimulate Shh signalling in the ex vivo
myofibre culture system and examined the effect on satellite cell behaviour. An initial
concentration of 100nM was chosen based on the dose-response curve of SAG in the Shh-
LIGHT2 cell line, which is a NIH3T3 clone that incorporates a Gli-luciferase reporter
(Chen et al., 2002b). However, a pilot experiment (proof of concept) was also performed
to determine whether this SAG concentration had an effect on satellite cells, in which EDL
myofibres isolated from C57BL/6 mice were cultured in the presence or in the absence
of a SAG gradient (from 20nM to 500nM) for 72h. 100nM was shown to be the SAG
concentration that yielded the highest mean value of Caveolin-1+ and Myogenin+ cells
at 72h (Fig.5.1 A). Interestingly, higher concentrations of SAG did not show any effect
on satellite cells, which was consistent with the finding that concentrations closer and
higher than 1µM dramatically decrease SAG-mediated effect (Chen et al., 2002b). To
further assess whether this concentration was able to modulate Shh response, C2C12 cells
were cultured for 48h in the presence of DMSO (control) or 100nM of SAG and cDNA
was prepared from these cultures. Gli1 mRNA expression levels were evaluated by semi-
quantitative RT-PCR. cDNAs from E.11.5 mouse embryos and H2O were used as positive
























Figure 5.1: Proof of concept experiment to test the effect of the Smoothened agonist SAG
on muscle cells. (A) EDL muscle fibres from C57BL/6 mice were cultured for 72h in the presence of
DMSO (control) or a gradient of SAG (from 20nM to 500nM). Myofibres were immunostained to detect
Caveolin-1 and Myogenin. Treatment with 100nM of SAG yielded the highest number of Caveolin-1+ and
Myogenin+ cells per fibre at 72h. Mean values are shown. Each mean is based on 15 myofibres from one
mouse. (B) mRNA expression levels in C2C12 cells after SAG (100nM) treatment for 48h were evaluated
by semi-quantitative RT-PCR analysis using Gapdh as internal control. Changes in gene expression were
calculated by normalising Gli1 to Gapdh band intensity using the ImageJ software. Gli1 expression was
visibly up-regulated in the presence of SAG compared to the control. Representative images of C2C12
cDNA coming from two independent sets of cell cultures are shown.
of Gli1 in the presence of SAG compared to the control (DMSO) (Fig.5.1 B). Therefore,
this concentration was used for further experiments.
Single EDL muscle fibres from C57BL/6 mice were cultured in the presence of the
Smoothened agonist SAG (100nM) or DMSO (control) and the distribution of Pax7/Myf5,
Pax7/ MyoD and Caveolin-1/Myogenin was determined by immunofluorescence analysis
at 24, 48 and 72h, respectively. Treatment of isolated myofibres with 100nM of SAG for
24h did not have any obvious effect on satellite cell behaviour, since Pax7+ cells were
activated normally as shown by the co-expression of Myf5 and Pax7 compared to control
(Fig.5.2 A-D and A’-D’). Moreover, the number of satellite cells did not change at 24h
upon Shh signalling stimulation (Fig.5.2 M). Likewise, treatment with SAG did not have
any effect on the number of Pax7+ nor MyoD+ satellite cells at 48h (Fig.5.2 E-H, E’-
H’ and M). Finally, no significant effect was observed in the number of Caveolin-1+ and
Myogenin+ cells at 72h after SAG treatment, although a tendency towards larger clusters
of differentiating satellite cells attached to the fibres under SAG conditions compared
to the control was observed (Fig.5.2 I-L and I’-L’ and M). These results suggest that
stimulation of the Shh signalling pathway using SAG is not sufficient to help expand
the population of satellite cells ex vivo. Moreover, SAG effect is highly variable from





Figure 5.2: Stimulation of Shh signalling with SAG does not affect the number of satellite
cells ex vivo. EDL muscle fibres from C57BL/6 mice were cultured for 24, 48 and 72h in the presence
of DMSO (control) or SAG (100nM). Myofibres were immunostained to detect Pax7 in red (B, B’, F and
F’), Myf5 (C and C’), MyoD in green (G and G’), Myogenin in red (J and J’) and Caveolin-1 in green (K
and K’). Nuclei were counterstained with DAPI in blue (A, A’, E, E’, I and I’). Merged images for each
time point are shown in D, D’, H, H’, L and L’. Magnified views for every channel are shown (regions
indicated by an arrow). SAG treatment did not affect the behaviour of satellite cells at 24h. At 48h and
72h following stimulation of the Shh signalling pathway with SAG, larger cluster of satellite cells could
be observed. Scale bar represents 50µm. (M) shows the quantitative analysis of the number of satellite
cells at 24h (Pax7 and Myf5), 48h (Pax7 and MyoD) and 72h (Caveolin-1 and Myogenin) per fibre in the
presence of DMSO (black boxes) or 100nM of SAG (gray boxes). No significant difference in the number
of satellite cells under SAG treatment was observed. Representative data from three individual mice
are shown, with 10 to 20 individual fibres per mouse for each time point. Boxes represent interquartile




Figure 5.3: Pilot experiment to test a concentration gradient of the Gli inhibitor GANT61
and the Smoothened agonist Cyclopamine on ex vivo myofibre cultures. EDL muscle fibres
from C57BL/6 mice were cultured for 72h in the presence of DMSO (control) or a gradient of GANT61
(A) (from 0.5µM to 10µM) and Cyclopamine (B) (from 1µM to 5µM) and myofibres were immunostained
to detect Caveolin-1 and Myogenin. (A) Treatment with 4 and 10µM of GANT appeared to decrease the
number of both Caveolin-1+ and Myogenin+ cells per fibre at 72h. (B) Treatment with 4 and 5µM of
Cyclopamine showed a tendency towards fewer Caveolin-1+ and Myogenin+ cells per fibre at 72h. Mean
values are shown. Each mean is based on 20 to 30 myofibres from one mouse.
5.2.2 Chemical blockade of the Shh signalling pathway reduces
the number of satellite cells in cultured myofibres
As Shh signalling pathway stimulation showed a tendency towards an increase in satellite
cell numbers, I asked whether Shh signalling was necessary for satellite cell activity. To
block Shh signalling in adult muscle stem cells, I inhibited the Shh pathway activity
using two pharmacological inhibitors: cyclopamine, which directly binds to the receptor
Smoothened and impedes its function (Taipale et al., 2000) and GANT61, which represses
Gli-mediated transcription by acting downstream of Smoothened (Lauth et al., 2007). An
initial concentration of 10µM of GANT61 was chosen based on the dose-response curve
of GANT61 in the NIH 3T3 cell line, where IC50 was of around 5µM (Lauth et al.,
2007). However, this concentration used by Lauth and colleagues had a cytotoxic effect
on the myofibres. The compound was then re-tested in a pilot experiment in our system
by applying a concentration gradient on 72h-cultured myofibres and the ideal working
concentration found was 4µM (Fig.5.3 A). On the other hand, the concentration of 5µM
of cyclopamine was chosen based on a gradient pilot experiment on 72h-cultured myofibres
(Fig.5.3 B). This cyclopamine concentration was also shown to be optimal to inhibit a
Gli-luciferase reporter in the NIH3T3 cell line (Taipale et al., 2000).
An initial proof-of-concept experiment was performed in which individual EDL muscle
fibres from Tg(GBS-GFP) mice were cultured in the presence of either DMSO (control),
4µM of GANT61 or 5µM of cyclopamine and the distribution of GFP-expressing cells
was determined by immunofluorescence analysis at 24, 48 and 72h (Fig.5.4 A-E, A’-
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Figure 5.4: Cyclopamine and GANT61 effectively block Shh response in satellite cells ex
vivo. EDL muscle fibres from Tg(GBS-GFP) mice were cultured for 72h in the presence of DMSO
(control), Cyclopamine (5µM) or GANT61 (4µM). Myofibres were immunostained to detect Myogenin
(red, B, B’ and B”), Caveolin (cyan, C, C’ and C”) and GFP (green, D, D’ and D”). Nuclei were
counterstained with DAPI (blue, A, A’ and A”). Merged images for each time point are shown in E, E’
and E”. Magnified views for every channel are shown (regions indicated by an arrow). Scale bar represents
20µm. (F) shows the quantitative analysis of the number of GFP+ satellite cells at 24h, 48h and 72h per
fibre in the presence of DMSO (white), 4 µM of GANT61 (gray) or 5µM of cyclopamine (black). There
was no difference in the number of GFP+ cells at 24h treated with either GANT61 nor cyclopamine. In
contrast, at 48h and 72h there was a significant difference in the number of GFP-expressing cells with
both treatments compared to control conditions (p=0.0143 and p=0.0081, respectively). Values are mean
and SEM. Each mean is based on 10 to 15 myofibres from two mice per time point. Statistical analysis
was performed using one-way ANOVA.
E’ and A”-E”). Immunofluorescence analysis at 24h showed that the number of Shh
responsive satellite cells (GFP+) was not significantly different after culturing myofibres
in the presence of either GANT61 nor cyclopamine compared to the control (Fig. 5.4
F). However, by 48h, a reduction of 64% and 42% of GFP+ satellite cells was observed
upon GANT61 and cyclopamine treatment, respectively (Fig.5.4 F). Finally, more than
50% reduction of GFP expression was observed at 72h with both inhibitors (Fig.5.4 A-E,
A’-E’ and A”-E”), indicating that cyclopamine and GANT61 can effectively block Shh
signalling response in satellite cells ex vivo.
Next, muscle fibres from C57BL/6 mice were cultured in the presence of cyclopamine
(5µM) or DMSO (control) and the distribution of Pax7/Myf5, Pax7/ MyoD and Caveolin-
1/Myogenin was determined by immunofluorescence analysis at 24, 48 and 72h, respec-
tively. Blockade of the Shh signalling pathway with cyclopamine in isolated myofibres
for 24h did not affect the activation of satellite cells, since the number and proportions
of Pax7+ and Myf5+ cells remained similar to control conditions (Fig.5.5 A-D, A’-D’
and M). Likewise, treatment with cyclopamine did not change the number of Pax7+ and
MyoD+ satellite cells at 48h compared to the control (Fig.5.5 E-H, E’-H’ and M). In-
terestingly, myofibres treated with cyclopamine for 72h showed a significant decrease in
the number of both Caveolin-1+ (44%) and Myogenin+ (47%) cells (Fig.5.5 M), with
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smaller clusters of differentiating satellite cells attached to the fibres compared to the
control (Fig.5.5 I-L and I’-L’). These results suggest that inhibition of Shh signalling us-
ing cyclopamine leads to a decrease in satellite cell numbers, including cells undergoing
differentiation ex vivo.
A similar experiment blocking the Shh pathway activity with GANT61 (5µM) or
DMSO (control) was carried out. Treatment of isolated C57BL/6 myofibres with GANT61
had no effect on satellite cells at 24h (Fig.5.6 A-D, A’-D’ and and M), confirming previous
observations with cyclopamine and indicating that Shh signalling is not required for satel-
lite cell activation. Importantly, GANT61 treatment resulted in a decrease in the number
of proliferating and differentiating satellite cells at both 48h and 72h compared to control.
For instance at 48h upon GANT61 treatment, a reduction of 42% in the number of Pax7+
and MyoD+ cells was observed compared to control conditions (Fig.5.6 E-H, E’-H’ and
M). Furthermore, blockade of Gli activity with GANT61 at 72h caused a reduction in
the number of Caveolin-1+ and Myogenin+ cells by 40% and 60%, respectively (Fig.5.6
I-L, I’-L’ and M). Taken together, these data corroborate that blocking Shh signalling
results in a decrease in satellite cell expansion with a concomitant reduction in satellite
cell differentiation. .
5.2.3 Blocking Shh signalling causes a delay in satellite cell-
mediated myogenesis ex vivo
Treatment of isolated myofibres with Shh signalling inhibitors causes an overall reduction
in the number of satellite cells at 72h, particularly in differentiating cells (Myogenin+)
compared to control conditions. Given that by 48h in ex vivo culture satellite cells have
completed their first cell divisions and beyond that point they greatly expand, I decided
to look at an intermediate time point between 48 and 72h in order to identify in more
details the satellite cell population affected by Shh signalling blockade. To do so, I treated
single myofibres with GANT61, harvest them at 60 and 72h after culture and performed
a Pax7/MyoD immunofluorescence analysis. 48h-cultured fibres in the presence of DMSO
or GANT61 were also included and taken as starting point for the analysis.
As previously shown, at 48h in control conditions, 93% of total cells counted were pro-
liferative progenitor cells (Pax7+/MyoD+), whereas 10% were self-renewing cells (Pax7+/
MyoD-) and 7% were progenitors entering differentiation (Pax7-/MyoD+) (Fig.5.7 I).
Upon GANT61 treatment, there was a 2-fold reduction in the number of Pax7+/MyoD+
cells (Fig.5.7 I). However, Shh signalling inhibition just caused a subtle change in the
proportion of the distinct satellite cell populations: around 94% of satellite cells were now
Pax7+/MyoD+, 3.7% were just Pax7+ and 2.3% expressed MyoD only (Fig.5.7 I). These





Figure 5.5: Blockade of Shh signalling with cyclopamine decreases the number of satellite
cells ex vivo. EDL muscle fibres from C57BL/6 mice were cultured for 24, 48 and 72h in the presence of
DMSO (control) or Cyclopamine (5µM). Myofibres were immunostained to detect Pax7 (red, B, B’, F and
F’), Myf5 (green, C and C’), MyoD (green, G and G’), Myogenin (red, J and J’) and Caveolin-1 (green,
K and K’). Nuclei were counterstained with DAPI (blue, A, A’, E, E’, I and I’). Merged images for each
time point are shown in D, D’, H, H’, L and L’. Scale bar represents 20µm. (M) shows the quantitative
analysis of the number of satellite cells at 24h (Pax7 and Myf5), 48h (Pax7 and MyoD) and 72h (Caveolin-
1 and Myogenin) per fibre in the presence of DMSO (black boxes) or 5µM of cyclopamine (gray boxes).
There was a significant difference in the number of Caveolin+ (p=0.0305) and Myogenin+ (p=0.0299)
cells at 72h upon Smoothened inhibition with cyclopamine compared to the control. Representative data
from three individual mice are shown, with 10 to 30 individual fibres per mouse for each time point.
Boxes represent interquartile ranges (RQ) and whiskers show minimum and maximum values. Statistical
analysis was performed using Student’s t-test.
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Figure 5.6: Inhibition of Shh signalling with GANT61 affects satellite cell expansion ex
vivo. EDL muscle fibres from C57BL/6 mice were cultured for 24, 48 and 72h in the presence of DMSO
(control) or GANT61 (4µM). Myofibres were immunostained to detect Pax7 (red, B, B’, F and F’), Myf5
(green, C and C’), MyoD (green, G and G’), Myogenin (red, J and J’) and Caveolin-1 (green, K and K’).
Nuclei were counterstained with DAPI (blue, A, A’, E, E’, I and I’). Merged images for each time point
are shown in D, D’, H, H’, L and L’. Magnified views for every channel are shown (regions indicated by an
arrow). Scale bar represents 20µm. M) shows the quantitative analysis of the number of satellite cells at
24h (Pax7 and Myf5), 48h (Pax7 and MyoD) and 72h (Caveolin-1 and Myogenin) per fibre in the presence
of DMSO (black boxes) or 4µM of GANT61 (gray boxes). There was a significant difference in the number
of Pax7+ (p=0.0412) and MyoD+ (p=0.0483) cells at 48h upon GANT61 treatment. Moreover, there
was a significant decrease in the number of Caveolin+ (p=0.0342) and Myogenin+ (p=0.0136) cells at 72h
upon Gli inhibition compared to the control. Representative data from three individual mice are shown,
with 13 to 25 individual fibres per mouse for each time point. Boxes represent interquartile ranges (RQ)
and whiskers show minimum and maximum values. Statistical analysis was performed using Student’s
t-test.
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proliferative progenitor cells (Pax7+/ MyoD+).
Between 48 and 60h, proliferating progenitor cells begin differentiating leading to a
2.5-fold reduction in the proportion of Pax7+/MyoD+ (22.2%) cells and a 3 and a 7-
fold increase in the number of Pax7+/MyoD- (26.4%) and Pax7-/MyoD+ (51.4%) cells,
respectively at 60h in control conditions (Fig.5.7 A-D, I and J). This trend exacerbates
at 72h in control conditions, where 6% of satellite cells were Pax7+/MyoD+, 32% were
Pax7+/MyoD- and 62% expressed MyoD only (Fig.5.7 E-H, I and J). This shows that
over time the population of proliferative progenitors (Pax7+/MyoD+) decreases with
a concomitant increase in the number of differentiating satellite cells (Pax7-/MyoD+),
which progressively up-regulate Myogenin expression and reach terminal differentiation.
Following inhibition of Shh signalling with GANT61, a 30% and 26% reduction in
the overall number of satellite cells was observed at 60 and 72h, respectively (Fig.5.7 I
and J). Concomitantly, proliferating progenitor cells (Pax7+/MyoD+, 58.9% compared
to 22.2%) were maintained and differentiating cells (Pax7-/MyoD+, 28.8% compared to
51.4%) and self-renewing cells (Pax7+/MyoD-, 12.3% compared to 26.4%) were fewer
at 60h upon GANT61 treatment (Fig.5.7 A’-D’, I and J). By 72h, 32% of satellite cells
were still proliferating (Pax7+/MyoD+) in GANT61 treated cultures whereas 22% were
Pax7+/MyoD- and 46% were Pax7-/MyoD+ (Fig.5.7 E’-H’, I and J). This indicates that a
a higher proportion of cells remained proliferative (Pax7+/MyoD+) at both 60 and 72h in
the presence of GANT61 compared to control conditions. Interestingly, the distribution
of satellite cell populations in GANT61-treated cultures at 72h resembles that of non-
treated cultures at 60h (Fig.5.7 I, compare bars 3 and 6), suggesting that blocking Shh
signalling causes a 12-hour delay in the progression of satellite cells through the myogenic
program.
As shown in Fig.5.7 I and J, at 60h upon GANT61 treatment there was a reduction in
the proportion of Pax7+/MyoD- cells. This cell population comprises cells that have not
switched on MyoD yet and cells that have returned to quiescence. To determine which cell
population was predominantly affected at this point, I performed an immunofluorescence
analysis of Pax7/Myf5 in 60h-cultured myofibres under GANT61 treatment. In control
conditions, 6.7% of satellite cells were quiescent satellite cells (Pax7+/Myf5-), 40.6% were
proliferative and differentiating progenitors (Pax7-/Myf5+) and 52.7% were committed
cells (Pax7+/Myf5+), indicating that just a small proportion of satellite cells are fated
to self-renew. Following GANT61 treatment, I observed an overall reduction of 75%
in the number of Pax7-/Myf5+ cells (Fig.5.8 E). Furthermore, there was a change in
the distribution of satellite cells, with 7.7% of satellite cells expressing Pax7 alone, 14%
expressing only Myf5 and 78.3% expressing both proteins. This indicates that inhibition
of the Shh signalling pathway at 60h causes a decrease in the number and proportion




Figure 5.7: Effect of Shh signalling inhibition on Pax7 and MyoD expression in satellite
cells ex vivo EDL muscle fibres from C57BL/6 mice were cultured for 48, 60 and 72h in the presence
of DMSO (control) or GANT61 (4µM). 60 and 72h-cultured myofibres were immunostained to detect
Pax7 (red, B, B’, F and F’) and MyoD (green, C,C’, G and G’). Nuclei were counterstained with DAPI
(blue, A, A’, E and E’). Merged images for each time point are shown in D, D’, H and H’. Magnified
views for every channel are shown. Inhibition of Shh signalling causes an increase in the proportion
of Pax7+/MyoD+ cells with a concomitant reduction of the Pax7+/MyoD- and Pax7-/MyoD+ cell
populations, suggesting that Shh inhibition delays the myogenic programme. Scale bar represents 20µm.
(I) shows the quantitative analysis of the number of Pax7+ and MyoD+ satellite cells at 48, 60h and 72h
per fibre in the presence of DMSO or 4µM of GANT61. There was a significant difference in the number
of Pax7+/MyoD+ cells at 48h upon Gli inhibition with GANT61 compared to the control (p=0.0310). At
60h under GANT61 treatment, the number of Pax7+/MyoD- cells increased, with a concomitant decrease
in the number of Pax7+/MyoD- and Pax7-/MyoD+ cells (p=0.0260 for Pax7+/MyoD-, p=0.0194 for
Pax7-/MyoD+ and p=0.0212 for Pax7+/MyoD+). By 72h, there was an increase in the number of
Pax7+/MyoD+ cells upon GANT61 treatment compared to the control (p=0.0077). Representative
data from three individual mice are shown, with 13 to 25 individual fibres per mouse for each time point.
Values are mean and SEM. Statistical analysis was performed using Student’s t-test. (J) shows the mean




Figure 5.8: Shh signalling inhibition does not affect the number of Pax7+/Myf5- self-
renewing satellite cells ex vivo. EDL muscle fibres from C57BL/6 mice were cultured for 60h in
the presence of DMSO (control) or GANT61 (4µM). Myofibres were immunostained to detect Pax7
(red, B and B’) and Myf5 (green, C and C’). Nuclei were counterstained with DAPI (blue, A and A’).
Merged images for control and treatment are shown in D and D’. Magnified views for every channel
are shown. Inhibition of Shh signalling causes an increase in the proportion of Pax7+/Myf5+ satellite
cells at the expense of more differentiated muscle progenitor cells (Pax7-/Myf5+). Scale bar represents
20µm. Quantitative analysis of the number of Pax7+ and Myf5+ satellite cells at 60h per fibre in the
presence of DMSO or 4µM of GANT61 is shown in E. There was a significant difference in the number
of Pax7-/Myf5+ (p=0.0339) cells at 60h upon Gli inhibition with GANT61 compared to the control.
Representative data from three individual mice are shown, with 13 to 15 individual fibres per mouse for
each time point. Values are mean and SEM. Statistical analysis was performed using Student’s t-test.
returning to quiescence (Pax7+/Myf5-). This is consistent with the possibility that loss
of Shh signalling causes a delay in myogenesis.
Next, to determine the identity of differentiating cells affected by GANT61, I per-
formed a MyoD/Myogenin immunofluorescence analysis on 72h-cultured myofibres. In
control conditions, 10% of satellite cells were initiating differentiation (MyoD+/Myogenin-
), 14% were reaching terminal differentiation (MyoD-/Myogenin+) and 76% were differ-
entiated myoblasts (MyoD+/Myogenin+) (Fig.5.9 A-D and E). Following Gli inhibition
with GANT61, there was an increase of 60% in the number of MyoD+/Myogenin- cells,
along with a 38% reduction in the number of MyoD+/Myogenin+ cells, respectively.
This also had an impact on the distribution of cell populations, as 33% of cells were
now initiating differentiation (MyoD+/Myogenin-), 2% only reached terminal differentia-
tion (MyoD-/Myogenin+) and 65% were differentiated myoblasts (MyoD+/Myogenin+)
(Fig.5.9 A’-D’ and E). This demonstrates that Shh signalling inhibition increases the
proportion of myoblasts that initiate differentiation at the expense of fully differentiated
myoblasts at 72h. This reenforces the idea that Shh signalling inhibition leads to a delay
in the myogenic process.
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Figure 5.9: Shh signalling inhibition delays the onset of Myogenin expression ex vivo. EDL
muscle fibres from C57BL/6 mice were cultured for 72h in the presence of DMSO (control) or GANT61
(4µM). Myofibres were immunostained to detect Myogenin (red, B and B’) and MyoD (green, C and C’).
Nuclei were counterstained with DAPI (blue, A and A’). Merged images for control and treatment are
shown in D and D’. Magnified views for every channel are shown (regions indicated by an arrow). Scale
bar represents 20µm. (E) shows that inhibition of Shh signalling causes an increase in the number and
proportion of MyoD+/Myogenin- satellite cells (p=0.046) and a decrease in the number and proportion
of MyoD+/Myogenin+ satellite cells (p=0.045) compared to the control. Representative data from three
individual mice are shown, with 14 to 15 individual fibres per mouse for each time point. Values are
mean and SEM. Statistical analysis was performed using Student’s t-test.
5.2.4 Inhibition of Shh signalling does not cause precocious dif-
ferentiation of satellite cells
Inhibition of Shh signalling leads to an overall decrease in proliferating and differentiating
satellite cells. This effect can be due to different mechanisms, including premature differ-
entiation of muscle progenitor cells. To assess this possibility, I cultured EDL myofibres
from C57BL/6 mice in the presence of 4µM of GANT61 or DMSO (control) for 48h to
analyse the expression of the myogenic regulatory factor Myogenin, which labels differ-
entiated satellite cells. Therefore, the distribution of Caveolin-1/Myogenin and MyoD/
Myogenin was determined by immunofluorescence analysis at 48h.
At 48h in control conditions some satellite cells undergoing early differentiation could
be observed, as shown by the early expression of Myogenin (Fig.5.10 A-D, E-H, I and
J ). Indeed, 17% and 24% of total satellite cells counted were positive for Caveolin-
1/Myogenin and MyoD/Myogenin, respectively. Following Shh signalling inhibition with
GANT61, the number of Myogenin+ cells dramatically decreased, representing then just
4% of the total cells counted (Fig.5.10 A’-D’, E’-H’, I and J), indicating that inhibition of
Shh signalling does not cause premature differentiation of satellite cells and instead delays
it. Furthermore, in line with previous data, following GANT61 treatment the number of
proliferative cells, including Caveolin-1+/Myogenin- cells was reduced by 2-fold. Taken
together, these results confirm that the Shh signalling pathway positively affects satellite
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Figure 5.10: Shh signalling inhibition does not cause premature differentiation of satellite
cells. EDL muscle fibres from C57BL/6 mice were cultured for 48h in the presence of DMSO (control)
or GANT61 (4µM). Myofibres were immunostained to detect Myogenin (red, B and B’) and Caveolin-1
(green, C and C’) or Myogenin (red, F and F’) and MyoD (green, G and G’). Nuclei were counterstained
with DAPI (blue, A, A’, E and E’). Merged images for control and treatment are shown in D, D’,
H and H’. Magnified views for every channel are shown (regions indicated by an arrow). Scale bar
represents 20µm. (I) and (J) show the quantitative analyses of the number of Caveolin/Myogenin and
Myogenin/MyoD positive satellite cells at 48h per fibre in the presence of DMSO or 4µM of GANT61.
Inhibition of Shh signalling causes a decrease in the number of both Caveolin+/Myogenin- (p=0.0095)
and Caveolin+/Myogenin+ (p=0.05) satellite cells compared to the control. Furthermore, GANT61
treatment also had a negative effect in the number of MyoD+/Myogenin+ (p< 0.0348) cells compared to
the control. Representative data from three individual mice are shown, with 16 to 20 individual fibres per
mouse for each time point. Values are mean and SEM. Statistical analysis was performed using Student’s
t-test.
cell progression through the myogenic program.
5.3 Discussion
5.3.1 Chemical manipulation of the Shh signalling pathway leads
to a change in satellite cell numbers.
During vertebrate embryonic development, Shh signalling controls the specification, growth
and patterning of epaxial, hypaxial and limb muscle progenitor cells (Anderson et al.,
2012, Borycki et al., 1999b, Gustafsson et al., 2002, Hu et al., 2012, Kruger et al., 2001,
McDermott et al., 2005). In the adult muscle, the role of Shh signalling remains ambigu-
ous, as some in vitro analyses have shown that Shh can promote muscle differentiation
(Elia et al., 2007, Li et al., 2004, Straface et al., 2009), whereas others claimed that it
prevents it (Koleva et al., 2005). These reports relied on the use of myogenic cell lines
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or primary cultures, which have the inconvenience of taking satellite cells out of their
native environment. Furthermore, these studies did not examine in details the sequence
of myogenic events that lead to satellite cell differentiation, and how these events may be
affected by Shh signalling stimulation or inhibition.
Here, I have performed gain and loss-of-function experiments using pharmacological
drugs that activate and inhibit Shh signalling in the ex vivo myofibre culture system and
showed that loss-of-function approaches lead to a decrease of satellite cell numbers. Specif-
ically, I showed that following treatment with the Shh signalling inhibitors cyclopamine
and GANT61, which caused a reduction in GFP expression in Tg(GBS-GFP) satellite
cells, there was a decrease in the number of Pax7+/MyoD+ and Caveolin-1+/Myogenin+
proliferating progenitor cells at 48 and 72h, respectively. The greater effect of GANT61
compared to cyclopamine (notably at 48h) could be due to the different nature of these
inhibitors. Cyclopamine is a steroidal alkaloid found in the plant Veratrum californicum
that inhibits Shh signalling by direct binding to the Smo heptahelical bundle (Chen et al.,
2002a). In contrast, GANT61 is a hexahydropyrimidine derivative that binds to the Gli1
protein and prevents its binding to the DNA (Agyeman et al., 2014, Lauth et al., 2007). As
GANT61 acts at the level of Gli proteins, which can be modulated in a Smo-independent
manner (Nolan-Stevaux et al., 2009, Stecca et al., 2007, Varjosalo et al., 2008), this may
explain its stronger activity. In addition, similar to SAG, cyclopamine can promote Smo
accumulation in the primary cilia, which may result in attenuated ability to inhibit the
pathway (Wang et al., 2009).
5.3.2 Shh signalling and apoptosis of satellite cells
Several mechanisms may explain the effect of Shh signalling on the expansion and differ-
entiation of satellite cells. First, it is possible that Shh signalling increases satellite cell
numbers by preventing apoptosis as described by others (Koleva et al., 2005). Indeed,
Shh signalling can directly regulate the expression of the anti-apoptotic factor Bcl2, pro-
moting survival of neural progenitor cells in the developing chick embryo (Cayuso et al.,
2006). Shh signalling has also been described as survival factor during tumour progression
through interaction with the pro-apoptotic protein CDON or the cytoprotective protein
polo-like kinase (Delloye-Bourgeois et al., 2013, 2014, Fingas et al., 2013). Other mecha-
nism by which Shh signalling mediates apoptosis includes the induction of cell death by
the Ptc/Caspase-9 complex in the chick spinal cord (Fombonne et al., 2012, Mille et al.,
2009, Thibert et al., 2003). However, despite several attempts at assaying cell death in
the ex vivo culture system, including TUNEL assay and Caspase-3 staining, these exper-
iments were not optimised and did not yield any convincing results. Therefore, a role
of Shh signalling in satellite cell survival cannot be ruled out and further analyses are
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needed to explore this possibility.
5.3.3 Shh signalling and proliferation of satellite cells
An alternative mechanism to explain the effect of Shh signalling in satellite cell expansion
is an increase in the proliferation of activated satellite cells as previously reported (Elia
et al., 2007, Koleva et al., 2005, Straface et al., 2009). Indeed, Shh is a well-known
mitogen of different embryonic cell types, including progenitor cells of the cerebellum and
the retina (Corrales et al., 2006, Locker et al., 2006). It also controls the proliferation
of adult stem cells in the hair follicle, the cervical loop of the teeth and the brain (Hsu
et al., 2014, Petrova et al., 2013, Seidel et al., 2010). Because a role of Shh signalling
in satellite cell proliferation is highly plausible, a whole chapter exploring this possibility
will be discussed later.
5.3.4 Satellite cell progression through the myogenic program
is affected by the Shh signalling pathway.
An interesting finding was that Shh signalling inhibition via GANT61 results in a delay in
satellite progression through the myogenic program ex vivo, leading to presence of cells in
a more primitive state at any given time and a concomitant decrease in the proportion of
more committed or differentiating muscle progenitor cells. As a result, the proportion of
satellite cells reaching terminal differentiation was reduced in GANT61-treated cultures.
What is mechanism implicated in this delay? During adult myogenesis, satellite cells
progress through the myogenic program by the sequential expression of the MRFs. Myf5
is the first MRF to be expressed in embryonic muscle progenitor cells and its mRNA is
already transcribed in around 90% of quiescent satellite cells, reflecting their commitment
to the myogenic lineage (Kuang et al., 2007). Once activated, satellite cells up-regulate
Myf5 and then MyoD and begin their expansion before activating Myogenin, which initi-
ates the differentiation program. One possibility is that in the absence of Shh signalling,
satellite cell activation is delayed. However, stimulation or inhibition of Shh signalling
had no effect on satellite cell activation, as the number and proportion of Pax7+ cell ex-
pressing Myf5 at 24h was not altered. Alternatively, satellite cells may be delayed because
their entry into the cell cycle is also delayed. Quiescent satellite cells express negative
regulators of the cell cycle including cyclin-dependent kinase inhibitors (p27 and p57)
and the retinoblastoma protein (Rb1) among others (Chakkalakal et al., 2014, Hosoyama
et al., 2011). Following muscle injury, damaged myofibres release signalling molecules that
stimulate cell cycle entry, including the insulin-like growth factor (IGF-I), which inacti-
vates FoxO1 through phosphorylation to down-regulate p27 expression (Machida et al.,
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2003). Therefore, it is possible that Shh signalling promotes cell cycle entry or progression
through the cell cycle by acting on one or several of these cell cycle regulators. Indeed, in
the cerebellum, the retina and the limb, cell cycle regulators like D-type cyclins, N-myc,
p27 and p57 have been identified as Shh signalling targets (Shkumatava and Neumann,
2005, Towers et al., 2008, Wall et al., 2009). Likewise, different MAPK pathways are func-
tional in activated satellite cells and are required to initiate the cell cycle or to control
transitions between cell cycle phases (Jones et al., 2005). This is relevant in the context
of this project, as some reports have suggested a link between Shh and the modulation of
MAPK/ERK and PI3K/Akt pathways in muscle progenitors (Elia et al., 2007).
And how is cell division coupled with myogenic differentiation? Satellite cells perform
both symmetric and asymmetric cell divisions. During the latter, cell fate determinants
are segregated asymmetrically to generate one stem cell and one committed cell that dif-
ferentiates. For instance, after asymmetric cell division, the arginine methyltransferase
Carm1 is segregated into the committed daughter cell, resulting in Pax7-mediated control
of Myf5 expression (Kawabe et al., 2012). Therefore, if the rate of satellite cell divi-
sion is altered in the absence of Shh signalling, the balance between symmetric versus
asymmetric cell division may be affected and may result in changes in the proportion of





Shh signalling controls satellite
cell progression through the cell
cycle.
6.1 Introduction
I have previously shown that Shh signalling controls the expansion of satellite cells and
their progression through the myogenic program likely via control of the cell cycle (chapter
5). Specifically, loss-of-function experiments using pharmacological Shh antagonists led
to a decrease of satellite cell numbers. Furthermore, Shh signalling inhibition results in a
delay in satellite cell-mediated myogenesis ex vivo. However, how this pathway regulates
the cell cycle dynamics or how this is linked to cell fate determination is still unknown.
Following skeletal muscle injury, satellite cells proliferate extensively between the sec-
ond and fourth days of regeneration (see chapter 3). Quiescent satellite cells, which are in
a reversible G0 state, become activated as early as 6 hours upon injury in vivo (Grounds
et al., 1992) and carry out their first S phase between 14 and 18h post-injury, indicating
the existence of a prolonged G1 phase that follows the exit from quiescence (Rocheteau
et al., 2012). Satellite cells complete their first cell division between 24 and 48h post-
injury and subsequent cell divisions occur every 8 to 10h until the onset of myogenic
differentiation (Rocheteau et al., 2012). This results in the expansion of both committed
and self-renewing satellite cells needed to contribute to myogenesis and to the stem cell
pool, respectively.
In this chapter I used the ex vivo myofibre culture system to explore changes in satel-
lite cell proliferation following Shh signalling inhibition. More specifically, experimental
strategies to assess differences in cell cycle dynamics were applied, which allow to propose
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a role of the Shh signalling pathway in the control of satellite cell cell cycle progression.
6.1.1 Hypothesis and aim
I hypothesise that Shh signalling controls satellite cell proliferation. Therefore, the aim
of this chapter is to assess the proliferative status of satellite cells in the absence of Shh
signalling.
6.2 Results
6.2.1 Effect of Shh signalling blockade on the expression of pro-
liferation markers during satellite cell-mediated myogen-
esis ex vivo.
I have previously showed that treatment of cultured muscle fibres with the Shh signalling
inhibitors cyclopamine or GANT61 results in an overall decrease in the number of satellite
cells. This change in cell numbers could be due to a decrease in cell proliferation. To
test this, I measured the proliferation rate of satellite cells using different proliferation
markers in the absence of Shh signalling.
First, single EDL muscle fibres from C57BL/6 mice were cultured in the presence of
the Gli inhibitor GANT61 (4µM) or DMSO (control), and the distribution of Pax7 and
the proliferation marker Ki67 was determined by immunofluorescence analysis at 24, 48
and 72h. Ki67 is an antigen present in the nuclei of cells during all active phases of the
cell cycle (G1, S, G2 and M) but absent in resting cells (G0) (Scholzen et al., 2000), as
shown by the absence of Ki67 expression in quiescent satellite cells (see figures 3.5 and
4.7). Ki67 is detected in about 32% of Pax7+ cells at 24h in control conditions. Following
GANT61 treatment at 24h, no changes in satellite cell numbers were observed, although
there was a tendency towards a decreased proportion of Pax7+ cells expressing Ki67 (16%)
(Fig.6.1 A-D, A’-D’ and M). At 48h in control conditions, 92% of satellite cells counted
expressed both Pax7 and Ki67, which shows that most of the cells are undergoing active
proliferation. As previously shown, upon GANT61 treatment the number of satellite cells
decreased drastically by 2-fold, but about 85% of the remaining cells were Pax7+/Ki67+,
indicating that these cells did not lose their proliferative potential (Fig.6.1 E-H, E’-H’ and
M). At 72h in control conditions, Ki67 expression was detected in Pax7+ (45.6%) and
Pax7- (39%) cells, which shows that at this time point differentiating satellite cells (Pax7-
/Ki67+) were still cycling. The remaining cells (15.4%) were Pax7+/Ki67- cells, which
are the cells deemed to self-renew. In agreement with my previous data, following Shh
signalling inhibition the differentiating progeny (Pax7-/Ki67+) was no longer detected
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and most of the remaining cells were either proliferating (Pax7+/Ki67+, 77.3%) or self-
renewing (Pax7+/Ki67-, 17.6%) cells (Fig.6.1 I-L, I’-L’ and M). Thus, satellite cells entry
into the cell cycle is delayed at 24h and a larger proportion of cells remain in the cell cycle
at 72h in the absence of Shh signalling. This suggests that inhibition of Shh signalling
impairs satellite cell progression through the cell cycle and as a consequence, the number
of cells entering differentiation.
To investigate whether a specific phase of the cell cycle was affected in the absence
of Shh signalling, I performed immunostaining analysis using the proliferation marker
phospho-histone 3 (PH3), which labels cells undergoing mitosis (Hans and Dimitrov,
2001). To do so, single EDL muscle fibres from C57BL/6 mice were cultured in the
presence of GANT61 (4µM) or DMSO (control) and the distribution of Pax7 and PH3
was determined by immunofluorescence analysis at 24, 48 and 72h. At 24h in control
conditions, a small proportion of Pax7+ cells were PH3+ (5%). This proportion was
reduced to 1% following Shh signalling inhibition with GANT61, which is in line with
the Ki67 analysis and shows that fewer satellite cells undergo mitosis in the absence of
Shh signalling (Fig.6.2 A-D, A’-D’ and M). At 48h, while the total number of satellite
cells was reduced in the presence of GANT61, the proportion of Pax7+/PH3+ cells was
not changed in GANT61-treated compared to control myofibres (28% versus 29%). This
indicates that the same proportion of cells were in mitosis in the absence of Shh signalling
and in control fibres (Fig.6.2 E-H, E’-H’ and M). However at 72h, cells in mitosis (PH3+)
represented about 6% of the total cells (4% were Pax7+/PH3+ and 1% were Pax7-/PH3+)
in control conditions and 15% following GANT61 administration (Fig.6.2 I-L, I’-L’ and
M). This indicates that by 72h, a higher proportion of cells remaining in M phase are
observed in the absence of Shh signalling.
To assess the S phase of the cell cycle, I measured cells undergoing DNA synthesis by
incubating cultured muscle fibres with 5-ethynyl-2-deoxyuridine (EdU). EdU is a thymi-
dine analogue that incorporates into DNA during replication and can be detected with
fluorescent azides through a Cu-mediated reaction (Salic and Mitchison, 2008). Thus,
myofibres were cultured in the presence of SAG (100nM), cyclopamine (1µM), GANT61
(4µM) or DMSO (control), incubated with EdU for 1 hour before harvesting and the
proportion of Caveolin-1+ satellite cells that have incorporated EdU was determined by
immunofluorescence analysis at 24, 48 and 72h.
At 24h, around 32% of Caveolin-1+ satellite cells were also positive for EdU in control
conditions. Following Shh signalling stimulation with SAG, the percentage of EdU+ cells
showed a slight increase but it was not significant. In contrast, upon Shh signalling
inhibition with either cyclopamine or GANT61, 19.3% and 4.3% of satellite cells were
EdU+, respectively (Fig.6.3 1A-1D and E). This indicates that Shh signalling promotes
satellite cell proliferation at 24h. As shown before, by 48h most of the satellite cells are
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Figure 6.1: Effect of Shh signalling inhibition on Ki67 expression ex vivo. EDL muscle fibres
from C57BL/6 mice were cultured for 24, 48 and 72h in the presence of DMSO (control) or GANT61
(4µM). Myofibres were immunostained to detect Pax7 (red, B, B’, F, F’, J and J’) and Ki67 (green, C,
C’, G, G’, K and K’). Nuclei were counterstained with DAPI (blue, A, A’, E, E’, I and I’). Merged images
for each time point are shown in D, D’, H, H’, L and L’. Magnified views for every channel are shown
(regions indicated by an arrow). Scale bar represents 20µm. (M) shows the quantitative analysis of the
number of Pax7+ and Ki67+ satellite cells at 24h, 48h and 72h per fibre in the presence of DMSO or
4µM of GANT61. There was a significant difference in the number of Pax7+/Ki67+ cells upon GANT61
treatment at 48h compared to the control (p=0.0043). Moreover, there was a significant decrease in
the number of Pax7-/Ki67+ cells at 72h following Gli inhibition compared to the control (p=0.0049).
Representative data from three individual mice are shown, with 10 to 30 individual fibres per mouse for




Figure 6.2: Effect of Shh signalling inhibition on PH3 expression ex vivo. EDL muscle fibres
from C57BL/6 mice were cultured for 24, 48 and 72h in the presence of DMSO (control) or GANT61
(4µM). Myofibres were immunostained to detect Pax7 (red, B, B’, F, F’, J and J’) and PH3 (green,
C, C’, G, G’, K and K’). Nuclei were counterstained with DAPI (blue, A, A’, E, E’, I and I’). Merged
images for each time point are shown in D, D’, H, H’, L and L’. Magnified views for every channel are
shown (regions indicated by an arrow). Scale bar represents 20µm. (M) shows the quantitative analysis
of the number of Pax7+ and PH3+ satellite cells at 24h, 48h and 72h per fibre in the presence of DMSO
or 4µM of GANT61. There was a significant difference in the number of Pax7+/PH3- cells at both
48 (p=0.0155) and 72h (p=0.0146) upon GANT61 treatment compared to the control. (N) shows the
average percentage of Pax7 and PH3 populations at 24, 48h and 72h per fibre in control or under GANT61
treatment. Representative data from three individual mice are shown, with 10 to 15 individual fibres per
mouse for each time point. Values are mean and SEM. Statistical analysis was performed using Student’s
t-test.
139
actively cycling. Here, EdU incorporation revealed that 61.4% of Caveolin-1+ were in S
phase in control conditions and no difference was observed in the percentage of EdU+ cells
after Shh signalling stimulation or inhibition (Fig.6.3 2A-2D and E), suggesting that after
an initial delay in entering the cell cycle, satellite cells are able to divide independently
of Shh signalling. However, as Shh signalling inhibition with cyclopamine or GANT61
caused an increase in EdU incorporation from 13.8% of Caveolin-1+ cells/fibre to 18.2%
and 33.2% (Fig.6.3 3A-3D and E), it suggests that Shh signalling is required for satellite
cell progression through the S phase of the cell cycle and in its absence, satellite cells
remain cycling for a longer period in S phase or fail to pass the checkpoint at the G/S
transition.
6.2.2 Inhibition of Shh signalling delays satellite cell entry and
progression through the cell cycle ex vivo.
To gain further insight into the role of Shh signalling in satellite cell proliferation, I
performed Shh signalling inhibition experiments on cultured myofibres from the R26p-
Fucci2 mice. R26p-Fucci2 mice carry a single transgene, in which the Rosa26 promoter
drives the expression of mCherry-hCdt1 and mVenus-hGem. mCherry-hCdt1 is a fusion
between the fluorescent reporter mCherry and the ubiquitinylation domain of the Cdt1
protein, which accumulates in the cell nucleus during G0, G1, and early S phases. mVenus-
hGem is a fusion of the fluorescent protein mVenus to the ubiquitinylation domain of the
Geminin protein, which accumulates in the cell nucleus during S, G2 and M phases (Fig.6.4
A) (Abe et al., 2013).
Single EDL muscle fibres from R26p-Fucci2 mice were cultured in the presence of
GANT61 (4µM) or DMSO (control) and the distribution of green and red satellite cells
was determined by immunofluorescence analysis at 0, 24, 48 and 72h. First, I observed
that myonuclei, which are post-mitotic, strongly expressed mCherry-hCdt1. Similarly,
97.4% of all Pax7+ cells counted in freshly isolated myofibres at 0h showed comparable
levels of mCherry-hCdt1 than myonuclei, confirming that these cells were in a quiescent
state (Fig.6.4 B and Fig.6.5). At 24h, 56% of satellite cells were in G1/S phase (low levels
of mVenus-hGem while still expressing mCherry-hCdt1). In addition, around 24% of cells
were in S phase (stronger levels of mVenus-hGem and low mCherry-hCdt1 expression),
11% were in G2/M phase (mVenus-hGem expression only) and 9% remained in the G0/G1
phase (Fig.6.4 C and Fig.6.5). Following GANT61 treatment, 45% of cells were in G1/S,
9% were in S and less than 2% were in G2/M phase. The remaining 44% of cells were
in G0/G1 (Fig.6.4 C’ and Fig.6.5). This indicates that fewer satellite cells entered into




Figure 6.3: Effect of Shh signalling pathway stimulation and blockade on EdU incorporation
ex vivo. EDL muscle fibres from C57BL/6 mice were cultured for 24, 48 and 72h in the presence of
DMSO (control), SAG (100nM), cyclopamine (1µM) or GANT61 (4µM). Myofibres were incubated with
10µM of EdU for 1 hour before harvesting and EdU was detected using the Click-iT kit. Merged images
for each time point and treatment are shown, where satellite cells are labelled with Caveolin-1 (green) and
cells in S-phase have incorporated EdU (red). Nuclei were counterstained with DAPI (blue). Magnified
views for every channel are shown (regions indicated by an arrow). Scale bar represents 20µm. (E) shows
the percentage of Caveolin-1+ that incorporated EdU at 24h, 48h and 72h per fibre in the presence of
DMSO, SAG (100nM), cyclopamine (1µM) or GANT61 (4µM). There was a significant difference in the
proportion of Caveolin-1+ cells expressing EdU at 24h upon GANT61 treatment (p=0.0019) compared to
the control. No change in the percentage of EdU+ cells was observed at 48h with any treatment compared
to the control. Finally, there was a significant difference in the proportion of Caveolin-1+ cells expressing
EdU at 72h upon GANT61 treatment (p=0.0001) compared to control conditions. Representative data
from three individual mice are shown, with 12 to 33 individual fibres per mouse for each time point.













Figure 6.4: Shh signalling inhibition affects satellite cell progression through the cell cycle.
EDL muscle fibres from R26p-Fucci2 mice were cultured for 24, 48 and 72h in the presence of DMSO
(control) or GANT61 (4µM). Freshly isolated myofibres at 0h were also analysed. A shows a diagram of
the expression of the Fucci2 transgene. mCherry-hCdt1 labels G0, G1 and early S phase nuclei in red,
whereas mVenus-hGem labels S, G2 and M phase nuclei in green. Yellow indicates overlapping expression
of red and green signals. Myofibres were immunostained to detect Pax7 or Caveolin-1 and mVenus-hGem
(GFP). mCherry-hCdt1 signal was detected without antibody amplification. Nuclei were counterstained
with DAPI. Merged images for each time point are shown in B, C, C’, D, D’, E and E’. Magnified views
for every channel are displayed in small panels, corresponding to regions indicated by an arrow. Scale
bar represents 20µm.
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Figure 6.5: Quantitative analysis of satellite cell cycle progression following Shh signalling
inhibition ex vivo. EDL muscle fibres from R26p-Fucci2 mice were cultured for 0, 24, 48 and 72h in the
presence of DMSO (control) or GANT61 (4µM). Myofibres were immunostained to detect Pax7/Caveolin-
1, mVenus-hGem and mCherry-hCdt1 and the percentage of cells in G0/G1, G1/S, S and G2/M was
quantified. There was a significant difference in the proportion of cells in G0/G1 (p=0.0066) and S
(p=0.0236) at 24h upon GANT61 treatment. In contrast, no significant difference was found at 48h after
Shh signalling inhibition. Finally, at 72h there was a significant difference in the proportion of G0/G1
(p=0.0150), G1/S (p=0.0129) and S (p=0.0275) phases following GANT61 administration. Representa-
tive data from three individual mice are shown, with 10 to 12 individual fibres per mouse for each time
point. Values are mean and SEM. Statistical analysis was performed using Student’s t-test.
At 48h, 65% of satellite cells were in the G2/M phase, 33% in S and 2% in G1/S in
control conditions. In agreement with my Ki67 and EdU data, I observed that following
Shh signalling inhibition, the proliferative status of satellite cells barely changed, as 59%
of cells were in G2/M phase, 33% in S, 5% in G1/S and 3% in G0/G1 (Fig.6.4 D and
D’ and Fig.6.5). This indicates that following the initial delay in initiating the cell cycle,
satellite cells succeed in entering the cell cycle. Finally, at 72h, 24% of the cells were
in G2/M phase, 23% in S, 33% in G1/S and 21% in G0/G1, suggesting that half of the
satellite cell population is still cycling whereas the other half has stopped dividing or is
close to exit the cell cycle to differentiate in control conditions (Fig.6.4 E and Fig.6.5).
In contrast, upon GANT61 treatment, 39% of satellite cells were in G2/M phase, 50%
in S, 10% in G1/S and just 1% were in G0/G1 (Fig.6.4 E’ and Fig.6.5). This indicates
that once entered into the cell cycle, satellite cells progress through the cell cycle more
slowly in the absence of Shh signalling than in control conditions. Specifically, satellite
cells remained in the S phase for longer, and failed to progress to G1 or G0 phase.
To confirm that satellite cells remain in the cell cycle upon inhibition of Shh signalling,
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single satellite cells were isolated from cultured myofibres and labelled with propidium
iodide (PI) to measure their DNA content. To obtain a cell cycle profile, the initial
cell population was gated according to the forward-scattered light (FSC) and the side-
scattered light (SSC), which give information on the size and granularity of the cells.
These features have to be determined experimentally for a particular cell type and in
this case, the C2C12 muscle cell line was used to do so. Next, doublets were excluded
from the analysis by plotting the area of the fluorescence light pulse (BL3-A) against the
width (BL3-W). Doublets usually have greater pulse width than single cells and therefore
were excluded from the analysis. The premise with PI staining is that it binds DNA
proportionally to the amount of DNA present in a given cell. Thus, cells in S phase have
more DNA than cells in G1 so they take up proportionally more dye and fluoresce more
brightly. Likewise, cells in G2/M phase are approximately twice as bright as cells in G1.
Therefore, the cell cycle profile is represented graphically in a histogram as the amount
of fluorescence emitted (X axis, BL3-H) and the number of cells that would emit that
fluorescence (Y axis, count).
PI-labelled satellite cells were analysed to determine the proportion of cells at different
stages of the cell cycle and compare this profile to satellite cells that have been treated
with GANT61. I found that around 57% of satellite cells isolated from 48h-cultured
myofibres were in G0/G1, whereas 18% and 25% of cells were in S and G2/M, respectively.
Following GANT61 treatment, 55% of satellite cells were in G0/G1, 23% in S and 22% in
G2/M (Fig.6.6 A, A’ and C). By 72h, analysis of satellite cells from myofibres cultured in
control conditions indicated that 78% of cells were in G0/G1, 8% in S and 14% in G2/M.
Following Shh signalling inhibition 72% of cells were in G0/G1, 11.5% in S and 16.5%
in G2/M (Fig.6.6 B, B’ and C). This indicates that Shh signalling inhibition causes an
accumulation of satellite cells in the S and G2/M phases at the expense of G0/G1.
6.3 Discussion
6.3.1 The satellite cell proliferation profile ex vivo: insights
from different experimental approaches.
At the time of activation, satellite cells enter the cell cycle to expand and supply progeny
to repair muscle damage. In this chapter, using different markers and experimental ap-
proaches I examined the normal proliferative behaviour of satellite cells during adult
myogenesis ex vivo.
Ki67 is a broad-spectrum marker of cell proliferation as it is detected in all active
phases of the cell cycle (G1, S, G2 and M) but not in resting cells. Thus, quiescent





Figure 6.6: Effect of Shh signalling inhibition on satellite cell cycle distribution ex vivo.
Single EDL myofibres from C57BL/6 mice were cultured in the presence of either DMSO (control) or
GANT61 (4µM). Satellite cells were subsequently isolated by enzymatic and mechanical dissociation to
obtain single cells. Isolated satellite cells were labelled with PI and were analysed according to their DNA
content. A, A’, B and B’ show the cell cycle profile of 48 and 72h-cultured satellite cells treated with
DMSO or GANT61. The G0/G1 interval would include both differentiating satellite cells and cells that
are actually in the G1 phase. C. The graph shows the percentages of satellite cells in different phases
of the cell cycle at 48 and 72h in control condition and GANT61 treatment. There was a difference
in the proportion of cells in S phase at 48h following GANT61 treatment compared to the control
(p=0.037). Additionally, less cells in G0/G1 phase were observed upon Gli inhibition compared to the
control (p=0.0190). Representative data from three independent experiments are shown. Values are
mean and SEM. Statistical analysis was performed using Student’s t-test.
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the R26p-Fucci2 mice, quiescent satellite cells were strongly labelled with mCherry-Cdt1,
which marks both G0 and G1 phases. This finding contradicts a previous study that
reported the absence of mKO2-hCdt1 expression in quiescent Pax7+ satellite cells and
led to the authors proposed that myonuclei, which are post-mitotic and mCherry-Cdt1+
were in a G1-like state (de Lima et al., 2014). However, the mKO2-hCdt1 probe used
in that study is now known to display variable and sometimes not high enough intensity
in several tissues (Abe et al., 2013). In contrast, the mCherry-hCdt1 transgene used
in this project is tightly regulated and has been reported to clearly label cells at G0
in other tissues (Oki et al., 2014). Likewise, all myonuclei also expressed high levels of
mCherry-hCdt1, confirming that cells in a G0 state were properly labelled.
Satellite cells in ex vivo cultures enter the cell cycle within the first 24h, as shown by
the expression of Ki67 and the up-regulation of mVenus-hGem. Interestingly, a higher
proportion of cycling cells expressing mVenus-hGem than Ki67 was observed (91% versus
32%). This was surprising as Ki67 is generally thought to mark cells at all phases of the
cell cycle. However, it should be mentioned that, although the expression of Ki67 at the
S phase is generally accepted, its expression during the very initial G1 phase of different
cell types has been largely debated (Scholzen et al., 2000). Therefore it is possible that
cells in the late G1/early S identified using the Fucci2 system are not labelled with Ki67.
This is consistent with the fact that at 24h, 32% of satellite cells incorporated EdU,
indicating that they were in S phase. Given that a similar proportion of cells (32%) were
labelled with Ki67, it suggests that Ki67 mainly labelled satellite cells in the S phase.
This percentage is also very similar to the proportion of cells in S phase detected with
the Fucci2 system (24%).
By 48h, satellite cells were actively cycling as shown by Ki67 expression, which is
consistent with previous studies (Le Grand et al., 2012). Specifically, most satellite cells
were either in S or G2/M phase, as shown by EdU incorporation, PH3 staining and Fucci2
analysis. However, the proportion of cells in S and G2/M phases detected using the Fucci2
system did not entirely match the proportions observed with EdU and PH3 staining. This
may be due to the fact that in the Fucci2 system cells in the late S phase do not express
mCherry-hCdt1 but do express mVenus-hGem just as cells in the G2 phase do, therefore
making it difficult to distinguish them (Sakaue-Sawano et al., 2008). Therefore, it is likely
that in R26p-Fucci2 myofibres the proportion of satellite cells in G2/M was overestimated
and that some of these cells were actually still in S phase. EdU co-staining is strongly
recommended to overcome this issue but unfortunately, I was not able to optimise this
double labelling in the ex vivo culture system.
Although some small discrepancies were also found between the Fucci2 system and
EdU staining at 72h, the same proliferative trend was observed with both approaches.
Importantly, the percentage of cycling cells in satellite cells from R26p-Fucci2 myofibres
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Table 6.1: Distribution of satellite cells in the phases of the cell cycle using different experimental
approaches
Time Proliferation markers Fucci2 Flow cytometry
G0/G1 S G2/M G0/G1 S G2/M G0/G1 S G2/M
0h 100% 0% 0% 100% 0% 0% NA NA NA
24h NA 32% NA 65% 24% 11% NA NA NA
48h NA 62% NA 2% 33% 65% 57% 18% 25%
72h 19% 14% NA 21% 23% 24% 78% 8% 14%
was similar to the one detected by Ki67 staining (81% and 79%, respectively), which
resulted in the same proportion of cells going into G0/G1 phase with both techniques
(19% and 21%, respectively). This is also consistent with previous studies (Zammit et al.,
2004). Along this line, it is important to discuss the proportion of cells in G0/G1 state
obtained by flow cytometry analysis at both 48 and 72h, which is higher than expected.
Again, this may be explained by the experimental method used. There, single satellite cells
were enzymatically and mechanically isolated from cultured myofibres and it is very likely
that myonuclei were present in the final cell solution. Since one single myofibre contains
hundreds of myonuclei, this number could have been added up to the final percentage of
G0/G1 cells in the analysis. A strategy to solve this problem is the labelling of satellite
cells with a fluorescent reporter. Indeed, muscle fibres from Tg:Pax7-EGFP mice were
used for some experiments but the GFP fluorescence was lost after ethanol fixation, which
is a requirement for PI staining. However, antibody staining can also be performed and
this is an approach that is highly recommended for future experiments. Overall, the use
of different techniques allowed me to establish a proliferation profile of satellite cells ex
vivo. This is relevant since a complete analysis of this type in satellite cells ex vivo has
not been reported and it gives an interesting perspective on the use and scope of cell
proliferation markers in our system (Table 6.1).
Most of the knowledge of satellite cell cell cycle dynamics comes from analysis of C2C12
myoblasts and isolated satellite cells, although some in vivo studies on satellite cells have
also been reported. Flow cytometry analyses have shown the cell cycle profile of cultured
myoblasts and human satellite cells before and after injury or acute exercise (Bellamy
et al., 2014, Kollu et al., 2015, Lin et al., 2012, McKay et al., 2010). Furthermore,
the dynamics of satellite cell proliferation have been analysed through label retention
techniques in vivo, including BrdU and [3H]thymidine labelling and doxycycline pulses
in TetO-H2B-GFP mice (Chakkalakal et al., 2014, Rocheteau et al., 2012, Schultz, 1996,
Shinin et al., 2006). This has contributed to establish the average length of the cell cycle
of satellite cells. In my analysis, I observed that satellite cells have a prolonged initial
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G1 phase, as 65% of satellite cells were in G1/S and 24-29% in S phase at 24h according
to Fucci2 and EdU analysis, which is consistent with previous reports (Rocheteau et al.,
2012, Schultz, 1996). I also observed that the number of satellite cells increased by
about 3-fold between 24 and 48h, indicating the completion of the first cell division and
probably also the second division in a subset of satellite cells. This is also in line with
previous studies reporting that satellite cells complete their first cell division between 24
and 48h (Mourikis et al., 2012b, Rocheteau et al., 2012, Schultz, 1996, Siegel et al., 2011)
and that subsequent cell divisions occur faster, about every 8 to 10h (Rocheteau et al.,
2012, Siegel et al., 2011). This indicates that the cell cycle dynamics of satellite cell ex
vivo are similar to those found in vivo. Additionally, genome-wide analysis of cell cycle
regulators has been performed in C2C12 myoblasts under proliferation and differentiation
conditions, demonstrating that the onset of differentiation coincides with down-regulation
of cyclins/Cdk complexes and up-regulation of cell cycle exit genes such as p21, p27 and
Rb1 (Shen et al., 2003). A similar analysis in satellite cells ex vivo would be highly
informative and would allow the refinement of the information I present in this chapter.
6.3.2 Shh signalling affects the cell cycle dynamics of satellite
cells at two different time points during myogenesis ex
vivo.
In chapter 5, I showed that activation or inhibition of Shh signalling triggered an increase
or a decrease of satellite cell numbers, respectively. Previous studies have reported a role
for Shh signalling in the control of myoblast proliferation (Elia et al., 2007, Koleva et al.,
2005, Straface et al., 2009) and two studies suggested a beneficial effect of Shh-mediated
therapy on satellite cell proliferation in vivo (Piccioni et al., 2014a,b). However, the extent
to which Shh signalling controls satellite cell proliferation is still poorly understood.
Using the myofibre culture system, I identified two different timing at which Shh
signalling is required for satellite cell cycle dynamics. First, within the first 24h of ex vivo
culture, inhibition of Shh signalling resulted in a decrease in the proportion of proliferating
satellite cells as shown by Ki67 and EdU staining. Furthermore, the proportion of cells
going into S phase was lower with a concomitant increase in the percentage of satellite cells
in G1 phase. These data indicate that Shh signalling is required for the timely initiation
of cell cycle in satellite cells, probably by affecting the G1/S transition. The control of
the G1/S checkpoint by Shh signalling has been described in other systems, including the
zebrafish retina, the chick wing bud and the mouse external genitalia (Seifert et al., 2010,
Towers et al., 2008, Wall et al., 2009). The molecular mechanism responsible for this
regulation includes the transcriptional control of G1/S regulators, in particular N-myc,
CyclinE1, CyclinD1, Dp1 and E2f1. In satellite cells it remains to establish whether Shh
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controls directly the transcription of G1/S regulators or acts indirectly via the control of
other transcription factors. Further experiments are needed to decipher between these
two possibilities.
The second effect of Shh signalling becomes noticeable at 72h: following inhibition
of Shh signalling, satellite cells remained in a proliferative state, with most cells in S or
G2/M and very few cells in G1 or G0. This indicates that Shh signalling controls cell
cycle progression and exit, and thus the number of cells going into terminal differentiation
or quiescence. Exit from the cell cycle in senescence, quiescence and differentiation is
characterised by a prolonged cell cycle arrest with diploid DNA content and high cyclin
dependent kinase inhibitor activity (p27 for quiescence and p21, p19 and p57 for terminal
differentiation) (Buttitta and Edgar, 2007). Along this line, Shh signalling directs cell
cycle exit through p57 activation in the zebrafish retina (Shkumatava and Neumann,
2005). Even more interesting is the fact that in the Xenopus laevis retina, a dual role of
Hh signalling in controlling cell cycle dynamics has been described, where Hh signalling
stimulates cell proliferation during early development and promotes cell cycle exit at
later stages (Locker et al., 2006). Future experiments to analyse the expression of cyclin
dependent kinase inhibitors may help identify the molecular targets of Shh signalling in
the control of satellite cell cycle. Also, next-generation RNA sequencing (RNA-seq) of
FACS-sorted satellite cells depleted of Shh signalling may provide further information of
the genes under the control of Shh.
To conclude, during adult myogenesis early transition from G1 to S phase as well as
cell cycle progression and exit prior differentiation is under the control of Shh signalling
(Fig.6.7). These findings are important as they provide us with a better understanding
of the extra-cellular cues that control satellite cell activity and more specifically, satellite
cell cell cycle dynamics. This knowledge is also invaluable to design novel protocols for
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Figure 6.7: Model for satellite cell cell cycle control by Shh signalling. During the activa-
tion phase of adult myogenesis (24h), Shh signalling stimulates cell proliferation by affecting the G1-S
transition. Conversely, pharmacological inhibition of the Shh pathway in satellite cells during the early
differentiation phase (72h) leads to an increase in the proportion of proliferative progenitors, delaying
the exit from the cell cycle and reducing the number of satellite cells reaching terminal differentiation.
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CHAPTER 7
Skeletal muscle regeneration is
impaired in the absence of Shh
signalling
7.1 Introduction
In previous chapters I have shown that activated satellite cells respond to Shh signalling
and that this response facilitates the entry and progression of satellite cells through the cell
cycle. Blockade of Shh signalling leads to a decrease in the number of satellite cells, delayed
cell cycle entry and delayed myogenesis. This evidence suggests that Shh signalling is
required for satellite cell activity ex vivo. Furthermore, I have shown that following
skeletal muscle injury in vivo, activated satellite cells respond to Shh signalling. However,
the requirement of this pathway in satellite cell function in vivo has not been determined
yet. One approach to investigate the role of Shh signalling in satellite cell biology in vivo is
the generation of knockout mice that disrupt Shh signalling transduction. In this study, I
used a conditional knockout model, the Pax7CreERT2-Smoflox/flox mice, to specifically delete
Smo expression in adult satellite cells.
The Cre-loxP system is the most efficient tool to generate tissue-specific inducible gene
deletion. The Cre recombinase catalyzes the reciprocal exchange between two DNA se-
quences of 34-bp of length, the loxP sites (Hamilton and Abremski, 1984). The inducible
system modifies the Cre recombinase by fusion with a mutated oestrogen receptor (ER),
which allows temporal control of gene deletion through the binding of the ER antagonist
tamoxifen (TM) (Feil, 2007). One of the best known application of this system in skele-
tal muscles was carried out by Lepper at al. to conditionally delete Pax7 expression in
Pax7+ satellite cells (Lepper et al., 2009). Since Pax7 is expressed in muscle progenitor
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Pax7+/+ ; Smoox/ox (control)
Pax7CreERT2/+ ; Smoox/+ (heterozygous, SmoΔ/+)
Pax7CreERT2/+ ;Smoox/ox (homozygous, SmocKO)
Figure 7.1: Tamoxifen (TM) and cardiotoxin (CTX) regimen and regeneration assay strat-
egy. Mice were injected intraperitonally for four days with TM. Mice were then fed with TM diet
until sacrifice. TA muscles of control, Smo∆/+ and SmocKO were injured by a single CTX injection and
analysed at various times during regeneration.
cells during embryonic development but only expressed in satellite cells post-natally, the
use of an inducible system allowed the deletion of Pax7 specifically in satellite cells from
mature muscles (Lepper et al., 2009). Likewise, Shh signalling is indispensable for em-
bryonic development and germline mutations of some of its components, including Smo,
are embryonically lethal (Zhang et al., 2001). Therefore, I took advantage of the Cre/Lox
inducible system to investigate the requirement of Shh signalling in satellite cell during
adult muscle regeneration in vivo.
7.1.1 Hypothesis and aim
Given that satellite cells respond to Shh signalling both ex vivo and in vivo and that
pharmacological manipulation of the pathway disrupts satellite cell cell cycle dynamics
ex vivo, I hypothesised that in the absence of functional Shh signalling, satellite cells
ability to repair muscles following injury would be impaired. Therefore, the aim of this
chapter is to conditionally delete Smo expression in Pax7+ satellite cells and investigate
the requirement of Shh signalling during muscle regeneration in vivo.
7.2 Results
7.2.1 Generation of the Pax7CreERT2-Smoflox/flox mutant mice.
To investigate the function of Shh signalling in adult muscles, the Smo receptor was specif-
ically deleted from satellite cells using the Cre/LoxP system. Two original breeding lines
of mice (Smoflox/+) and (Pax7CreERT2/+) were used to generate mutant Pax7CreERT2/+-
Smoflox/flox newborns, also referred as SmocKO, heterozygous Pax7CreERT2/+-Smoflox/-, re-
ferred as Smo∆/+, and control Smoflox/flox mice (Fig.7.1).
152
In this conditional knockout model, the deletion of Smo is triggered by administration
of tamoxifen (TM). Insufficient dose of TM may cause incomplete recombination (Günther
et al., 2013) and too high dose of TM may have cytotoxic effects. Also, prolonged expo-
sure to TM (15 months) can improve body musculature in dystrophic mice, which may
have influence on the phenotype caused by Cre recombination (Dorchies et al., 2013).
The experimental design of the TM treatment takes into account several factors, includ-
ing dose, administration and duration, which can lead to variable levels of gene deletion
(Günther et al., 2013). Therefore, a long-term treatment (up-to 3 weeks) with relative
low doses of TM was adopted for my experiments in order to achieve high percentage of
recombination. TM was administered intraperitonally at 3mg/40g of body weight daily
for 4 days before CTX-induced injury. From day 5 mice were fed with TM chow (approx-
imate dose of 40 mg/kg/day) until sacrifice (Fig.7.1). This protocol has been used by
others and was found to give over 80% of recombination (von Maltzahn et al., 2013). For
the present study, quantification of the Cre recombination rate was done by PhD student
Kamalliawati Mohd using Pax7CreERT2/+-Smo∆/+ Rosa26-YFP mice. These mice allow
to monitor Pax7-expressing satellite cells that have undergone Cre-mediated recombina-
tion through the quantification of YFP expression. EDL myofibres from Pax7CreERT2/+-
Smo∆/+ Rosa26-YFP were analysed by immunofluorescence after 0 and 24h in culture to
detect the expression of the satellite cell marker Caveolin-1 and the YFP protein (Fig.7.2,
A). This analysis showed that around 83.81% and 90.50% of cultured satellite cells at
0 and 24h underwent recombination after TM injections/diet (Fig.7.2, B). This experi-
mental aspect is crucial when working with inducible knockout systems, as incomplete
recombination can mask the deletion phenotype and lead to debatable conclusions.
7.2.2 Effect of satellite cell-specific deletion of Smo on muscle
architecture following CTX injury.
To test the requirement for Shh signalling pathway during muscle repair, regeneration
following CTX-induced injury was analysed in SmocKO mice (Fig.7.1).
First, I examined the morphology of non-injured and CTX-injured TA muscles from
control, SmocKO and Smo∆/+ mice using hematoxylin and eosin staining (Fig.7.3) and
Laminin α-2 immunolabelling to assess the cross sectional area (CSA) of myofibres (Fig.7.4).
Healthy non-injured TA muscles from the three different genotypes showed a uniform ar-
chitecture, myonuclei were located at the periphery of muscle fibres and most of the
myofibres were between 1500 and 2000µm2 of size (Fig.7.3 A-C and Fig.7.4 A-D). At two
days post-injury, necrosis and infiltration of mononucleated cells was wide-spread at the
site of injury in all mice (Fig.7.3 D-F yellow arrows). This resulted in the damage of the







Figure 7.2: Efficiencies of Cre-mediated recombination measured by YFP expression.
Pax7CreERT2/+-Smo∆/+ Rosa26-YFP mice were injected intraperitonally for four days with TM and
then fed with TM diet until sacrifice. EDL muscle fibres from these mice were cultured ex vivo for 0 and
24h and then immunostained to detect Caveolin-1 and YFP expression. Myonuclei were counterstained
with DAPI. (A) Merged image of a 24h-cultured myofibre showing Caveolin-1 and YFP co-expression.
Magnified view is also shown (region indicated by an arrow). Scale bar represents 32µm. (B) show
the quantitative analyses of the percentage of Caveolin-1 and YFP+ cells at 0 and 24h per myofibre.
Representative data from two individual mice are shown. Values are mean and SEM.
ence was observed at this point between genotypes. The infiltration of inflammatory cells
and satellite cells continued at 4 days post-injury. New fibres with centrally located my-
onuclei were already visible in both control and Smo∆/+ but hardly detectable in SmocKO
mice (Fig.7.3 G-I). This was consistent with the presence of a higher frequency of small
fibres in SmocKO mice (less than 500µm2) than other mice (Fig.7.4 E-H). At 7 days post-
injury, newly regenerated myofibres were highly abundant in all mice (Fig.7.3 G-I red
arrows). Interestingly, in both SmocKO and Smo∆/+ accumulation of mononucleated cells
was still visible (Fig.7.3 J-L yellow arrows) and persisted until 14 days post-injury (Fig.7.3
M-O). Additionally, the frequency of myofibres with small size was higher in SmocKO and
Smo∆/+ compared to control muscles (Fig.7.4 I-L). Constistent with this observation, my-
ofibres from SmocKO and Smo∆/+ muscles hardly reached 1500µm2 in size and most of
the fibres were rather small (less than 500µm2) whereas control muscles had regenerated
myofibres of up to 3000µm2 in size at 14 days post-injury (Fig.7.4 M-P). Concomitantly, a
higher number of regenerating myofibres was observed per section in SmocKO and Smo∆/+
muscles. Together, this indicates that the partial or total loss of Smo function in satellite
cells affects negatively the regeneration process following muscle injury, as shown by the
abundance of small-caliber fibres and the accumulation of mononucleated cells at both 7







Figure 7.3: Regeneration following CTX-induced muscle injury in SmocKO mice Uninjured
and cardiotoxin-injured (2, 4, 7 and 14 days) TA muscles from control, SmocKO and Smo∆/+ mice were
analysed by H&E staining to assess changes in muscle architecture. Non-injured TA muscle from all mice
had fibres with homogeneous size and appearance (A-C). All injured muscles showed similar morphological
changes in myofibre shape due to necrosis and cell infiltration of different types of mononuclear cells at 2
(D-F) and 4 days (G-I) post-injury. Newly regenerating myofibres were visible from day 4 in both control
and Smo∆/+ but not really detectable in SmocKO mice. Centrally located nuclei were more evident by day
7 post-injury in control and Smo∆/+ and already visible in SmocKO mice. (J-L). Muscle architecture was
restored by 14 days post-injury in control mice, with the presence of fully regenerated myofibres (M). In
contrast, Smo∆/+ and SmocKO muscles had altered architecture, showing some regenerating regions with
small fibres and infiltrating cells (N and O). Non-injured areas, infiltrated cells and fibres with centrally
located nuclei are shown with green, yellow and red arrows, respectively. Representative images from










Figure 7.4: Myofibre size declines in regenerating TA muscles of SmocKO and Smo∆/+ mice.
Uninjured and cardiotoxin-injured (4, 7 and 14 days) TA muscles from control, Smoflox/+ and SmocKO
mice were analysed by Laminin alpha-2 (Lama2) immunostaining and the cross sectional area (CSA) of
myofibres was analysed. Scale bar represents 50µm. The relative frequency of fibres was plotted against
fibre cross-sectional area in µm2. A high percentage of small fibres (less than 500µm2) was observed to
be higher at 14 days post-injury in SmocKO and Smo∆/+ mice compared to control mice (p< 0.0001).
Representative data from three individual mice per time point, where three cross-sectional fields (0.154
mm2) of regenerating muscle per mouse were analysed. Values are mean and error bars show SEM.
Statistical analysis was performed using Student’s t-test.
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7.2.3 Satellite cell-specific deletion of Smo increases fibrosis dur-
ing muscle regeneration.
Efficient skeletal muscle regeneration is orchestrated by the interplay between satellite cells
and non-muscle cells, including inflammatory cells and fibroblasts. Fibroblasts produce
extracellular matrix components such as collagen type I, fibronectin, elastin and laminin
(Mann et al., 2011). Indeed, transient collagen deposition following CTX-induced injury
is a feature of muscle regeneration and it is thought to contribute to muscle stabilisation
and to help sequester growth factors that stimulate satellite cell function (Cornelison,
2008, Kääriäinen et al., 2000). However, excessive collagen deposition can lead to fibrosis
and interfere with muscle regeneration. Therefore, to assess the extent of fibrosis in
regenerating muscles, I performed an immunostaining analysis to detect collagen type I
deposition at 7 and 14 days post-injury.
I observed that regenerating control muscles had about 16% of collagen deposition
at 7 days post-injury (Fig.7.5 A and G). This percentage was reduced to 9% at 14 days
post-injury, indicating that collagen deposition is transient and decreases as regeneration
progresses (Fig.7.5 D and G). In contrast, in both SmocKO and Smo∆/+ muscles, collagen
accumulated significantly at 7 days compared to control muscles (deposition of 34.5% and
45.4%, respectively) (Fig.7.5 B, C and G). Furthermore, the amount of collagen deposition
remained high at 14 days post-injury in SmocKO muscles (deposition of 37%), whereas
in Smo∆/+ muscles collagen deposition was reduced between 7 and 14 days but was
significantly different from the control by 14 days post-injury (deposition of 23%). This
suggests that loss of functional Shh signalling in satellite cells had a negative impact on
the progression of muscle regeneration, leading to the persistent accumulation of collagen
type I.
Next, in order to see if changes in fibre size and accumulation of fibrosis had an impact
on the overall size of the muscles, weight ratio of injured and non-injured TA muscles was
determined. Against all expectations, the ratio of muscle weight in SmocKO and Smo∆/+
mice was similar to the control (Fig.7.6), indicating that the knockout of Smo in satellite
cells does not cause muscle loss or atrophy. It can be possible, however, that the high
accumulation of collagen and the increase in fibre number might compensate for any loss
of muscle mass.
7.2.4 The absence of active Shh signalling in satellite cell delays
muscle regeneration in vivo.
Previous work has established that in the embryonic limb, myogenesis is delayed in the
absence of Shh signalling (Anderson et al., 2012). Similarly, ex vivo inhibition of the
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Figure 7.5: Collagen type I deposition increases in SmocKO and Smo∆/+ regenerating mus-
cles. 7-day (A-C) and 14-day (D-F) CTX-injured TA muscles from control, SmocKO and Smo∆/+ mice
were analysed by collagen type I immunostaining and the percentage of collagen deposition was calculated
(G). Myonuclei were counterstained with DAPI. The percentage of fibrosis was calculated by averaging
the area of positive collagen staining in multiple sections per TA-injured muscle. There was a significant
difference between the amount of collagen in SmocKO and Smo∆/+ muscles at 7 days compared to con-
trol (p=0.0391 and p=0.0335, respectively). Likewise, the deposition of collagen at 14 days post-injury
in SmocKO and Smo∆/+ muscles was significantly different from the control (p=0.0464 and p=0.0285,
respectively). Representative data from two to three individual mice per time point, where three to four
cross-sectional fields (0.154 mm2) of regenerating muscle per mouse were counted. Values are mean and





























Figure 7.6: Specific deletion of Smo in satellite cells does not affect the weight of regener-
ating muscles. 2, 4, 7 and 14-day CTX-injured TA muscles from control, SmocKO and Smo∆/+ mice
were weighted and normalised to contralateral uninjured TA muscles (intact). No significant difference
was found between genotypes. Boxes represent RQ and whiskers show minimum and maximum values.
Representative data based on two to three mice per time point. Statistical analysis was performed using
using Student’s t-test.
Shh signalling pathway in satellite cells leads to a delay in the progression through the
myogenic program. Therefore, I decided to test if the lack of functional Shh signalling
affected MRF expression in adult satellite cells in vivo.
Regenerating TA muscles were harvested at 2, 4, 7 and 14 days after CTX injection and
MyoD immunostaining was performed. I observed that total and partial Smo-inactivation
in satellite cells resulted in a significant decrease in the number of MyoD+ cells at 2 days
post-injury compared to control muscles (37% and 44% reduction for SmocKO and Smo∆/+,
respectively) (Fig.7.7 A-C and M). Importantly, a 80% decrease in the number of differ-
entiating Myogenin+ cells was also observed in both SmocKO and Smo∆/+ muscles at 2
days compared to the control (Fig.7.8 A-C and M). At 4 days post-injury, the number of
MyoD+ and Myogenin+ cells in SmocKO and Smo∆/+ muscles was not significantly differ-
ent from the control, although a trend towards reduced MyoD and Myogenin expression
was apparent in SmocKO muscles (Fig.7.7 D-F and M and Fig.7.8 D-F and M). These data
indicate that the absence of Shh signalling affects satellite cell progression through the
myogenic program in regenerating adult muscles.
As shown in chapter 3, by 7 days post-injury the number of both MyoD+ and Myo-
genin+ cells decreases importantly and this coincides with the gradual restoration of
the muscle architecture in normal muscles. However, no such decrease was observed in
SmocKO and Smo∆/+ muscles (Fig.7.7 G-I and M and Fig.7.8 G-I and M). By 14 days
post-injury, a significant number of MyoD+ and Myogenin+ cells remained present in
SmocKO and Smo∆/+ muscles compared to the control (Fig.7.7 J-L and M and Fig.7.8 J-L
and M). More specifically, there was a 2.5 and 5-fold increase in the number of MyoD+
cells and more than a 14-fold increase in the number of Myogenin+ cells was observed for
SmocKO and Smo∆/+ muscles, respectively. This strongly suggests that in the absence of
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Shh signalling, satellite cells are delayed in their muscle repair program.
To determine whether SmocKO and Smo∆/+ injured muscles would recover at later time
points, I performed immunostaining to analyse MyoD expression in 21-day post-injury
muscles. Control muscles had a uniform architecture and most regenerated myofibres
with centrally located myonuclei were of similar size. Importantly, similar to the 14-day
post-injury muscles, no MyoD expression was detected (Fig.7.9 A and A’). In contrast,
the architecture of SmocKO and Smo∆/+ muscles was not homogeneous as small caliber
fibres were still present. Moreover, MyoD+ cells were still detected in SmocKO but not in
Smo∆/+ muscles (Fig.7.9 B-C’). This indicates that inactivation of Smo in satellite cells
causes severe impairment in muscle regeneration in response to injury.
The decrease in the number of MyoD+ and Myogenin+ cells in SmocKO and Smo∆/+
muscles suggests that satellite cells may fail to proliferate in the absence of Shh signalling.
Therefore, I examined the expression of the proliferation marker Ki67 in sections from
2, 4, 7 and 14-day CTX-injured muscles. Overall, cell proliferation at 2, 4 and 7 days
following acute injury was not significantly different in muscles lacking one or two copies
of Smo in satellite cells compared to control muscles (Fig.7.10 A-I and M). In contrast,
a 6-fold increase in the number of Ki67+ cells in both SmocKO and Smo∆/+ muscles was
observed at 14 days post-injury compared to the control. Most of these Ki67+ cells were
in a sublaminar position and hence are likely to be satellite cells (Fig.7.10 J-L and M).
This is consistent with the increase of MyoD+ myoblasts at 14 days and strengthens the
idea that in the absence of Shh signalling, satellite cells delay their progression into the
myogenic program and remain proliferative at late stages of muscle regeneration.
To further investigate the behaviour of Smo-inactivated satellite cells, I analysed how
the expansion dynamics of these cells was affected upon loss of Shh signalling. To do so,
control and SmocKO mice were treated with TM and myofibres were isolated after one week
on TM diet and cultured for 0, 24, 48 and 72h. Fibres were then immunostained to detect
Pax7/Myf5 (0 and 24h), Pax7/MyoD (48h) and Caveolin-1/Myogenin (72h) expression. I
observed that the number of Pax7+ cells in freshly isolated myofibres was similar in both
control and SmocKO mice (Fig.7.11 C). Likewise, at 24 and 48h, the number of activated
Pax7+/Myf5+ and Pax7+/MyoD+ satellite cells did not changed significantly in SmocKO
compared to the control, although there was a tendency towards a reduced number of
satellite cell (Fig.7.11 C). In contrast, at 72h in SmocKO fibres, the number of Caveolin-
1+/Myogenin- and Caveolin+/Myogenin+ satellite cell was reduced by 45% and 55%,
respectively, whereas the differentiated Caveolin-1-/Myogenin+ population completely
dissapeared (Fig.7.11 A-C). These results are consistent with my previous experiments
using GANT61 and cylopamine to block Shh signalling. Together, these data confirm
that in the absence of Shh signalling, satellite cells delay their progression through the
myogenic program with a concomitant reduction in satellite cell numbers.
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Figure 7.7: Loss of Smo affects the number of MyoD+ satellite cells in regenerating muscles.
CTX-injured (2, 4, 7 and 14 days) TA muscles from control, SmocKO and Smo∆/+ mice were analysed
by immunofluorescence to detect MyoD (red). Cell nuclei were counterstained using DAPI (blue) and
muscles fibres were outlined with Laminin alpha 2 (green). Merge images from three channels are shown
for each genotype at 2, 4, 7 and 14 day-injured muscles in A’ to L’. Magnified views for merged images
are shown (regions indicated by an arrow). Scale bar represents 50µm. There was a significant difference
in the number of MyoD+ cells at 2 days in SmocKO and Smo∆/+ muscles compared to the control
(p=0.0057 and p=0.0229, respectively). Moreover, a significant increase in MyoD+ cells was observed
at 14 days in SmocKO and Smo∆/+ muscles compared to control (p=0.0340 and p=0.0444, respectively).
Representative data from three individual mice per time point, where four to six cross-sectional fields
(0.154 mm2) of regenerating muscle per mouse were counted. Boxes represent RQ and whiskers show
minimum and maximum values. Statistical analysis was performed using Student’s t-test.
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Figure 7.8: Decrease of satellite cell differentiation in the absence of Shh signalling. CTX-
injured (2, 4, 7 and 14 days) TA muscles from control, SmocKO and Smo∆/+ mice were analysed by
immunofluorescence to detect Myogenin (red). Cell nuclei were counterstained using DAPI (blue) and
muscles fibres were outlined with Laminin alpha 2 (green). Merge images from three channels are shown
for each genotype at 2, 4, 7 and 14 day-injured muscles in A’ to L’. Magnified views for merged images are
shown (regions indicated by an arrow). Scale bar represents 50µm. There was a significant difference in
the number of Myogenin+ cells at 2 days in SmocKO and Smo∆/+ muscles compared to control (p=0.0081
and p=0.0019, respectively). Similarly, there was a significant increase in the number of Myogenin+ cells
at 14 days in SmocKO and Smo∆/+ muscles compared to control (p< 0.0001 and p=0.0150, respectively).
Representative data from three individual mice per time point, where four to six cross-sectional fields
(0.154 mm2) of regenerating muscle per mouse were counted. Boxes represent RQ and whiskers show
minimum and maximum values. Statistical analysis was performed using Student’s t-test.
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Figure 7.9: Regeneration at 21 days post-injury in SmocKO and Smo∆/+ CTX-injured
muscles. CTX-injured TA muscles from control (A-A’), SmocKO (B-B’) and Smo∆/+ (C-C’) mice were
analysed by immunofluorescence to detect MyoD (red). Cell nuclei were counterstained using DAPI (blue)
and muscles fibres were outlined with Laminin alpha 2 (green). Merge images from three channels are
shown for each genotype. Magnified views for merged images are shown (regions indicated by an arrow).
Regenerating muscles at 21 days post-injury exhibit a homogeneous architecture made up of fibres with
centrally located myonuclei and no MyoD expression. On the other hand, SmocKO and Smo∆/+ muscles
had smaller fibres and MyoD-expressing cells were still detectable in SmocKO mice. Representative images
from one individual mouse per phenotype.
7.3 Discussion
7.3.1 The absence of Shh signalling impairs muscle regeneration
in vivo.
In this chapter, I used Pax7CreERT2/+-Smoflox/flox mice to induce deletion of Smo in satellite
cells and investigate muscle regeneration for up to 21 days following CTX injury. I
observed that deletion of Smo in satellite cells leads to impaired muscle regeneration:
1) Satellite-cell specific deletion of one or two Smo alleles leads to reduced fibre size in
7 and 14-day regenerating muscles; 2) The reduced fibre caliber is accompanied by an
increased deposition of collagen type I; 3) An overall delay in the progression through the
myogenic program was observed in SmocKO and Smo∆/+ muscles.
Although previous studies reported that disrupting Shh signalling impairs muscle re-
generation (Renault et al., 2013a,b, Straface et al., 2009), this is the first report of a direct
requirement for Shh signalling in satellite cells. Indeed, previous studies reported that
transfection of injured and dystrophic adult muscles with a plasmid encoding human Shh
improved muscle regeneration in mice (Piccioni et al., 2014a,b). However, the direct effect
of Shh on satellite cells was not assessed and the authors presumed that Shh signalling
was positively affecting both angiogenesis and myogenesis. Loss-of-function approaches
have consisted so far in analysing muscle repair following the systemic administration of
cyclopamine. This resulted in impaired muscle regeneration with low numbers of activated
satellite cells (Straface et al., 2009). In another report using a conditional knockout model
to delete Gli3 in post-mitotic skeletal muscles (using a human α-skeletal actin promoter)
(HSACreERT2; Gli3flox/flox), the authors observed delayed ischemia-induced myogenesis
(Renault et al., 2013b). However, the significance of these observations is unclear as Gli3
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Figure 7.10: Satellite cells remain proliferative at late stages of regeneration in the absence
of Shh signalling. CTX-injured (2, 4, 7 and 14 days post-injury) TA muscles from control, SmocKO
and Smo∆/+ mice were analysed by immunofluorescence to detect the proliferation marker Ki67 (red).
Cell nuclei were counterstained using DAPI (blue) and muscles fibres were outlined with Laminin alpha
2 (green). Merge images from three channels are shown for each genotype at 2, 4, 7 and 14 day-injured
muscles in A’ to L’. Magnified views for merged images are shown (regions indicated by an arrow).
Scale bar represents 50µm. There was a significant difference in the number of Ki67+ cells at 14 days
in SmocKO and Smo∆/+ muscles compared to control muscles (p=0.0166 and p=0.0190, respectively).
Representative data from three individual mice per time point, where four to six cross-sectional fields
(0.154 mm2) of regenerating muscle per mouse were counted. Boxes represent RQ and whiskers show
minimum and maximum values. Statistical analysis was performed using Student’s t-test.
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Figure 7.11: Smo deletion impairs the expansion of activated satellite cells. EDL muscle
fibres from control and SmocKO mice were cultured for 0, 24, 48 and 72h. 0 and 24h-cultured myofi-
bres were immunostained to detect Pax7 and Myf5; 48h-cultured myofibres for Pax7 and MyoD and
72h-cultured fibres for Caveolin-1 and Myogenin. Merged images for 72h-cultures are shown in A and B.
Magnified views for every image are shown in A’ and B’. Scale bar represents 20µm. Quantification of im-
munofluorescence analysis is shown in C. Smo deletion caused a decrease in the number of both Caveolin-
1+/Myogenin- (p=0.0214), Caveolin-1-/Myogenin+ (p=0.05) and Caveolin-1+/Myogenin+ (p=0.0125)
cells at 72h. Representative data from two individual mice are shown, with 14 to 31 individual fibres per
mouse for each time point. Values are mean and SEM. Statistical analysis was performed using Student’s
t-test.
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was in this case removed from myofibres but not satellite cells, and I have shown using
the Tg(GBS-GFP) mice that only satellite cells respond to Shh signalling in myofibre
preparations. Finally, a study using Smo heterozygous mice demonstrated that the loss
of a single copy of Smo altered muscle repair (Renault et al., 2013a). However, in this
study Smo deletion occurred before birth, which, given the role of Shh in embryonic myo-
genesis (Anderson et al., 2009, 2012, Borycki et al., 1999b, Kruger et al., 2001), opens
the possibility that the phenotype observed in adult muscles originates during embryonic
development. Therefore, although these studies reported a general impairment of skeletal
muscle regeneration linked to the disruption of Shh signalling, including increased fibro-
sis, decreased MRF expression and reduction of angiogenesis (Renault et al., 2013a,b,
Straface et al., 2009), a direct requirement for Shh signalling in satellite cells was not
demonstrated. Here, the study of Pax7CreERT2-Smoflox/flox conditional knockout mice al-
lowed me to overcome the requirement of Shh signalling during embryonic myogenesis and
to demonstrate a specific role of Shh signalling in satellite cell-mediated adult myogenesis.
7.3.2 Shh signalling is required for satellite cell progression through
the myogenic program.
Following injury, SmocKO and Smo∆/+ muscles presented showed aberrant progression
through the myogenic program, as fewer MyoD+ and Myogenin+ cells were observed
at 2 days post-injury compared to control muscles. Moreover, sustained expression of
MyoD+ and Myogenin+ cells was observed in SmocKO and Smo∆/+ muscles at 14 days
post-injury, indicating a delay in myogenesis. The MyoD+ and Myogenin+ satellite cells
observed in SmocKO and Smo∆/+ muscles at 14 days post-injury are likely to be cycling,
as shown by the corresponding numbers of Ki67+ cells at that time point. However,
double immunofluorescence analysis with a satellite cell marker is needed to confirm this
possibility. Although I cannot rule out that cell proliferation in SmocKO and Smo∆/+
satellite cells is normal, as no satellite cell marker was used along with Ki67, my analysis
of SmocKO cultured myofibres uncovered a 50% decrease in the number of differentiating
cells at 72h in the absence of Smo, suggesting a defect in satellite cells expansion. These
findings are consistent with the loss-of-function experiments reported in chapter 5 and
with the role of Shh signalling in the control of satellite cell proliferation described in
chapter 6. Shh signalling has been shown previously to control the proliferation of other
adult stem cells, including neural progenitor cells, bulge stem cells, hematopoietic stem
cells and lung progenitor cells (Hsu et al., 2014, Krause et al., 2010, Petrova et al., 2013,
Trowbridge et al., 2006). Although little is known about the mechanisms mediating Shh-
induced proliferation in these adult stem cells, it has been shown that Shh signalling
up-regulates the expression of the G1 regulator cyclin D1 during the proliferation of
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hematopoietic stem cells (Trowbridge et al., 2006). Whether this mechanism is conserved
in other stem cell types has not been demonstrated yet. However, my ex vivo analysis of
satellite cell cell cycle dynamics suggests a delay in G1/S transition in the absence of Shh
signalling, which is consistent with fewer MyoD+ cells observed at 2 days post-injury in
SmocKO mice compared to control mice. Further analysis of the expression of cell cycle
regulators would be needed to confirm this.
7.3.3 Dose-dependent effect of Shh signalling in satellite cell
function
I observed that mice heterozygous for Smo (Smo∆/+) behaved similarly to their homozy-
gous counterpart (SmocKO), suggesting that the removal of a single allele of Smo is suf-
ficient to impair skeletal muscle regeneration. This also suggests that Shh signalling
has a dose-dependent effect on satellite cell activity and cell cycle progression. Such dose-
dependent effect has been described in other systems and thus, may be a conserved feature
of Shh signalling. For instance, Shh signalling is essential for neurogenesis in the subven-
tricular zone of the adult brain, and the generation of olfactory bulb cells is sensitive to
the level of Shh signalling, specifically to activity levels of the Gli3 repressor (Petrova
et al., 2013). The dose-dependent effect of Shh signalling during embryonic development
is also well known. In this case, a gradient of Shh is established along the dorso-ventral
axis of the neural tube so that cells close to the ventral region are exposed to higher con-
centrations of the Shh ligand, which translates into the induction of different transcription
factors in a dose-dependent manner (Chamberlain et al., 2008, Ribes and Briscoe, 2009).
How does this dose-dependent effect impact the transduction of Shh signals? It has been
shown that increasing levels of Shh ligand induce high levels of Smo phosphorylation,
which in turn promotes the accumulation of Smo in the primary cilia and the degree of
pathway activation downstream of Smo (Chen et al., 2011, Jia et al., 2004, Su et al.,
2011). This corresponds to different levels of intracellular signalling driven by changes in
the balance between Gli repressor and Gli activator forms. Thus, high levels of Shh induce
high levels of Smo phosphorylation and blockade of Gli processing into repressor forms to
favour the production of Gli activators (increased ratio of Gli full-length/repressor) (Hui
and Angers, 2011). In contrasts, low levels of Shh results in low Smo phosphorylation
and in little production of both Gli activator and repressor forms. Finally, no Shh leads
to inactivation of Smo and the processing of Gli proteins into repressor forms (decreased
ratio of Gli full-length/repressor) (Hooper, 2003). How are reduced levels of Smo sensed
at the level of gene transcription? if Smo levels decrease, as in the case of Smo∆/+ mice,
the ratio of Gli activator/repressor may be reduced, resulting in the repression of Shh
target genes. It may also be possible that Shh target genes containing high affinity Gli
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binding sites may be activated but those with low affinity may not (Ashe and Briscoe,
2006). Alternatively, the transcription of Shh target genes with multiple Gli binding sites
may not be induced when Smo levels are reduced (Vokes et al., 2007). All these mecha-
nisms may result in aberrant or unbalanced transcriptional activity in Smo∆/+ mice and
hence the phenotypic similarity to SmocKO mice.
7.3.4 The role of Shh signalling in adult muscles differs from its
role in embryonic myogenesis.
Shh signalling is a well-conserved molecular pathway with multiple roles in patterning and
morphogenesis during early vertebrate development (Briscoe and Thérond, 2013, Ingham
and McMahon, 2001). The Shh protein is secreted by the notochord and the zone of
polarising activity of the limb bud and patterns the ventral neural tube, the somite, hind
gut and the limb (Ribes and Briscoe, 2009, Riddle et al., 1993). Thus, mutations of the
Shh gene in the mouse embryo is lethal and leads to several defects in the development of
the anterior central nervous system (cyclopia, forebrain reduction and separation of the
dorsal midline), limb (truncation of limb, lack of digits), somite derivatives (absence of
ribs, sternum, defects on muscle patterning) (Chiang et al., 1996). Smo-/- mutant mouse
embryos have growth retardation and stronger developmental defects compared to Shh-/-
mutants. Also, Smo-/- mice die earlier than Shh-/- and Ihh-/- mice as a result of blocking
the transduction of both ligands (Zhang et al., 2001).
In embryonic myogenesis, Shh signalling controls muscle progenitor cell specification
(through direct control of Myf5 transcription) (Anderson et al., 2012, Borycki et al.,
1999b, Hu et al., 2012), muscle patterning (through its control of Laminin α1 produc-
tion, a component of the myotomal basement membrane) (Anderson et al., 2009), muscle
precursor cell migration (distal limb muscles) (Hu et al., 2012) and proliferation (Towers
et al., 2008). In the adult, Shh signalling controls satellite cell proliferation, affecting the
progression through the myogenic program. Although analysis of cultured myofibres from
SmocKO mice showed a decrease in the number of Pax7+/Myf5+ satellite cells at 24h, it
is unlikely that Shh signalling controls Myf5 transcription in satellite cells, as around 90%
of quiescent satellite cells already express Myf5 (Kuang et al., 2007). It is also possible
that Shh signalling may control satellite cell patterning, as previous work from the lab has
shown that inhibition of Shh signalling in satellite cells cultured ex vivo causes a reduc-
tion in the number of Laminin α1+ satellite cells (Rayagiri, 2014). However, the extent
of this effect needs to be explored further. Likewise, the role of Shh signalling in satellite
cell migration needs to be investigated, as part of satellite cell activation involves their
migration to the site of injury (Siegel et al., 2009). Finally, my study strongly supports
a role of Shh signalling in the control of satellite cell proliferation. This effect was not
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unexpected, since Shh signalling controls the proliferation of muscle progenitor cells in
embryonic limb muscles (Chinnaiya et al., 2014, Towers et al., 2008). Importantly, I used
EDL satellite cells in my experiments, which are derived from limb muscles during em-
bryogenesis. Indeed, it has been shown that satellite cells from different muscles behave
differently, suggesting the existence of satellite cell heterogeneity depending on the muscle
of origin in which they reside. For instance, satellite cells from head muscles have distinct
characteristics than satellite cells from the trunk, including different embryonic origin and
mechanisms of gene expression (Harel et al., 2009, Ono et al., 2010, Sambasivan et al.,
2009). Therefore, it would be interested to see if the control of Shh signalling on the







In this thesis, I investigated the role of Shh signalling in satellite cell-mediated myogenesis.
I hypothesised that Shh signalling controls satellite cell function in mammalian adult
muscles in a manner reminiscent to its effect in muscle progenitor cells in the embryo.
Through a combination of ex vivo and in vivo approaches, I showed that, unlike quiescent
satellite cells, activated satellite cells respond to Shh signalling, as following injury Shh
response occurs in activated satellite cells and persists during the satellite cell expansion
phase before declining when satellite cells enter differentiation. I also demonstrated that
Shh signalling contributes ex vivo and in vivo to muscle regeneration and to satellite cell
proliferation. Further analysis of the effect of Shh on the cell cycle showed that Shh
signalling promotes the entry of satellite cells into the cell cycle and their progression
through S phase. Together, these observations led me to propose a model for the role
of Shh signalling in the control of satellite cell-mediated myogenesis whereby satellite
cell progression through the cell cycle and through myogenesis requires Shh signalling
(Fig.8.1).
8.2 Shh signalling activity is recapitulated during adult
myogenesis
Adult muscle regeneration recapitulates, to a certain extent, the events occurring during
embryonic myogenesis to generate differentiated myofibres in response to exercise, injury
or congenital diseases such as muscular dystrophies. This involves the redeployment of
signalling pathways implicated in embryonic myogenesis for adult myogenesis. Indeed, a
role for FGF, BMP, Notch and Wnt signalling has been reported previously (Chakkalakal
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Figure 8.1: Shh signalling during adult muscle regeneration. Quiescent satellite cells do not
respond to Shh signalling. By contrast, activated satellite cells become responsive to Shh signalling and
this response is required for their progression through the cell cycle and myogenesis. In the absence of
Shh signalling (via pharmacological inhibition or in SmocKO mice), satellite cells progression through the
cell cycle and myogenesis is impaired, resulting in delayed regeneration following muscle injury.
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et al., 2012, Le Grand et al., 2009, Mourikis et al., 2012b, Ono et al., 2011, Yablonka-
Reuveni et al., 1999b). In contrast, Shh signalling has not been investigated in satellite
cell biology. My findings add now Shh signalling to the list of signalling pathways with
dual activity in embryonic and adult myogenesis.
I have demonstrated that quiescent satellite cells do not respond to Shh signals, which
is consistent with previous reports showing absence of Shh activity in healthy skeletal
muscles (Pola et al., 2003, Straface et al., 2009). The absence of Shh activity in resting
skeletal muscles may be linked to the low turnover rate of this tissue. Indeed, in adult
tissues with a high turnover such as the skin, Shh signalling appears to be present and
active: in resting hair follicles (telogen), Gli2 and Gli3 are broadly expressed, and Gli1
and Ptch1 expression is readily detected in resting epithelial cells of the dermal bulge,
which allows for a quick response to Shh signalling during regeneration (Brownell et al.,
2011). Likewise, in the resting adult intestinal tract, Hh-responsive cells (Ptch1+ and
Gli1+) are numerous at the crypts and in the submucosa, indicating an ongoing Shh
response during homeostasis (Kolterud et al., 2009). Therefore, Shh signalling response
may have adapted to fulfil the requirements of adult stem cells with different cell cycle
dynamics, and may explain why Shh signalling is inactive in quiescent satellite cells.
Shh signalling activity appears to be regulated spatio-temporally in adult skeletal mus-
cles, since Shh response in satellite cells is detected as cells become activated following
injury or ex vivo culture. The onset of Shh response may be controlled in different ways,
which are not necessarily mutually exclusive. First, Shh response may be modulated by
the availability of Shh ligands, which can be sequestered by ECM components (Blaess
et al., 2004, Pons et al., 2001). It is possible that the disruption of the ECM that accom-
panies muscle injuries facilitates release of Shh, while the gradual restoration of the muscle
architecture that follows satellite cell differentiation and muscle repair triggers a decline
of Shh response through the capture of Shh ligands into the restored ECM. Second, it is
possible that Shh ligand is synthesised during muscle injury, as suggested by the increase
and decrease in the levels of Shh mRNA in whole muscles in response to injury (Straface
et al., 2009). Although the precise source of the Shh ligand in skeletal muscles remains
unknown, I have shown that neither myofibres nor satellite cells are able to synthesise
Shh mRNA. Biochemical evidence suggests that the Shh protein is able to diffuse at long
ranges in the form of soluble multimeres (Zeng et al., 2001), opening the possibility that
Shh may originate from distant sources such as blood capillaries, lymphatic vessels or
nerves (Brownell et al., 2011, Dierks et al., 2007, Yao et al., 2014). Finally, it has been
shown that follicular dendritic cells in peripheral lymphoid tissue secrete Shh (Sacedón
et al., 2005), opening the possibility that immune cells may deliver Shh proteins following
muscle injury (Sacedón et al., 2005).
My findings demonstrate that Shh response in satellite cells is required for their entry
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into the cell cycle and that this response persists during the expansion phase (48h ex vivo
and 2 days post-injury in vivo). Importantly, Shh response is gradually lost over time,
especially in self-renewing satellite cells and terminally differentiated cells. This down-
regulation of Shh signalling response may be related to the availability of the ligand, to the
specific down-regulation of components of the Shh response pathway or to the negative
regulators of the pathway such as Gli3 and Hip, as well as to the negative feedback exerted
by increased Ptch1 expression. Dampening of Shh signalling activity in satellite cells may
be important for signal relay and to prime satellite cells to respond to other signalling
molecules. For instance, mesenchymal cells in the developing limb bud are primed by Shh
signalling to create a gradient of BMP activity that determines digit identity (Dahn and
Fallon, 2000, Drossopoulou et al., 2000). In skeletal muscles, BMP signalling has been
proposed to control the balance between proliferation and differentiation of satellite cells
(Ono et al., 2011). Therefore, it may be possible that Shh signalling acts synergistically
with BMP signalling to control satellite cell function. However, further experiments would
be needed to identify the signalling pathways acting up and downstream of Shh signalling
in satellite cells.
8.3 Control of cell cycle progression by Shh signalling
The results presented in this thesis identified two different phases at which Shh signalling
regulates satellite cell cell cycle dynamics. First, I have shown that Shh signalling con-
trols the initial progression of satellite cells into the cell cycle, specifically through the
G1/S transition. Second, Shh signalling controls satellite cell exit from the cell cycle,
affecting the overall number of cells going into terminal differentiation or quiescence. The
mechanisms by which Shh signalling induces a mitogenic response in other tissues are
diverse, and can involve the direct control of cell cycle regulators or the modulation of
signalling pathways known to control cell proliferation. For instance, Shh signalling pro-
motes progression through G1/S by regulating N-myc, CyclinE1, CyclinD1, Dp1 and
E2f1 in the zebrafish retina, chick wing bud, mouse epidermis, mouse cerebellar granular
neural precursors (CGNPs) and mouse external genitalia (Kenney et al., 2004, Mill et al.,
2003, Oliver et al., 2003, Seifert et al., 2010, Towers et al., 2008, Wall et al., 2009). Other
mechanisms of cell cycle regulation by Shh signalling include blockade of p21-mediated
growth arrest (Fan and Khavari, 1999) and the sequestration of Cyclin B1 by Ptch1,
which acts as a tumour suppressor of basal cell carcinoma (BBC) to repress the G2/M
transition (Barnes et al., 2001). Finally, Hh signalling can promote cell cycle exit through
the control of the cyclin kinase inhibitors p57 and p27 in the vertebrate retina (Masai
et al., 2005, Shkumatava and Neumann, 2005). These different cell cycle regulators are
attractive candidate targets of Shh signalling in our system and additional experiments
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to identify such targets are under way.
On the other hand, Shh sigalling may stimulate cell proliferation through the activa-
tion of mitogenic molecules such as receptor tyrosine kinase (RTK)-mediated signalling
pathways. For instance, Shh signalling acts synergistically with PI3K/Akt and mTOR
signalling to induce proliferation of CGNPs in the cerebellum (Kenney et al., 2004, Main-
waring and Kenney, 2011). Shh signalling also stimulates the activity of the p38 MAPK
signalling to control astrocyte proliferation (Atkinson et al., 2009). This is interesting as
Shh signalling can promote myoblast proliferation through PI3K/Akt and ERK1/2 sig-
nalling (Elia et al., 2007, Madhala-Levy et al., 2012). Also, Shh signalling can stimulate
proliferation of mouse embryonic stem (ES) cells by activating the Ca2+/PKC pathway,
which in turn transactivates the epidermal growth factor receptor (EGFR) pathway (Heo
et al., 2007). In skeletal muscles, growth factors such as FGF and IGF-1 activate the
PI3K/Akt and ERK1/2 signalling and cyclin D/Cdk2, 4 and 6 complexes to stimulate
proliferation while restricting differentiation (Guo et al., 1999, Yablonka-Reuveni et al.,
1999b). This promotes the regulation of other cyclins to allow cell cycle progression.
Eventually, down-regulation of ERK1/2 signalling activity leads to the inhibition of cell
proliferation (Knight and Kothary, 2011). Therefore, modulation of RTK-mediated sig-
nalling pathways by Shh signalling is a highly plausible strategy to regulate cell cycle
progression in satellite cells.
Not only Shh signalling blockade in satellite cells delays their progression through
the cell cycle, but it also affects how satellite cells progress through the myogenic pro-
gram. These observations raise the possibility that Shh signalling may affect myogenic
differentiation by controlling the orientation of cell division in satellite cells. Consistent
with this idea, inhibition of Shh signalling in postnatal CGNPs causes an increase in the
proportion of symmetric cell divisions, indicating that Shh signalling normally stimulates
CGNP asymmetric division (Haldipur et al., 2015). Conversely, constitutive activation of
Shh signalling in neural stem cell of the subependymal zone results in an increase in the
number of symmetric cell divisions (Ferent et al., 2014). This suggests that Shh signalling
can regulate both symmetric and asymmetric cell divisions. Therefore, it remains possible
that Shh controls the fate of satellite cells (differentiation) via its control of cell division
orientation.
Finally, a whole body of evidence from cancer models has demonstrated that activating
mutations of Shh signalling components lead to cancer formation. For instance, Gorlin
syndrome is a rare autosomal-dominant inherited disease characterised by an increased
incidence of tumours like BBCs, medulloblastomas and embryonic rhabdomyosarcomas
(eRMS), a tumour of skeletal muscles (Scotting et al., 2005). Heterozygous loss-of-function
mutation in PTCH accounts for the occurrence of this syndrome, as well as SUFU muta-
tions and over-expression of GLI1 (Hahn et al., 1996, Johnson et al., 1996, Tostar et al.,
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2006). Although some evidence suggests that eRMS are not generated by Shh signalling
overactivation in satellite cells, eRMS tumours up-regulate both myogenic and Shh sig-
nalling genes (Rajurkar et al., 2013). Moreover, it has recently been demonstrated that
Shh signalling is required for self-renewal and tumorigenicity of eRMS (Satheesha et al.,
2015), which is in line with the role of Shh signalling in the control of satellite cell prolif-
eration. Therefore, understanding the function of Shh signalling in satellite cell cell cycle
dynamics is also relevant to therapeutically target eRMS.
8.4 A requirement of Shh signalling in adult skeletal
muscles
To investigate the role of Shh signalling in adult skeletal muscles in vivo, I used tamoxifen-
induced conditional knockout mice to delete Smo expression specifically in Pax7+ satellite
cells (SmocKO). Following cardiotoxin-mediated muscle injury, Shh signalling inactivation
in satellite cells resulted in impaired muscle regeneration, with reduced fibre size, in-
creased collagen deposition and delay in the progression through the myogenic program.
Although previous studies have reported that disrupting Shh signalling impairs muscle
regeneration (Renault et al., 2013a,b, Straface et al., 2009), this is the first evidence of a
direct requirement for Shh signalling in satellite cell-mediated muscle regeneration.
Smo gene inactivation in satellite cells led to an aberrant progression through the
myogenic program and an overall reduction in the number of satellite cells, which results
in reduced myogenic fusion and insufficient myonuclei contribution to new myofibres.
SmocKO injured muscles do not recover even after 21 days-post injury, indicating a dras-
tic failure in the repair process. Interestingly, I observed that MyoD+ satellite cells are
still present in regenerating muscles of SmocKO mice. How is it possible that even in the
presence of activated satellite cells muscle repair does not occur? Failure to successfully
repair muscle damage leads to the alteration of the architecture and an increased prolif-
eration of fibroblasts, which can impair the myogenic process (Mann et al., 2011). It may
be possible that once fibrosis occurs, regeneration cannot take place. Indeed, following
muscle injury, fibroblasts proliferate in close association with satellite cell so that both
populations peak at 5 days post-injury and gradually decrease from day 7 post-injury
(Murphy et al., 2011). Therefore, satellite cells face a race against time, where the precise
timing of their activity may overcome the deleterious effects of fibroblasts. Consistent
with this, conditional ablation of Pax7+ satellite cells in BaCl2-injured muscles causes a
complete loss of muscle regeneration, which is accompanied by a dramatic increased in
fibrosis (Murphy et al., 2011). My results indicate that impaired satellite cell-mediated
myogenesis in SmocKO mice favours fibroblast activity, which leads to over-deposition of
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collagen between regenerating fibres.
8.5 Shh signalling and implications in muscular dis-
eases and therapies
Loss of muscle mass and fibrosis are common features of muscular disorders including age-
related sarcopenia and muscular dystrophies. This is also accompanied by a progressive
reduction of satellite cell numbers, which affects the regenerative potential of skeletal
muscles (Boldrin et al., 2009, Chakkalakal et al., 2012, Liu et al., 2013). Shh signalling
response has been shown to be reduced in aged and dystrophic mice, and thus may
contribute to the loss of regenerative capacity of older skeletal muscles (Piccioni et al.,
2014a,b). Cell and gene therapy are two of the most promising tools for the treatment
of muscle disorders. In the case of gene therapy, injection of a plasmid encoding human
Shh into normal, dystrophic and aged mouse muscles has been shown to improve muscle
regeneration following injury, including reduction of fibrosis and increase in the number
of regenerating myofibres (Palladino et al., 2011, Piccioni et al., 2014a,b). These effects
are quite robust and are likely to involve both a systemic mechanism on angiogenesis and
a direct stimulation of myogenesis.
The treatment of degenerated muscles may involve also cellular therapies and previous
attempts have made use of non-myogenic as well as myogenic cells. Non-myogenic cells
such as bone marrow-derived cells (hematopoietic and mesenchymal stem cells) (Dezawa
et al., 2005, Torrente et al., 2004), mesoangioblasts (Sampaolesi et al., 2006, 2003), embry-
onic stem (ES) cells (Albini et al., 2013, Darabi et al., 2008, Salani et al., 2012, Shelton
et al., 2014) and induced pluripotent stem (iPS) cells (Li et al., 2015, Tedesco et al.,
2012) have been harnessed towards the myogenic lineage for therapeutical purposes. For
instance, iPS cells from limb-girdle muscular dystrophy type 2D (LGMD2D) patients have
been generated, differentiated into mesoangioblast-like cells and genetically corrected to
express α-sarcoglycan protein. Injection of these cells into LGMD2D mice has restored
α-sarcoglycan expression and functionally improved the dystrophic phenotype (Tedesco
et al., 2012). Similar approaches have been used to treat Duchenne muscular dystrophy
(DMD) (Darabi et al., 2012, Filareto et al., 2013, Kazuki et al., 2010). Strategies to
treat muscle disorders using muscle cells include the transplantation of intact myofibres
and satellite cells expanded in vitro (Hall et al., 2010, Marg et al., 2014). Unfortunately,
several challenges arise with the use of both non-myogenic and myogenic cells for trans-
plantation. First, large quantities of cells with high purity are needed and in the case of
satellite cells, it has been shown that their expansion in vitro decreases their regenerative
capacity, compromising their clinical application (Montarras et al., 2005). Second, the
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maintenance of stemness (self-renewal potential) is required, so that transplanted cells can
contribute to several cycles of regeneration (Sacco et al., 2008). Third, most of the proto-
cols to generate muscle cells involve the ectopic expression of myogenic regulatory factors
of genetic correction, which requires immortalization or extensive cell expansion (Ouster-
out et al., 2013). Finally, the delivery of transplanted cells has mainly been achieved by
direct injection into recipient muscles and this represents a major barrier for the treatment
of muscle disorders. How can all these challenges be overcome? The ideal system would
use a source of cells that allow easy purification, amplification and the derivation to myo-
genic cells without introduction of genes. Specifically, new strategies to maintain myogenic
cells in vitro using specific signalling molecules to recreate their natural microenviroment
along with systemic delivery methods are highly desirable (Cosgrove et al., 2009). Indeed,
the manipulation of intrinsic and extrinsic signalling factors in satellite cells are currently
being undertaken, which has improved their expansion in vitro (Charville et al., 2015, Fu
et al., 2015). The data presented in this thesis support a role of Shh signalling in the
control of satellite cell myogenesis and cell cycle progression, which might contribute to
improve the in vitro expansion of satellite cells for clinical applications.
8.6 Future directions
The data presented in this thesis report a role for Shh signalling in the control of satellite
cell cell cycle progression and its requirement during skeletal muscle regeneration. Fur-
ther work is required and is underway to determine the molecular mechanism by which
Shh controls cell cycle progression in satellite cells. Smo-deficient mouse satellite cells
Pax7CreERT2/+; Smoflox/flox; Rosa26-YFP are being isolated by FACS at 4 days following
muscle injury in order to carry out a genome-wide RNA-seq analysis to identify target
genes under the control of Shh signalling. Another question that we need to address is
whether Shh signalling affects satellite self-renewal. This may be achieved by monitor-
ing symmetric and asymmetric cell divisions in SmocKO or GANT61-treated wild type
myofibres, and combine this to repeated injuries in SmocKO mice. Finally, it would be
interesting to examine the effects of constitutive activation of Shh signalling in satellite
cells in vivo to complement the gain-of-function experiments described in chapter 4. This
could be achieved by either using a conditional activated allele of Smo (SmoA2) or a
conditional loss of function allele of Ptch1 (Ptch1flox/flox) and Pax7CreERT2 mice (Halla-
han et al., 2004). One prediction would be that constitutive activation of Shh signalling
results in an increase in the number of activated satellite cells. Finally, the identity of
non-muscle cells responding to Shh signalling during muscle regeneration in vivo should
be determined in order to see the requirement of Shh signalling in non-myogenic cells
using the Cre-Lox technology. Finally, it would be interesting to include Shh in protocols
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to drive mesenchymal stem cells into the myogenic lineage and explore its effects on their
expansion in vitro.
8.7 Final remarks
The role of Shh signalling in adult skeletal muscles was until recently poorly understood,
with contradicting evidence supporting cell proliferation and differentiation of satellite
cells. However, the exogenous administration of a plasmid encoding Shh into injured
and dystrophic muscles was known to enhance muscle repair (Piccioni et al., 2014a,b).
The present study demonstrates that Shh signalling is required for adult skeletal muscle
regeneration and provides novel insights into the role of Shh signalling in the control of
satellite cell progression through the cell cycle and through myogenesis. Understanding
how Shh signalling affects satellite behaviour is important for skeletal muscle biology
and add to our knowledge of Shh function in other adult stem cell systems, including
neural, hair follicle, crypt and lung stem cells (Petrova and Joyner, 2014). Finally, the
requirement of Shh signalling in satellite cells provides a novel framework for designing
approaches to drive expansion of satellite cells or generate myogenic progenitor cells from
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Lauth, M., Bergström, Å., Shimokawa, T., and Toftg̊ard, R. (2007). Inhibition of GLI-mediated tran-
scription and tumor cell growth by small-molecule antagonists. Proceedings of the National Academy
of Sciences, 104(20):8455–8460.
Le Grand, F., Grifone, R., Mourikis, P., Houbron, C., Gigaud, C., Pujol, J., Maillet, M., Pagès, G.,
Rudnicki, M., Tajbakhsh, S., et al. (2012). Six1 regulates stem cell repair potential and self-renewal
during skeletal muscle regeneration. The Journal of Cell Biology, 198(5):815–832.
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